Biophysical Investigation of the 'Ironome' of Jurkat Cells and Saccharomyces cerevisiae by Jhurry, Nema
BIOPHYSICAL INVESTIGATION OF THE ‘IRONOME’ OF JURKAT CELLS 
AND SACCHAROMYCES CEREVISIAE   
 
A Dissertation 
by 
NEMA DEVI JHURRY  
 
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
Chair of Committee,  Paul A. Lindahl  
Committee Members, David P. Barondeau 
 Michael Polymenis 
 Gregory Reinhart 
Head of Department, Gregory Reinhart 
 
 
December 2013 
 
Major Subject: Biochemistry 
 
Copyright 2013 Nema Devi Jhurry
  ii 
ABSTRACT 
 
The speciation of iron in intact Jurkat cells and their isolated mitochondria was 
assessed using biophysical methods.  [Fe4S4]2+ clusters, low-spin (LS) FeII heme centers, 
non-heme high-spin (NHHS) FeII species, ferritin-like material and FeIII oxyhydroxide 
nanoparticles were detected, via Mössbauer,  in intact Jurkat cells and their isolated 
mitochondria.  EPR spectroscopy was used to quantify Fe-containing species in the 
respiratory complexes.  Contributions from heme a, b and c centers were quantified 
using electronic absorption spectroscopy.  Results were collectively assessed to estimate 
the first “ironome” profile of a human cell. 
The Fe content of Jurkat cells grown on transferrin-bound iron (TBI) and FeIII 
citrate (FC), and of isolated mitochondria therefrom, was characterized.  On average, 
only 400 ± 100 Fe’s loaded per ferritin complex, regardless of the medium Fe 
concentration. The extent of nanoparticle formation scaled nonlinearly with the 
concentration of FC in the medium. Nanoparticle formation was not strongly correlated 
with ROS damage. Cells could utilize nanoparticles Fe, converting them into essential 
Fe forms. Cells grown on galactose rather than glucose respired faster, grew slower, 
exhibited more ROS damage, and generally contained more nanoparticles. Cells grown 
with TBI rather than FC contained lower Fe concentrations, more ferritin and fewer 
nanoparticles. Frataxin-deficient cells contained more nanoparticles than comparable 
WT cells. Data were analyzed by a chemically-based mathematical model.    
  iii 
Fermenting Saccharomyces cerevisiae cells grown with varying [Fe] were also 
studied. The high-affinity Fe import pathway was active only in Fe-deficient cells. 
Whether Fe-deficient cells were grown under fermenting or respirofermenting conditions 
had no effect on Fe content; such cells prioritized their use of Fe to essential forms 
devoid of nanoparticles and vacuolar Fe. Fermenting cells grown on Fe-sufficient and 
Fe-overloaded medium contained 400 – 450 µM Fe. In these cells the concentration of 
nonmitochondrial NHHS FeII declined 3-fold, relative to in Fe-deficient cells, whereas 
the concentration of vacuolar NHHS FeIII increased to a limiting cellular concentration of 
~ 300 µM. Isolated mitochondria contained more NHHS FeII ions and substantial 
amounts of FeIII nanoparticles. The Fe contents of cells grown with excessive Fe in the 
medium were similar over a 250-fold change of nutrient Fe levels.  
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CHAPTER I 
 INTRODUCTION 
 Iron is an essential transition metal for cellular function and viability of almost all 
organisms.  Iron can assume multiple oxidation states, which makes it ideal for electron 
transfer processes, and for binding various biological ligands 1.  The most common 
biological oxidation states of iron are the divalent and trivalent iron (Fe2+ and Fe3+), 
although the tetravalent Fe4+ and the pentavalent Fe5+ also occur transiently during 
certain iron-catalyzed redox reactions 1.  
Iron participates in cellular functions as various cofactors to proteins and 
enzymes, most commonly in the form of iron-sulfur (Fe/S) clusters and hemes.  Heme 
iron is essential for numerous biological functions such as oxygen binding and transport 
(e.g. myoglobin and hemoglobin) 2, inactivation of reactive oxygen species (e.g. 
catalases and peroxidases) 3, 4, mitochondrial respiration (Complexes II, III and IV, and 
cytochromes, and Complex I in most organisms) 5-8 .  Fe/S clusters are essential 
prosthetic groups for a number of proteins involved in processes such as glucose 
metabolism (mitochondrial aconitase) 9.  Other types of iron-containing centers exist, 
such as the di-nuclear iron center of ribonucleotide reductase 10, and these are also 
important for cellular function.  In mammalian cells, excess iron is normally stored in 
ferritin as a crystalline ferric oxyhydroxide core 11.  Iron deficiency can be detrimental to 
cells, leading to cell growth inhibition, and eventually cell death.  However, iron 
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overload can be harmful as well. Iron overload in cells can lead to an increase in ferrous 
iron, which can participate in Fenton chemistry, resulting in the formation of hydroxyl 
radicals from hydrogen peroxide, according to the following equation 12: 
  Fe2+  +  H2O2    Fe3+  +   HO  +  HO- 
Furthermore, ferrous iron can reduce molecular oxygen to generate superoxide 
anions according to the following reaction: 
  Fe2+  +  O2           Fe3+   +    O-2 
Hydroxyl radicals and superoxide anions are highly damaging to lipids, proteins 
and nuclei acids 13.  Therefore, the iron status of the cell is tightly controlled via 
regulation of the expression of proteins involved in iron uptake, efflux, storage, and 
utilization. 
Iron uptake in the majority of mammalian cell types is mediated via the 
transferrin pathway 14.  Transferrin (Tf) is an 80 kD soluble blood-plasma glycoprotein. 
At physiological pH, it binds two ferric ions per molecule with high affinity (Kd~ 10-23 
M) 14.  However, transferrin is normally only ~30% saturated with iron under 
physiological conditions. The plasma concentration of diferric transferrin is ~ 5-20 µM 
(i.e. ~ 10-40 µM transferrin-bound iron, TBI) 1, 15, 16.  The abundance of apo-transferrin 
in blood plasma provides a buffering effect, whereby sufficient apo-transferrin is 
available to bind free iron in the event of an increase in plasma iron concentration.  This 
prevents the build-up, in blood plasma, of non-transferrin-bound iron (NTBI), which has 
been implicated in cellular iron overload and oxidative damage 17.  
 3 
Diferric transferrin binds to transferrin receptors 1 and 2 (TfR1 and TfR2) 18 
located at the cell membrane, which triggers clathrin-mediated endocytosis of the Tf-
TfR complex.  TfR1, a transmembrane glycoprotein, forms a homodimer of 180 kD.  
This protein is the major transferrin-receptor utilized by most cells for TBI uptake 19, 
whereas select cell types, such as liver cells, also express TfR2 20.  Each receptor can 
bind up to two diferric transferrin molecules.  The endosome containing the transferrin-
receptor complex is subsequently acidified via uptake of H+ through a v-ATPase proton 
pump located on the endosomal membrane.  Endosomal acidification decreases the 
affinity of transferrin for ferric iron, and causes the release of Fe3+ from the transferrin 
molecules 21.  A ferrireductase (STEAP3) located on the endosomal membrane reduces 
Fe3+ to Fe2+, which is then exported from the endosome via the membrane-bound 
divalent metal transporter 1, called DMT1 22 .  Fe2+ exits into the cytosol and presumably 
becomes part of the cytosolic labile iron pool.  Iron in this pool can be trafficked to 
various destinations for use, storage, or efflux (in certain cell types) 23.  The endosome 
containing the apo-transferrin-TfR1 complex is cycled back to the cell membrane, 
releasing the apo-transferrin into the blood plasma to bind more iron, and making 
available the transferrin receptors at the cell membrane to bind more diferric transferrin 
(Figure 1-1) 24.  
Iron uptake can also occur through a transferrin-independent pathway, which 
involves the uptake of non-transferrin-bound iron (NTBI) 25.  Plasma concentrations of 
NTBI are generally < 1 µM under normal physiological conditions but increases 
drastically in a variety of iron overload diseases, such as hereditary hemochromatosis 
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and β-thalassemia 26, 27.  The uptake mechanisms of NTBI are not fully understood, but a 
number of transport proteins, such as L-type voltage gated calcium channels 28, DMT1 
(divalent metal transporter 1) 29, and Zip14 (a zinc transporter protein) 30 have been 
found to facilitate NTBI uptake.  The chemical nature of NTBI is also not well 
characterized, but ferric citrate is hypothesized to be the major form of NTBI in the 
blood plasma.  Other iron-binding proteins and iron-containing species, such as lipocalin 
24p3 31, serum ferritin 32 and hemes 33, are also possible sources of NTBI that can be 
taken up by cells.  The uptake of NTBI may involve a plasma-membrane bound 
ferrireductase, such as the duodenal cytochrome b561 (DCytb) 34 (Figure 1-2).  This 
enzyme reduces Fe3+ to Fe2+ before uptake of ferrous iron via a plasma-membrane bound 
divalent metal transporter such as DMT1.  Recent evidence also suggests that 
extracellular Fe3+ can be reduced by ascorbate 35, independent of a ferrireductase.  NTBI 
may also penetrate cells non-specifically via fluid-phase endocytosis or pinocytosis 36. 
Iron taken up by mammalian cells presumably enters the cytosol’s labile iron pool (LIP), 
which is described as a pool of iron, both Fe2+ and Fe3+, bound weakly to low- 
molecular-weight (LMW) ligands.  This pool represents a small percentage of the total 
cellular iron (3-5%) 37.  The LIP is also known as the chelatable iron pool in some 
literature due to being loosely bound to biological ligands and hence being easily 
chelated.  In addition to being fed with iron via the transferrin pathway, the LIP can also 
be replenished as a result of degradation of iron-containing proteins. This process occurs 
primarily in the lysosomes 38. 
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Figure 1-1. Model of the transferrin-dependent iron uptake pathway, and the proposed 
fate of iron that exits the endosome.  
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Figure 1-2. Model of the transferrin-independent iron uptake pathway, and the proposed 
fate of iron that enters the cell as NTBI.  
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The chemical composition of the cytosolic LIP is not well understood, but the 
iron is hypothesized to bind LMW organic chelates such as phosphates, citrates, and 
carboxylates, and ligands such as polypeptides and siderophores 39.  The LIP, being 
weakly chelated and hence more readily available for redox reactions, is often implicated 
in the formation of reactive oxygen species (ROS) via Fenton chemistry.  The cytosolic 
LIP is hypothesized to be the major iron feedstock for iron trafficking to other parts of 
the cell, namely to the mitochondria, and to ferritin for storage when present in excess.  
Mitochondria are the ‘hub’ of cellular iron metabolism, since the majority of iron 
taken up by the cell is trafficked to mitochondria for Fe/S cluster and heme biosynthesis 
40.  The pathway of iron trafficking from the cytosolic LIP to mitochondria is not well 
characterized.  However, the mammalian siderophore 2,5-dihydroxybenzoic acid was 
recently found to be the iron-binding moiety of lipocalin 24p3, and was implicated as the 
major siderophore that binds cytosolic labile iron and aids in its trafficking to 
mitochondria for metabolism 31.  Mitoferrin-1 (Mfrn1) and Mitoferrin-2 (Mfrn2) are the 
only two iron importers that are known to facilitate iron uptake through the inner 
mitochondrial membrane 41, 42.  In developing erythroid cells, Mfrn1 is stabilized by 
ABCB10, a member of the ATP-binding cassette transporter 43.  In spite of being highly 
homologous, Mfrn1 and Mfrn2 are not functionally redundant, since mitochondrial iron 
depletion due to knockdown of Mfrn 1 cannot be corrected by ectopic over-expression of 
Mfrn2 42.   
Apart from Mfrn1 and Mfrn2, other pathways of iron import into mitochondria, 
although not fully characterized, presumably exist.  For example, siderophore-bound 
 8 
iron uptake supports mitochondrial heme biosynthesis, but a mitochondrial siderophore-
iron transporter has yet to be identified 44.  Another model for iron delivery to 
mitochondria, termed the “kiss-and-run” model, was derived mainly from imaging data 
and postulates that endosomes containing transferrin-bound iron deliver iron by direct 
contact with mitochondria, although the mediators of this process are yet to be identified 
45.  
Mitochondrial iron is utilized for heme and Fe/S cluster biosynthesis, and excess 
mitochondrial iron is stored in mitochondrial ferritin (mitoferritin, MtFt) 46.  Fe/S 
clusters are composed of iron and inorganic sulfur and are involved in processes such as 
electron transport in the respiratory chain complexes, regulatory sensing of iron, and 
DNA repair 47.  The most common types of Fe/S clusters in mammalian cells are the 
[Fe2S2], [Fe3S4], and [Fe4S4] clusters.  In mammalian cells, Fe/S cluster biogenesis 
occurs in mitochondria, as well as in the cytosol, and probably also in the nucleus 48.   
The first step of Fe/S biogenesis is catalyzed by the multimeric protein complex 
formed by a dimer of cysteine desulfurase (NFS1) and two monomers of a scaffold 
protein (ISCU) at either end 49.  Using a pyridoxal phosphate cofactor, NFS1 functions 
by removing sulfur from cysteine residues and supplying it to the Fe/S biogenesis 
process 50.  ISCU provides the scaffold and the cysteine ligands upon which biosynthesis 
of a new Fe/S cluster occurs.  Fe/S clusters consist of iron covalently bound to the 
cysteine ligands, and inorganic sulfur bridging the iron atoms 51.   
The source of iron for Fe/S cluster biogenesis is still being debated, although 
existing evidence indicate that frataxin 52, or a complex of glutathione and glutaredoxin 
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binding an Fe/S cluster, might be potential iron donors 53.  The role of frataxin is still not 
elucidated, since reports involving structural modeling of frataxin binding to NFS1 and 
ISCU suggest that frataxin might be acting as an allosteric switch for Fe/S cluster 
biosynthesis, rather than an iron donor 54.  Frataxin’s newfound role appears to be to 
bring about conformational change in the NFS1-ISCU complex to enhance Fe/S cluster 
synthesis.  In mammalian cells, NFS1 is stabilized by a small partner protein called 
ISD11 55.  The latter has been detected in the mitochondrial matrix, the cytosol, and the 
nuclei of mammalian cells.  Fe/S biogenesis also requires a source of electrons, which 
are hypothesized to be delivered into Fe/S biogenesis via glutaredoxin 5 (GLRX5) 56 and 
ferredoxin 57.  After an Fe/S cluster is synthesized on the NFS1-ISCU-ISD11-Frataxin 
complex, it needs to be transferred to apo-proteins that require Fe/S clusters for their 
function.  Many aspects of this process still need to be elucidated.  However, current 
evidence suggests the participation of a highly conserved chaperone-co-chaperone 
system, which, in mammalian cells, involves binding of the mammalian co-chaperone 
HSC20 (heat shock protein) to ISCU 58.  The HSC20-ISCU complex, potentially aided 
by HSC70, may facilitate the transfer of an Fe/S cluster from ISCU to target apo-
proteins 59.  The exact mechanism of selective insertion of Fe/S clusters into target 
proteins is not known, but is hypothesized to involve interactions between the target 
apoproteins and the binding surfaces of the chaperone-co-chaperone complex.   
For many years, Fe/S cluster biogenesis was thought to occur primarily in 
mitochondria.  In the Saccharomyces cerevisiae model, the mitochondrial exporter 
protein Atm1 was proposed to export either fully formed Fe/S clusters or some form of 
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sulfur compound for cytosolic Fe/S biogenesis 50.  However, this model has been called 
into question, as new evidence, albeit controversial, suggests that Fe/S biogenesis 
systems can be sustained in the cytosol and even in nuclear compartments, 
independently of the mitochondria.  The cysteine desulfurase, NFS1, its binding partner 
ISD11, the scaffold proteins ISCU and NFU1, as well as the co-chaperone HSC20, are 
reported to be expressed in small amounts in the cytosolic and/or nuclear compartments 
60.  Disruptions in mitochondrial Fe/S biogenesis have been repeatedly associated with 
mitochondrial iron overload and cytosolic iron depletion in mammalian cells. 
Mitochondrial iron is also utilized for heme biosynthesis, a pathway that is 
significantly better characterized than the Fe/S biosynthesis pathway.  Hemes are 
structurally defined as tetrapyrroles with an iron atom coordinated within, which imparts 
hemes with the ability to act as electron carrier and a catalyst for redox reactions 61.  The 
first step, which is also the rate-limiting step, in the heme biosynthesis pathway is 
catalyzed by an enzyme called ALA synthase. This enzyme carries out the condensation 
reaction between glycine and succinyl-CoA to form 5-aminolevulinic acid (ALA) 62.  
ALA then exits the mitochondria via an unknown mitochondrial transporter, and 
subsequent steps of heme biosynthesis occur in the cytosol.  The cytosolic enzyme 
aminolevulinate dehydratase (ALAD) catalyzes the condensation of two molecules of 
ALA into the monopyrrole porphobilinogen 63.  The formation of a tetrapyrrole of 
porphobilinogen, an unstable molecule called hydroxymethylbilane (HMB), is then 
catalyzed by porphobilinogen deaminase (PBGD) 64.  HMB subsequently serves as the 
substrate for the enzyme uroporphyrinogen III synthase (URO3S), which converts HMB 
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to uroporphyrinogen III (URO’GEN III), resulting in the closure of the tetrapyrrole 65.  
URO’GEN III is then converted to coproporphyrinogen III (COPRO’GEN III) by the 
enzyme uroporphyrinogen decarboxylase (UROD), which catalyzes the removal of the 
carboxyl groups of the acetic acid side chains 66.  Sequential decarboxylation of the 
propionate groups of pyrrole rings A and B of COPRO’GEN III to vinyl groups by the 
enzyme coproporphyrinogen oxidase (CPO) follows, giving rise to protoporphyrinogen 
IX (PROTO’GEN IX) 67. This process takes place in the intermembrane space of the 
mitochondria.  The enzyme protoporphyrinogen oxidase (PPO) then oxidizes 
PROTO’GEN IX to protoporphyrin IX 68.  The final step in heme biosynthesis involves 
the insertion of iron into protoporphyrin IX by the enzyme ferrochelatase, and occurs on 
the inner surface of the inner mitochondrial membrane 69. 
Excess iron that is not utilized for Fe/S cluster or heme biosynthesis is stored in the 
cytosolic iron storage protein ferritin.  In some cell types, iron can also be exported 
through the membrane-bound iron exporter, ferroportin 70.  Mammalian cytosolic ferritin 
is composed of a protein shell made of two functionally and genetically distinct subunit 
types: H-chain (heavy chain, ~ 21 kD) and L-chain (light chain, ~ 19 kD).  These 
subunits assemble in varying ratios depending on the cell type 11.  Mitochondrial ferritin, 
on the other hand, consists of 100% H-subunits, irrespective of cell type 46.  
The dinuclear iron catalytic center, where the oxidation of FeII to FeIII takes place 
in the presence of molecular oxygen or hydrogen peroxide, is present on the H-subunit.  
The L-subunit is believed to enhance the nucleation of the iron core, hence the more L-
subunits present in ferritin, the greater its ability to store iron 71.  The H/L subunit ratio 
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varies according to tissue type. For example, up to 70% H-subunits may be present in 
ferritins of tissues such as the heart and the brain, which exhibit high ferroxidase 
activity, whereas ferritins in tissues involved mainly in iron storage, such as the liver and 
the spleen, exhibit up to 90% L-subunits 11.  Mitochondrial ferritin, unlike cytosolic 
ferritin, consists only of H-subunits 72. Mammalian cytosolic ferritins can store up to 
4500 iron atoms in their core in the form of a crystalline mineral ferrihydrite 73.   
The mechanisms of iron oxidation and mineralization in ferritins have been studied 
for more than 30 years.  The prevalently accepted mechanism involves binding of FeII at 
the H-subunit catalytic sites, oxidation to FeIII, and displacement of the ferric ions into 
the protein cavity, leading to the formation of a stable nucleation point for formation of 
mineral ferrihydrite 74.  Recently, poly(rC) binding protein, PCBP1 was discovered to act 
as an iron-chaperone, aiding the delivery of cytosolic iron to ferritin 75.   
Mammalian ferritin can also act as a source of iron during iron depletion of the 
cell.  The mechanism of iron release from ferritin is not well understood, although 
certain processes, such as ferritin proteolysis in lysosomes, or reductive release of iron 
from the ferritin core, have been proposed 76.  Incomplete degradation of ferritin in 
lysosomes is believed to lead to the formation of hemosiderin 77.  
Many of the proteins involved in cellular iron homeostasis (import, sequestration, 
utilization and export) are themselves regulated by the cellular iron concentration.  The 
mRNAs of these proteins contain an iron-responsive element (IRE) in either their 5’ or 
their 3’-untranslated region (5’-UTR or 3’-UTR) 78.  IREs are heterogenous sequences of 
28-30 nucleotides that form stem-loop structures that can be recognized by the iron-
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regulatory proteins (IRPs).  Iron-regulatory proteins 1 and 2 (IRP1 and IRP2) are highly 
homologous proteins that possess ~64% sequence identity in human cells 79.  They bind 
to the IREs of transcripts to regulate protein translation in response to the iron status of 
the cell.  IRP1 is a [Fe4S4]-binding protein that acts as cytosolic aconitase when iron is 
abundant, but loses its Fe/S cluster and functions as iron-regulatory protein when iron is 
scarce 80.  Recent evidence suggests, however, that iron deficiency alone could not be 
responsible for loss of Fe/S cluster by cytosolic aconitase, and that iron sensing by IRP1 
may also require the action of reactive nitrogen species (RNS) and ROS such as 
nitroxide (NO), superoxide (O-2), or hydrogen peroxide (H2O2) 81, 82.  RNS and ROS 
were found to lead to the activation of cytosolic aconitase into the RNA-binding IRP1 
form.  S138 phosphorylation of IRP1 by protein kinase C was also found to lead to 
accumulation of the RNA-binding form of IRP1 83.  IRP2, on the other hand, is 
stabilized and functions in post-transcriptional regulation during iron-depleted 
conditions.  This protein is targeted for degradation by the ubiquitin-proteasome 
pathway when cells are iron replete.  Recently, an E3 ubiquitin ligase, FBXL5, was 
found to ubiquitinate IRP2, and target it for degradation under iron replete conditions 84, 
85.  FXBL5 itself contains a hemerythrin domain that binds 2 iron atoms (yielding a di-
iron center) under iron replete conditions, and thus, is stabilized by oxygen and iron 
abundance 86.  Interestingly, IRP1 was also found to be a substrate of FBXL5.  When 
IRPs are stabilized during iron scarcity, they can stabilize mRNAs of some proteins by 
binding with high affinity to the 3’-UTR (e.g. mRNA of TfR1 or DMT1).  They can also 
destabilize the mRNAs of other proteins by binding to the 5’-UTR (e.g. mRNA of 
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ferroportin or H- and L-chains of ferritin) 87.  Other proteins that have IREs in their 
transcripts include erythroid δ-aminolevulinic acid synthase (eALAS) and mitochondrial 
aconitase (mAcon).  IRPs bind IREs of different transcripts with affinities varying over a 
9-fold range 79.  For example, IRP2 has higher affinity for ferritin H- and L-chain IREs 
than for mAcon IRE, rendering the regulation of ferritin more sensitive than mAcon to 
variations in intracellular iron concentration 88.   
Recently, a secondary pathway, independent of the IRP pathways, and involving 
the mammalian target of rapamycin (mTOR) protein, was found to regulate iron 
homeostasis in cells.  Tristetraprolin (TTP), a protein formally known to be involved in 
anti-inflammatory response, was discovered to be the downstream target of mTOR.  TTP 
was found to bind to the mRNAs of transferrin receptor 1 and ferroportin and enhance 
their degradation.  mTOR regulates TTP expression, thus altering cellular iron flux 
through modulation of iron transporters.  The mTOR pathway is believed to act more by 
fine-tuning cellular iron utilization to satisfy the metabolic needs of the cell, since the 
changes in iron levels in cells were modest when mTOR was targeted 89. 
Excess cellular iron is exported from cells via the only known membrane-bound 
iron exporter, ferroportin (Fpn) 70.  Lack of Fpn results in cellular iron accumulation in 
cell types that are known to express Fpn and export iron 90. Iron taken up by enterocytes 
enters the blood stream through Fpn-mediated export.  Fpn present in macrophages is 
involved in iron export into the bloodstream following recycling of iron from senescent 
red blood cells 91.  Fpn has 9-12 transmembrane domains, and its oligomerization state is 
still under debate, with some studies portraying Fpn as a monomer and others as a dimer.  
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The preponderance of the evidence would seem to favor the model of Fpn as a dimer 92-
94.  The mechanism of Fpn-mediated iron export is still obscure, although the fact that 
iron transport is dependent on an extracellular ferroxidase (such as ceruplasmin or 
hephaestin) suggests that the FeII state is the substrate for Fpn 95. 
Diseases of iron metabolism encompass both iron deficiency and iron overload, 
exemplifying the two-faced nature of iron in human health.  Systemic iron deficiency 
results in anemia, which affects approximately 2 billion people worldwide 96.  The most 
common forms of anemia include iron-deficiency anemia (IDA) 97, anemia of chronic 
disease (ACD) 98, and iron-refractory iron-deficiency anemia (IRIDA) 99.  IDA normally 
occurs due to nutritional iron deficiency, leading to hypochromic and microcytic anemia.  
ACD tends to occur in hospitalized patients suffering from conditions that cause chronic 
activation of the immune system.  IRIDA appears to be genetically linked, leading to 
increased levels of hepcidin, a peptide that regulates systemic iron homeostasis by 
causing degradation of ferroportin, which prevents iron from entering the bloodstream.  
Iron overload diseases are characterized by excessive iron accumulation in 
different tissues and organs, which is harmful because of iron’s tendency to participate 
in redox reactions leading to the formation of damaging ROS.  Two typical iron overload 
diseases, such as hereditary hemochromatosis and β-thalassemia, are characterized by an 
increase in non-transferrin-bound iron in the blood plasma 26, 27.  These diseases are also 
accompanied by an increase in plasma malondialdehyde, and a decrease in α-tocopherol, 
signatures of oxidative stress 100, 101.  NTBI may appear in the bloodstream even if 
plasma transferrin is not fully saturated.  Hereditary hemochromatosis is typified by 
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excessive iron accumulation in the liver, heart, pancreas, parathyroid and pituitary 
glands 102.  β-thalassemia is a secondary iron overload disease, characterized by 
excessive α-globin production.  This leads to α-globin precipitation in red blood cells, 
ineffective erythropoiesis, and iron overload 103.  Other forms of iron overload diseases, 
such as Friedreich’s ataxia and X-linked sideroblastic anemia, involve disruption in 
mitochondria proteins involved in iron metabolism.  Friedreich’s ataxia is a result of 
frataxin deficiency, leading to defective Fe/S cluster biosynthesis.  X-linked 
sideroblastic anemia is a result of ABCB7 deficiency, an inner mitochondrial membrane-
bound transporter possibly involved in the export of an unknown molecule necessary for 
iron homeostasis in cells 104, 105. 
Iron exists as various species in the mammalian cell.  A comprehensive 
understanding of the fate of iron in healthy and diseased states requires the ability to 
probe the iron speciation and distribution in cells with minimal disturbance to the 
equilibria that exist between different iron-containing species inside the cell.  Previous 
methods involving cellular and/or organellar sub-fractionation 106-108, and use of 
fluorescent Fe chelator in intact cells 109-111, have mainly been designed to probe the 
labile iron pool (also functionally defined as the chelatable iron pool) in various cell 
types and their organelles.  Cellular and/or organellar subfractionation usually requires 
separation of cellular components into several fractions and quantification of iron 
content of each fraction.  This method has been used primarily to probe the elusive labile 
iron pool(s) of cells, in an attempt to quantify them. The main problem with this method 
is its disruptive nature, which inevitably leads to decompartmentalization of cellular 
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iron, and a shift in oxidation state of the Fe during fractionation, resulting in inaccurate 
quantification of iron-containing species and large variations from study to study 112.  
More recently, studies have used fluorescent chelators to selectively probe the chelatable 
iron pool inside intact cells.  This minimizes the invasiveness of the experiment, and 
requires small sample volumes.  However, the specificity of the chelators again 
disallows the comprehensive speciation of all iron present in the cells, and their affinities 
for Fe may still lead to shifts in the equilibria of iron-containing species.  These 
problems can be avoided by adopting biophysical and spectroscopic techniques 
performed on intact whole cells, or isolated organelles. Recently, laser ablation 
inductively coupled plasma mass spectrometry (LA-ICP-MS) has been successfully used 
as a powerful, highly sensitive tool for probing the distributions of metals and non-metal 
species within biological samples 113, 114.  
Our approach to probing the iron distribution in cells and organelles relies on the 
use of biophysical methods, namely Mössbauer spectroscopy, Electron Paramagnetic 
Resonance spectroscopy (EPR), and Electron Absorption Spectroscopy (UV-Vis).  
Mössbauer spectroscopy is based on the recoil-free, resonant absorption and emission of 
gamma rays in solids, as described by Rudolf Mössbauer in 1957 115.  Mössbauer 
spectroscopy is similar, in principle, to Nuclear Magnetic Resonance spectroscopy 
(NMR), since both techniques probe transitions in the nuclear spin of the sample.  
Mössbauer spectroscopy may alternatively be called Nuclear Gamma Ray Resonance 
spectroscopy, since it is used to probe nuclear transitions from a ground state to an 
excited state that require a substantial amount of energy, which can only originate from a 
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gamma ray source.  Mössbauer spectroscopy is limited by the need for a suitable 
gamma-ray source, which means that it can only be presently used to detect 57Fe in 
samples, since 57Fe absorbs the gamma-ray, of energy 14.4 keV, emitted by 57Co.  
Mössbauer spectroscopy measures the nuclear transitions of 57Fe from a ground spin 
state I = ½ to the excited spin state I = 3/2.  The energy of the gamma rays incident upon 
the sample is modulated by moving the 57Co back and forth, resulting in the Doppler 
Effect of the energy observed by the sample.   
The major parameters of a Mössbauer spectrum, namely the isomer shift, the 
quadrupole splitting, and the magnetic hyperfine interactions, can provide detailed 
information regarding the iron oxidation states, the spin states (low-spin or high-spin), 
and the nature of the ligand environments around the iron centers.  No 57Fe is Mössbauer 
silent, and spectral intensities are proportional to the amount of iron containing species 
detected, since the extinction coefficient for every species is the same, making 
Mössbauer spectroscopy one of the most powerful tools to probe iron distribution and 
speciation in a sample.  Furthermore, the disruption of biological samples is not 
required, and they are frozen to very low temperatures during analysis (4-70K), which 
eliminates the possibility of alterations in the chemical properties or equilibria of the 
iron-containing species in the sample.  The main drawback of Mössbauer spectroscopy is 
its insensitivity (detection limit ~ 50 µM 57Fe), which means that biological samples 
need to be scaled up and enriched with the expensive 57Fe isotope, which is only 2.2% 
abundant in nature.  Mössbauer analysis of biological samples containing low 
concentrations of 57Fe require several hours of running time, and can last for up to two 
 19 
weeks, which makes Mössbauer spectroscopy a very time-consuming technique.   Our 
lab has successfully exploited Mössbauer spectroscopy to probe the iron distribution of 
yeast cells, and isolated yeast organelles, such as mitochondria and vacuoles 116-120. 
Electron Paramagnetic Resonance is the next most powerful biophysical technique 
available at our hands to characterize iron-containing species 121.  EPR spectroscopy has 
a much lower detection limit than Mössbauer spectroscopy (~0.1 µM). It is commonly 
used complementarily with Mössbauer spectroscopy to probe paramagnetic Fe-
containing species. As its name suggests, EPR spectroscopy is not specific to iron and 
can probe transitions in unpaired electrons from any species in the presence of an 
externally applied magnetic field.  Similarly to Mössbauer spectroscopy, EPR can be 
used on intact cellular or organellar samples, and also provide information about the 
redox state, the spin state and the ligand environment of the species being studied.  The 
main limitation of EPR is that species that do not have unpaired electrons are EPR silent. 
However, these species, if present in large enough concentrations, can be detected via 
Mössbauer spectroscopy.  
Energy-dispersive X-Ray Imaging (EDX), combined with Scanning Transmission 
Electron Microscopy (STEM), is a powerful tool in direct visualization of iron 
accumulated in biological samples 122.  EDX consists of bombarding the biological 
specimen with high-energy electrons and detecting the characteristic X-rays produced, 
via use of an energy-dispersive spectrometer.  The X-rays produced are indicative of the 
element (s) present in the sample. When combined with STEM, EDX imaging can  
provide a high-resolution elemental map of a biological specimen being studied, 
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relatively rapidly.  Furthermore, overlaying elemental maps can provide information 
about which elements follow the same map patterns, and hence provide insight regarding 
the elements associated with accumulated iron in our samples.  This can confirm the 
nature of the ligands associated with accumulated iron in biological samples.  The main 
disadvantage of this technique is that it has a high detection limit, and hence requires 
significant accumulation of iron in biological samples to be detectable.   
Other analytical techniques, such as Electron Absorption Spectroscopy (a.k.a UV-
Vis spectroscopy) and Inductively-Coupled Plasma Mass Spectrometry (ICP-MS) are 
used complementarily with the biophysical methods.  UV-Vis spectroscopy is used to 
detect the levels of reduced hemes in samples, and can resolve hemes a, b and c 123.  
ICP-MS provides us with concentrations of metal ions in our samples, and can 
distinguish between 57Fe and 56Fe, thus providing information about the percent 
enrichment of the samples with 57Fe. Total Fe concentrations, in combination with 
percentages of various species detected via Mössbauer spectroscopy, can provide us with 
‘absolute’ concentration values for each Mössbauer species observed in the sample.   
Transmission Electron Microscopy is used mainly to determine the purity and 
integrity of isolated mitochondria, to make sure that the isolated organelles are mostly 
intact after isolation.  Molecular biology techniques, such as Western Blotting, and 
mammalian cell genetics are also employed in our attempts to better understand the 
‘ironome’ of the human cell.  Western blotting is used mainly to monitor the purity of 
the isolated mitochondria in the final mitochondrial fraction, and to determine protein 
levels relative to normal cells, when proteins are either over-expressed or knocked-
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down.  Changing the levels of proteins of interest allows us to determine how the 
‘ironome’ of the cell and the isolated mitochondria is perturbed.   
As described in this dissertation, the objective of my research has been to use the 
biophysical, bioanalytical and molecular biology techniques available to probe the iron 
distribution and speciation in the human cell and isolated mitochondria.  Our initial 
Mössbauer studies revealed the presence of ferric nanoparticles in whole cells and 
isolated mitochondria of cells grown on 10 µM ferric citrate 124.  We then probed various 
grown conditions, such as iron source and concentration, as well as carbon source, to 
determine the effect on the formation of the ferric nanoparticles in the cells and isolated 
mitochondria.  We found that cells are most prone to formation of ferric nanoparticles 
when grown with non-transferrin-bound iron, or when grown on galactose instead of 
glucose.  We studied the nature of the ferric nanoparticles further using STEM combined 
with EDX imaging, and found them to be associated with phosphorus, suggesting that 
they may be chemically similar to ferric phosphate nanoparticles found to accumulate in 
yeast cells depleted in proteins involved in iron metabolism and homeostasis.  Our work 
provides insight into the phenomenon of iron accumulation in human cells in iron 
overload diseases.  
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CHAPTER II 
BIOPHYSICAL INVESTIGATION OF THE IRONOME OF HUMAN JURKAT 
CELLS AND ISOLATED MITOCHONDRIA 
 
Introduction 
 
Iron is an essential component of human cellular metabolism, due to its 
impressive redox, catalytic and substrate-binding abilities 125. A comprehensive 
molecular-level understanding of cellular iron metabolism will require an understanding 
of individual Fe-containing proteins in the cell, but it will also require a systems-level 
understanding of iron trafficking and regulation. Connecting these two levels, the focus 
of this study, will be especially challenging.   
Much is known of individual iron-containing proteins (though much also remains 
to be determined). One of the two pathways known to import Fe into the cell 24 involves 
transferrin (Tf), a blood plasma protein that binds FeIII ions reversibly 14. The binding of 
Tf to its receptor on the plasma membrane stimulates endocytosis. The resulting 
endosome is acidified, promoting the release of iron from Tf and reduction to the FeII  
*This chapter is reproduced with permission from: “Biophysical Investigation of Ironome 
of Human Jurkat Cells and Mitochondria” by Nema. D. Jhurry, Mrinmoy Chakrabarti, 
Sean P. McCormick, Gregory P. Holmes-Hampton, and Paul A. Lindahl, 2012, 
Biochemistry, 51, 5276-5284. Copyright 2012 American Chemical Society. 
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state 126. FeII ions are pumped into the cytosol where they are either incorporated into 
iron-dependent apo-proteins or trafficked into other cellular compartments. FeIII citrate is 
taken up by a transferrin-independent pathway 127. A cell-surface ferrireductase reduces 
FeIII to FeII prior to uptake 128.  
Mitochondria are “traffic hubs” in the cell, as they account for 20-30% of cellular 
iron 129. Cytosolic Fe enters mitochondria via mitoferrins 41 and perhaps other 
transporters. Mitochondria may also import Fe by direct contact with transferrin-
containing endosomes 45 and/or via the siderophore 2,5-dihydroxybenzoic acid 44.  Most 
cellular Fe/S clusters and all heme prosthetic groups are biosynthesized in mitochondria. 
The final step of heme biosynthesis, inserting FeII into protoporphyrin IX, occurs in the 
mitochondria 61.  
The Fe used to build Fe/S clusters in the mitochondria is transferred onto Fe/S 
scaffold proteins in the matrix 130. These clusters are inserted into various recipient apo-
proteins including respiratory complexes RCI – RCIV 131. RCI contains 2 [Fe2S2] 
clusters and 6 [Fe4S4] clusters 5. RCII, a.k.a. succinate dehydrogenase, contains a low-
spin (LS) heme b as well as [Fe2S2], [Fe4S4] and [Fe3S4] clusters 6. RCIII, a.k.a. 
cytochrome bc1, contains a [Fe2S2] Rieske cluster, one heme c and two heme b centers 7. 
Cytochrome c contains a LS heme c center, while RCIV, a.k.a. cytochrome c oxidase, 
harbors a di-copper center (CuA), a heme a center, and an active-site heme a3 center 
interfaced to the CuB center 132.  
Ferritin is a cytosolic Fe storage protein that mobilizes Fe under iron-depleted 
conditions. It stores Fe as an insoluble magnetically-interacting ferrihydrite, which 
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prevents Fe from participating in Fenton chemistry (FeII + H2O2  FeIII + OH- + ⋅OH) 11.  
Ferritin can store up to ~4500 iron atoms in its inner core, estimated to correspond to 
60% to 88% of total cellular iron 133. Mössbauer spectra of ferritin at low temperatures 
(4.2 K) exhibit a broad sextet pattern similar to mononuclear high-spin (HS) FeIII 
complexes. At ~ 70 K and higher, the sextet collapses into a broad quadrupole doublet 
with Mössbauer parameters of a superparamagnetic FeIII species 134.  Unlike 
mononuclear HS FeIII species, ferritin is EPR-silent at low temperatures and gives rise to 
a broad EPR signal in the g = 2 region as temperatures are raised above 50 K 135.  
A proportion of cellular iron has been hypothesized to be loosely coordinated and 
to function either as feedstock for the biosynthesis of Fe centers or as trafficking species 
that can be imported into organelles. These forms of Fe are collectively referred to as the 
Labile Iron Pool (LIP). There is substantial, albeit circumstantial, evidence for an LIP in 
the cytosol and mitochondrial matrix 136. The mitochondrial LIP may be used for Fe-S 
cluster and heme biosynthesis, whereas the cytosolic LIP may report on the Fe status of 
the cell and be imported into various organelles 112. The LIP may also participate in 
Fenton chemistry and thus generate ROS. Aging and various neurodegenerative diseases 
such as Alzheimer’s and Parkinson’s are exacerbated by oxidative stress 112.   
In this study, we evaluated the ironome of whole human Jurkat cells and their 
mitochondria from a systems-level perspective using a biophysical approach centered on 
Mössbauer spectroscopy. Our results indicate that ferritin and mitochondrial Fe are 
indeed dominant players in cellular Fe metabolism. Also significant are nonheme HS 
FeII species, which are present at concentrations exceeding previous estimates, and FeIII 
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oxyhydroxo nanoparticles which were found in both isolated mitochondria and whole 
cells. These results allow an estimate of the overall distribution and speciation of iron in 
a human cell.  
 
Experimental Procedures 
 
Bioreactor Design 
 We adopted the design for a Chemglass 7 L bioreactor (Catalogue # CLS-1384-
01) and modified the design into a 25-L water-jacketed, all-glass bioreactor for these 
studies (Figure 2-1).  The 12” diameter stainless-steel lid plate had 4 evenly spaced 1” 
ID ports with screw tops surrounding a central stir-motor connection.  Two 1” × 3” and 
two 1” × 30” Teflon rods were inserted into the ports.  The long rods were used to add 
media, harvest cells, and bubble gases through the culture.  The short rods were used to 
deliver gases to the headspace and exhaust gases.  A small hole was drilled into the short 
Teflon rod used to exhaust gases, through which a thin tube connected to a syringe was 
threaded.  This tube was used to remove small samples of culture for cell count and to 
assess viability. A rounded-rectangular (3” × 24”) Teflon paddlewheel was attached to 
the underside of the lid, and a stir-motor (Arrow Engineering Co., Inc model 350) 
rotated it at ~ 60 rpm.  The bioreactor was autoclaved for 3 hours before use, with 
Aervent filters (Millipore) on all openings, and allowed to cool down to room 
temperature before inoculation.  The bioreactor was wrapped with a black cloth during 
cell growth to prevent photo-induced degradation of media components. 
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Figure 2-1. Design of the bioreactor. (a) motor to rotate impeller, (b) 0.2 micron 
Aervent filters, (c) tube for exhaust gases, (d) tube for gas delivery to headspace, (e) tube 
for sparging gas mixture into media, (f) flat impeller, (g) tube for loading/ unloading of 
media/cell culture into/out of bioreactor, (h) water inlet (i) water outlet, (j) thin tube to 
sample bioreactor culture for cell count, and (k) 1 mL sterile syringe. 
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Human Cell Culture 
Starter cell cultures were grown in a CO2 incubator (Nuaire, Model NU-5500), 
starting from a 100 mL culture, which was scaled up to 1 L once growth was evident.  
When the 1 L culture reached a density of ~3 ×106 cells/mL (the maximum density), it 
was used to inoculate 2 L of medium in the bioreactor.  T-REx Jurkat cells (Invitrogen,  
R72207) were grown in the bioreactor under an atmosphere of 75% N2, 20% O2, and 5% 
CO2 as established with a high-precision gas mixer (MG Industries).  All gases were 
99.9% pure (certified grade) and were delivered to the culture medium at a combined 
flow rate of ~ 3 mL/min.  Temperature was maintained at 37° C by circulating water 
through the jacket of the bioreactor (Chemglass).  Additional medium was added when 
cells reached maximum density.  When the culture volume was < 10 L, gases were 
delivered to the headspace above the liquid; when the volume was > 10 L, gases were 
bubbled through the liquid.  Cells in all culture volumes were grown in RPMI 1640 
medium (Sigma Aldrich) supplemented with 5% Newborn Calf Serum (Invitrogen) and 
an antimycotic-antibiotic cocktail (Invitrogen) to give final concentrations of 100 units/L 
penicillin, 100 µg/L streptomycin, 0.25 µg/L amphotericin B, and 10 µM 56Fe or 57FeIII 
citrate.  Pluronic F-68 (Sigma Aldrich) was added to a final concentration of 0.05% w/v 
to prevent hydrodynamic damage to the cells.  Samples were removed daily and 
inspected by phase-contrast microscopy for viability and contamination, using 0.4% 
Trypan Blue solution.  Cells were harvested when the cells reached maximum density.  
Cells were removed from the bioreactor using a peristaltic pump and centrifuged at 
800×g for 10 min (Beckman Coulter Avanti J-26 XP centrifuge, JLA 8.1 rotor). 
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Whole Cell Mössbauer and EPR Sample Preparation 
 EPR and Mössbauer samples of cells were prepared from 1 to 3 L of cultures 
that had reached maximum density. Cells were washed with phosphate-buffered saline 
(PBS, pH 7.4) containing 1 mM EGTA, followed by another wash with EGTA-free PBS 
buffer. Cells were then packed into 3 mL Mössbauer cups or 4 mm OD quartz EPR tubes 
by centrifugation at 800×g for 1 hr. The supernatant was removed and samples were 
frozen in liquid N2 aerobically.  
 
Mitochondria Isolation
Pellets of freshly harvested cells (wet weight 50-60 g) from 24 L of culture were 
washed twice with PBS buffer (pH 7.4).  Pelleted cells were re-suspended in ~ 500 mL 
of degassed Mitochondria Isolation Buffer (MIB: 225 mM D-mannitol, 75 mM sucrose, 
5 mM HEPES, 1 mM EGTA and 1 mM PMSF, pH 7.4) to a cell density of ~2 x 107 
cells/mL. From this point onwards, all manipulations were conducted anaerobically, 
mostly in an Ar-atmosphere MBraun Labmaster glove box containing less than 5 ppm 
O2 as monitored by a Teledyne O2 analyzer (Model 310). For centrifugation steps, 
samples were sealed in airtight centrifuge bottles inside the glove box before removing 
for centrifugation; afterwards, they were returned to the box before being opened for 
further manipulations. Cells were disrupted anaerobically by nitrogen cavitation at 800 
psi for 30-40 min, using a disruption vessel (Model 4635, Parr Instruments). The 
cavitation extract was centrifuged at 800×g for 10 min and the pellet was discarded. The 
supernatant was centrifuged again at 9000×g for 30 min using a Sorvall Evolution 
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centrifuge with SLA-1500 rotor. The resulting pellet, which contained crude 
mitochondria, was re-suspended in ~ 2 mL of MIB buffer, layered over a discontinuous 
gradient of 7.5 mL of 6% Percoll/3 mL of 17% Histodenz/3 mL of 35% Histodenz in 
MIB as described 137 and centrifuged at 45,000×g for 1 hr using a Beckman Coulter 
Optima L-90K ultracentrifuge with a SW 32 Ti swinging-bucket rotor. Mitochondria 
were collected from the 17-35% Histodenz interface and washed once with MIB. 
Mitochondria were then packed into Mössbauer cups by centrifugation in the 
ultracentrifuge (SW 32 Ti rotor) at 10,000×g for 1 hr.  The supernatant was removed and 
the mitochondrial samples were frozen and stored in liquid N2.  
 
Protein Concentrations 
Protein concentrations were determined using a BCA Protein Assay kit (Thermo 
Scientific Pierce Protein Research Products) as per manufacturer’s instructions. Bovine 
serum albumin (BSA) was used to generate a standard curve (0-2 mg/mL). Absorbances 
were measured at 562 nm. 
 
Biophysical Studies 
EPR spectra of whole cells and isolated mitochondria were collected on an X-
band EMX spectrometer (Bruker Biospin Corp., Billerica, MA) equipped with an 
Oxford Instruments ER900A cryostat. Spin quantifications were performed with 
SpinCount (http://www.chem.cmu.edu/groups/hendrich/facilities/index.html), using 1.00 
mM CuSO4-EDTA as standard.  Mössbauer spectra were acquired using a Model MS4 
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WRC spectrometer (SEE Co. Edina, MN) and a model LHe6T spectrometer (SEE Co., 
Edina MN). The latter instrument was equipped with a variable field superconducting 
magnet capable of generating 0 - 6 Tesla fields. Both instruments were calibrated using a 
spectrum of α-Fe foil collected at room temperature.  
 
Packing Efficiencies 
Jurkat cells were packed into an EPR tube by centrifugation at 800×g for 1 hr 
(Beckman Avanti-J26 XP centrifuge). Isolated mitochondria were similarly packed at 
10000×g (Beckman Ultracentrifuge). The supernatant was discarded. Packed pellets of 
volume Vpellet consisted of the sample and interstitial buffer (Vpellet = Vsample + Vint). To 
determine packing efficiency, defined as 100⋅Vsample/Vpellet, the pellet was re-suspended in 
a known volume of buffer (Vbuffer1) containing 100 µM of a membrane-impermeable 
fluorescent Compound 5 120. The sample was packed again for 1 hr. The supernatant, of 
volume Vsup1 and containing Compound 5 at concentration Csup1, was removed. Csup1 was 
determined using a fluorescence spectrometer (Koala 90080, ISS Inc). The conservation 
of matter requires that 
 
where Vint1 is the volume of the interstitial buffer in the pellet. This equation was 
solved for Vint1 allowing the first packing efficiency (100⋅Vsample1/Vpellet1) to be 
determined.  
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The pellet was re-suspended in a known volume of buffer (Vbuffer2) lacking the 
fluorescent compound and the suspension was packed again. In this case, the 
conservation of matter requires that 
 
Csup2, Vsup2 and Vpellet2 were measured as above, allowing Vint2 and a second packing 
efficiency (100⋅Vsample2/Vpellet2) to be calculated. The two packing efficiencies were 
averaged. Results from this experiment are summarized in Table A3 (Appendix I).  
 
ICP-MS 
Packed whole cells and isolated mitochondria from EPR tubes were diluted with 
a known volume of buffer (PBS buffer for whole cells, MIB for mitochondria). 
Suspensions were placed in 15 mL BD Falcon tubes and digested in concentrated trace-
metal-grade nitric acid (final concentration ~20-30%) for ~12 hr. Samples were diluted 
with distilled and deionized water to a final acid concentration of 3%. The metal 
concentrations of digested samples were determined in both H2 reaction and He collision 
modes using ICP-MS (Agilent Technologies model 7700x). Values obtained from both 
modes were adjusted for dilution factors and packing efficiencies, and then averaged.  
 
Electron Absorption Spectroscopy 
Packed cell and mitochondrial samples from EPR tubes were diluted 3-fold with 
isolation buffer. Suspensions were placed in a custom 2 mm pathlength quartz UV-Vis 
cuvette (Precision cells), sealed with a septum, and removed from the glove box. Spectra 
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were acquired on an Hitachi U3310 spectrometer with a Head-on photomultiplier tube, 
then simulated using OriginPro as described 119.  
 
Western Blots 
Forty µg of protein from cell extracts or mitochondria was loaded and separated 
on a 12% polyacrylamide gel (Bio-Rad) using SDS-containing running buffer and 100 V 
potential. Proteins were transferred to Immun-Blot PVDF membranes (Bio-Rad) 
overnight at 20 V. The membranes were incubated for 2 hr using BlockerTM Casein 
solution (Thermo Scientific). Mouse monoclonal primary antibodies (Abcam) specific to 
human mitochondrial porin, human endoplasmic reticular protein PDI, human nuclear 
protein p84 were all diluted 1:1000 and mouse monoclonal antibody specific to human 
lysosomal protein LAMP1 was diluted 1:10,000 in BlockerTM casein solution. 
Membranes were incubated with primary antibody solutions for 1 hr, followed by 
another blocking step for 30 min using BlockerTM casein. Membranes were then 
incubated with goat anti-mouse HRP conjugated secondary antibody (Invitrogen) diluted 
1:3000 in BlockerTM casein solution, followed by detection using the Thermo Scientific 
Enhanced Chemiluminescent Western Blotting Substrate. Images were obtained using 
the FujiFilm LAS-4000 mini imager and analyzed using ImageJ.  
 
Electron Microscopy 
Mitochondria were fixed in 3% (v/v) glutaraldehyde in MIB, washed 3 times 
with MIB, fixed in 1% (v/v) osmium tetroxide, infiltrated and embedded in epoxy resin 
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by polymerization at 60° C overnight. Ultrathin sections were obtained using an Ultracut 
E microtome (Reichert-Jung) and post-stained on drops of 2% (w/v) uranyl acetate and 
100 mM lead citrate as described 138. EM images were obtained on a JEOL 1200 EX 
Transmission Electron Microscope. 
 
Results 
 
Analytical Characterization 
Eighteen batches of Jurkat cells were grown in medium containing ~ 6 µM 
endogenous 56Fe, as measured by ICP-MS, and supplemented with 10 µM 57FeIII citrate. 
The percent enrichment (ca. 75%) indicates that the cells incorporated both sources of 
Fe. Mitochondria were isolated from 11 of these batches. Due to limited amounts of 
material, not every batch could be characterized by every technique; characterizations 
performed on each batch are summarized in Table A1 and A2 (see Appendix I).  
Purities of 6 batches of isolated mitochondria were evaluated by Western blots 
and the membrane integrity of 4 batches was assessed using EM (Table A2). Western 
analysis indicated a 10-fold increase in the porin protein, a marker of mitochondria, in 
isolated mitochondria relative to in the same number of mg of cell extract. Isolated 
mitochondria contained small levels of contaminating proteins, including the marker 
proteins LAMP1 from lysosomes, p84 from nuclei, and PDI from ER (Figure 2-2, top 
panel). EM images of isolated mitochondria (Figure 2-2, bottom panel) generally  
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 Mitochondria n Whole Cells n 
Protein (mg/mL) 52 ± 12 4 62 ± 11 4 
[Fe] (µM) 1120 ± 95 5 400 ± 70 5 
[Cu] (µM) 115 ± 8 5 28 ± 4 5 
[Zn] (µM) 167± 94 5 408 ± 135 5 
[Mn] (µM) 14 ± 3 5 7.2 ± 0.6 5 
FeIII oxyhydroxy nanoparticles (%) 37 3 18 2 
Ferritin-like (%)  15 3 40 2 
Central Doublet (%) 27 3 27 2 
Non-Heme HS FeII 8 3 11 2 
HS FeII Hemes  4 3 4 2 
g = 1.94 (µM) 3.3 ± 0.6 4 0.3±0.1 4 
g = 1.90 (µM) 3.3 ± 0.6 4 0.3±0.1 4 
g = 2.00 (µM) 0.2 ±0.06 4 ~ 0 4 
g = 4.3 (µM) 6 ±0.6 4 1.5 ± 0.5 4 
g = 6.0 + (6.4, 5.4) 0.5 ±0.3 4 ~ 0 4 
Reduced [Heme a] (µM) 37 ± 5 4 10 ± 2 4 
Reduced [Heme b] (µM) 21 ± 4 4 5 ± 2 4 
Reduced [Heme c] (µM) 75 ± 11 4 20 ± 3 4 
Cytochrome c oxidase (µM) ~ 18  n/a  
Cytochrome c (µM) ~ 70  n/a  
Cytochrome bc1 (µM) ~ 4  n/a  
Succinate Dehydrogenase (µM) ~ 4  n/a  
Respiratory Complex I (µM) ~ 1  n/a  
 
Table 2-1.  Analytical properties of whole Jurkat cells and isolated mitochondria.  
Reported metal, UV-vis and EPR concentrations refer to packed cells and mitochondria 
after dividing by packing efficiencies.  Values reported for isolated mitochondria were 
obtained by also dividing measured values by 0.75, to account for presumed metal-free 
impurities.  The absolute uncertainty in percentages obtained by Mössbauer 
spectroscopy is ± 3%.  Replicates n is given in the column to the right of the 
corresponding parameter.  Concentrations of respiration-related mitochondrial proteins 
are estimated from the collective results of this study.  
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Figure 2-2.  Characterization of isolated mitochondria. Top, western blot of isolated 
mitochondria; A, Porin (mitochondria); B, LAMP1 (lysosomes); C, Endoplasmic 
reticulum (PDI); and D, p84 (nuclei).  Bottom, electron micrograph of isolated 
mitochondria, magnification = 40,000×. 
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showed intact organelles with sharp cristae, though some unidentified electron density 
was evident. In summary, the EM and western blot analysis suggests that the 
mitochondria used in this study were 70% - 80% pure and generally intact.  
We determined the absolute concentration of metal ions and protein in 5 batches 
of mitochondria and 5 batches of whole cells (summarized in Table 2-1, individual 
determinations in Appendix I, Table A4). These values were obtained by dividing 
observed concentrations in packed mitochondria and cells by measured packing 
efficiencies (65% ± 10% and 81% ± 6%, respectively).  
 
Biophysical Characterization of Mitochondria 
Three batches of isolated mitochondria were analyzed (results summarized in 
Table 2-1). Low-temperature low-field Mössbauer spectra exhibited 4 distinguishable 
species; the spectrum from one batch is shown in Figure 2-3A while others are given in 
Figure A1 (see Appendix II). The dominating feature consisted of two overlapping 
quadrupole doublets in the center of the spectrum. This includes the central doublet (CD) 
with parameters typical of S = 0 [Fe4S4]2+ clusters and low-spin (LS) ferrous heme 
centers (δ = 0.46 mm/s; ΔEQ = 1.2 mm/s), and a broad doublet with parameters δ = 0.48 
mm/s and ΔEQ = 0.57 mm/s. These parameters are typical of FeIII (phosphate) oxy-
hydroxo nanoparticles, as has been observed previously in various genetic strains of 
yeast mitochondria 117, 139. The blue and purple lines in Figure 2-3A are respective 
simulations of these two doublets.  
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Figure 2-3.  Mössbauer spectra of mitochondria isolated from Jurkat cells. A, 5 K and 
0.05 T; the red line is a total simulation (see Table 2-1 for percentages); B, same as A 
but at 70 K, with simulation of NHHS FeII; C, same as A except at 6 T and 4.3 K. The 
brown line simulates the ferritin sextet while the blue line simulates the CD; D, same as 
C but after subtraction of sextet and CD simulations. The red line is a 6 T, 4.3 K 
spectrum of yeast mitochondria isolated from Aft1-1up cells 120. The applied magnetic 
field was parallel to the γ radiation in A and B, perpendicular in C and D. mm/s; ΔEQ = 
2.00 mm/s) was simulated (brown line, Figure 2-3A). The doublet simulated by the 
green line had parameters (δ = 1.30 mm/s; ΔEQ = 3.00 mm/s) typical of non-heme HS 
FeII ions.   
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Figure 2-3 (Continued) 
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The magnetic properties associated with the two doublets were investigated by 
collecting a Mössbauer spectrum at high applied magnetic field (Figure 2-3C).  The solid 
blue line simulates the CD and confirms that the species associated with this doublet are 
diamagnetic. The nanoparticle doublet broadened significantly at 6 T. Although we have 
not simulated this feature, we collected the corresponding spectrum of a yeast sample 
dominated by FeIII oxyhydroxo nanoparticles 120. Within the noise of the data, the 
spectral features (Figure 2-3D) were similar, adding evidence that the second doublet in 
the low-field spectrum arises from similar nanoparticles in human mitochondria.  The 
low-temperature, low-field spectrum of human mitochondria included 3 minor features. 
A quadrupole doublet with parameters typical of HS FeII hemes (δ = 1.00 coordinated by 
ligands with predominately O and N donors. The concentrations of heme centers in 
isolated mitochondria were quantified most accurately by electronic absorption 
spectroscopy (Figure A on Pg. 45 and Table 2-1).  
The final low-intensity feature in the 5 K 0.05 T spectrum of isolated 
mitochondria included broad features that were barely distinguishable from the baseline 
and were spread over the recorded velocity range (Figure 2-3A). At 70 K, these features 
collapsed into the center of the spectrum (Figure 2-3B) as is typical of ferritin. At 6 T, 
the same features sharpened slightly, revealing the same positions as the ferritin sextet in 
whole cell spectra (Figure 2-3C). These features in mitochondria could arise from either 
contaminating ferritin, mitoferritin or other materials with ferritin-like spectral features.  
In the g = 2 region, low-temperature EPR spectra of isolated mitochondria were 
dominated by signals with gave = 1.94, 1.98, 2.00 and 2.02 (Figure A on Pg. 42). Spin 
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quantifications are given in Table 2-1. The signals at gave = 1.98 and gave = 2.09 may 
arise from Fe/S clusters but this is uncertain. The gave = 2.00 signal probably originates 
from an organic radical, whereas the gave = 1.94 signal probably arises from the [Fe2S2]+ 
cluster of succinate dehydrogenase 116.  A low-intensity signal at gave = 2.15 was 
reproducibly present, but its origin is unknown.  
In the low-field region, mitochondria exhibited two EPR signals (Figure 2-4B). 
The one at gave = 4.3 was assigned to non-heme HS FeIII species with rhombic symmetry. 
The signal at gave = 6.0, which corresponds to a HS FeIII heme, probably arises from the 
active site of cytochrome c oxidase in a mixed redox state in which heme a3 is oxidized 
and Cub is reduced 140. At high temperatures, a broad EPR signal in the g = 2 region 
developed, with inverse Curie law temperature dependence (Figure 2-4C). Such 
behavior is characteristic of superparamagnetic species such as FeIII oxyhydroxo 
nanoparticles.  
 
Biophysical Characterization of Whole Cells 
Two batches of whole Jurkat cells were characterized (results summarized in 
Table 2-1). The dominant feature in the 5 K 0.05 T Mössbauer spectrum (Figure A on 
Pg. 43) was a broad sextet with effective isomer shift and quadrupole parameters (δ = 
0.55 mm/s; ΔEQ = 0.25 mm/s; Hint = 480 kG); the light-brown line is a simulation. This 
species was reminiscent of the HS FeIII ions in ferritin 141. The sextet was also observed 
at 4.3 K and 6 T field (Figure C on Pg. 43); under these conditions the magnetic  
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Figure 2-4.  X-band EPR spectra of Jurkat cells and mitochondria. A, high-field 
region of (i) cells and (ii) mitochondria (ave. of 5 and 3 scans, respectively). Simulations 
iii, iv, v, and vi were of the gave = 1.94, 1.90, 2.00, and 1.98 signals, respectively. The 
solid line overlaying ii is a combined simulation. Temperature, 8 K; frequency, 9.47 
GHz; microwave power, 2.012 mW. B, low-field region of (i) cells and (ii) mitochondria 
(ave. of 5 and 3 scans, respectively). Simulations iii and iv are of the g = 4.3 and 6.0 
features, respectively. The solid line overlaying ii is a combined simulation (same EPR 
conditions). C, wide-sweep spectra of mitochondria at 8 K (i) and 80 K (ii). Frequency, 
9.46 GHz, power, 20.12 mW. In all spectra, modulation amplitude was 10 G, modulation 
frequency, 100 kHz, conversion time, 164 ms, and sweep time, 336 sec.  
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Figure 2-4 (Continued) 
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Figure 2-5.  Mössbauer spectroscopy of Jurkat cells. A, 5 K and 0.05 T. Colored lines 
above the spectrum are individual simulations; the overlaid red line is a total simulation 
(see Table 2-1 for percentages). B, 70 K 0.05 T. The green line simulates the NHHS FeII 
doublet. C, 6 T and 4.3 K. The brown and blue lines simulate the sextet and CD 
respectively.  
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hyperfine interactions were similar to those of ferritin (δ = 0.54 mm/s; ΔEQ = 0.20 mm/s; 
Hint = 450 kG; η = 1.00). At 70 K, the sextet collapsed into a quadrupole doublet (Figure 
2-5B) as is again typical of ferritin (δ = 0.50 mm/s; ΔEQ = 0.75 mm/s).  We conclude 
that the sextet arises from ferritin or other very similar superparamagnetic FeIII material. 
The other features of the 5 K, 0.05 T Mössbauer spectrum of whole Jurkat cells were 
essentially identical to those found in spectra of isolated mitochondria. These included a 
central doublet (δ = 0.46 mm/s; ΔEQ = 1.20 mm/s), a nanoparticle doublet (δ =  0.48 
mm/s; ΔEQ = 0.57 mm/s), a quadrupole doublet from HS FeII hemes (δ = 1.00 mm/s; 
ΔEQ = 2.00 mm/s) and a doublet arising from non-heme HS FeII species (δ = 1.30 mm/s; 
ΔEQ = 3.00 mm/s). Concentrations of FeII heme a, b and c centers in whole Jurkat cells 
were quantified (Figure 2-6, Table 2-1).  
The low-temperature X-band EPR spectra of whole cells exhibited numerous 
low-intensity features similar to those from isolated mitochondria, including at gave = 
1.94, 1.98, 2.00 and 2.02 in the high field region, and gave = 6.0 and 4.3 at low field 
(Figure 2-4, A and B). These signals were 5-7 fold less intense in whole cell EPR spectra 
relative to in corresponding mitochondrial spectra.  
 
Discussion 
 
We determined the absolute concentrations of iron and other transition metals in 
Jurkat cells and mitochondria by determining packing efficiencies, and using them to 
correct the concentration of metals obtained in packed samples. There are few previous  
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Figure 2-6.  Electronic absorption spectra of mitochondrial (A) and cell (C) 
suspensions. Simulated spectra B and D were generated by combining individual spectra 
of isolated proteins containing the different types of hemes.  
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reports of absolute metal ion concentrations in mammalian cells; most are given as 
Fe:protein concentration ratios. Some reports of total intracellular iron concentration, as 
well as mitochondrial iron content, agree with our measurements of Fe:protein ratios 106, 
107, 142.  However, other published ratios are dramatically different. Assuming a cellular 
volume of 200 fL 143 we calculated from published data 144 that lymphocytes contain ~ 5 
mM Fe, 12 times higher than we measured. Another determination in the same type of 
cells indicated 0.3-0.4 µmol Fe/g protein 145, 45-fold lower than we measured. Rat 
intestinal epithelial cells reportedly contained ~ 1.4 µmol Fe/g protein 129, ~10-fold 
lower than our measurements. Besides being outside the range of concentrations that we 
observed, these reported concentrations are inconsistent with the Mössbauer and EPR 
intensities observed here. A 5 mM Fe sample would exhibit far greater % effect and spin 
intensities than we observed, and spectra would be unobtainable with samples that 
contain < 100 µM Fe. The Fe concentrations reported here and in some previous reports 
are fully consistent with the spectroscopic intensities exhibited by our samples.  
Our results allow us to estimate the fraction of Jurkat cell volume due to 
mitochondria (Vmito/Vcell). Heme a is exclusively found in cytochrome c oxidase, a 
mitochondrial protein, and the UV-Vis spectral absorption due to reduced heme a is well 
isolated from other heme signals so that its intensity in whole cells vs. mitochondria can 
be compared with reasonable accuracy.  This comparison (Table 2-1) suggests Vmito/Vcell 
≈ 0.27. Heme c may also be found exclusively in mitochondria (as cytochrome c and 
cytochrome bc1); in this case, the heme c concentrations in Table 2-1 suggest the same 
value for Vmito/Vcell. After correcting for dilution factors, packing efficiencies and an 
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estimated 25% heme-free impurities, mitochondrial spectra were 4.3 times as intense as 
whole cell spectra, suggesting Vmito/Vcell ≈ 0.23.  
Our Fe concentrations, when considered with the cytosolic location of ferritin 
and the conservation of matter suggests the relationship  
(1) 
where [Fe]other is the average [Fe] in all non-mitochondrial compartments of the cell. 
Solutions of this equation are restricted by our data such that Vmito/Vcell < 0.29. 
Comparing EPR signal intensities in whole cell vs. mitochondria spectra suggested a 
lower ratio, Vmito/Vcell ≈ 0.17, but the uncertainty associated with this number is larger. 
We conclude from all of these measurements that Vmito/Vcell ≈ 0.20 ± 0.04. Previous 
electron microscopy studies have measured this ratio in liver cells to be 0.18 146.  
Our results also allow us to estimate the concentrations for the respiratory 
complexes in human mitochondria (Table 2-1, lower section). The concentration of 
cytochrome c oxidase is ~ 18 µM, half of the concentration of heme a+a3, as determined 
by UV-vis. This concentration (and others in Table 2-1 and below) refer to moles per 
mitochondrial volume; the concentration within the particular compartment of the 
mitochondria where the enzyme is located (the IM, in this case) will be substantially 
higher. Heme a is LS and likely contributes to the CD, while heme a3 is HS and 
contributes to the HS FeII doublet. Cytochrome c oxidase binds 3 Cu ions, suggesting 
that about half (54 µM out of 115 µM) of the Cu in mitochondria is associated with this 
enzyme. Most of the remainder may be associated with a Cu pool 147. Since no CuII EPR 
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signals were apparent in spectra of mitochondria, we conclude that most or all of the Cu 
ions in this pool are in the Cu1+ state. 
By assuming that 20% of Jurkat cell volume is occupied by mitochondria, the 
same type of conservation-of-matter relationships as used for Fe suggests that the 
average concentrations of Cu, Mn, and Zn in non-mitochondrial locations within the cell 
are 6, 4, and 375 µM, respectively. Thus, 82%, 39% and 8% of the Cu, Mn, and Zn in 
the cell, respectively, appear to be located in mitochondria.    
The HS FeIII heme EPR feature at gave = 6 (corresponding to FeIII heme a3 and 
Cub1+) represents ~ 3% of cytochrome c oxidase molecules.  This signal has been called 
a “transient” catalytic intermediate arising from the one-electron reduction of the 
oxidized OH state 148, 149. However, our results demonstrate that it is not a transient – it is 
stable and present reproducibly under non-turnover conditions in both whole cells and 
anaerobically isolated mitochondria. Establishing whether this state functions in 
catalysis will require further study, but at minimum, our results suggest that the 
thermodynamic reduction potential of the heme a3 (FeIII/FeII) couple is less positive than 
that of the Cub2+/Cub1+ couple under in vivo conditions.  This conclusion is supported by 
a previous determination of E0’ = 210 mV vs. SHE for heme a3 and 340 mV for CuB 8. 
We calculate a potential of ca. 170 mV for the solution in equilibrium with this site, 
under the (anaerobic) conditions of our experiments. 
We estimate a concentration of ~ 4 µM for cytochrome bc1 in mitochondria, 
based primarily on the spin concentration of the gave = 1.90 signal due to the Rieske Fe/S 
cluster associated with this respiratory complex. This complex contains 1 and 2 
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equiv/mol of LS heme c1 and LS heme b, respectively, both of which would have 
contributed to the CD. We estimate a similar concentration for RCII in mitochondria, 
based on the gave = 1.94 signal intensity which we presume arises from its [Fe2S2]1+ 
cluster.  This enzyme also contains 1 LS Heme b, an [Fe3S4] cluster and an [Fe4S4] 
cluster. Collectively, the heme b contribution of both respiratory complexes is ~ 8 µM, 
suggesting that ~ 14 µM of heme b is due to other mitochondrial proteins such as 
catalase and cytochrome c peroxidase. The heme c contribution due to cytochrome bc1 is 
minor, suggesting that concentration of cytochrome c in the mitochondria is ~ 70 µM.  
Heme c centers are LS, as is the heme a center of cytochrome c oxidase and, we 
estimate, about half of the heme b centers. Collectively, this corresponds to ~ 100 µM, 
about 9% of mitochondrial Fe, and it would be contained in the CD. Since the CD 
represents ~ 27% of the Fe in the mitochondria, we conclude that ~ 17% (200 µM) is 
due to Fe in the form of [Fe4S4]2+ clusters.  After subtracting ~ 4 µM [Fe4S4] due to 
succinate dehydrogenase, we are left with ~ 46 µM [Fe4S4]-containing proteins.  
The ratios of RCI:RCIII:RCIV have been measured in various rat and bovine 
tissues to be ca. 1:3:8 150. The ratio of RCIII:RCIV in our mitochondrial samples is 3:18, 
which suggests an RCI concentration of 0.5 - 1 µM. Since RCI contains 6 [Fe4S4] 
clusters and 2 [Fe2S2] clusters, ~ 6 µM of [Fe4S4] clusters due to RCI would contribute to 
the CD, leaving ~ 40 µM [Fe4S4] clusters due to the sum of all other mitochondrial 
proteins (e.g. aconitase, homoaconitase, dihydroxyacid dehydratase, biotin synthase, 
lipoic acid synthase etc). As with yeast mitochondria 119, the concentration of [Fe2S2]2+ 
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clusters in human mitochondria seems low since a doublet due to this species is not 
observed in Mössbauer spectra.  
If 20% of the cell volume is due to mitochondria, then ~ 55% of the Fe in the cell 
(220 µM) should be mitochondrial. Of this, ca. 27% (60 µM) is due to the CD.  This 
would correspond to about 12% of the Fe in the whole cell spectrum. But the CD in the 
whole cell spectrum represents 27% of spectral intensity, corresponding to 108 µM. The 
difference 100 – 60 µM = 40 µM Fe represents the CD material in the cell that is not 
present in the mitochondria. This should be some combination of [Fe4S4]2+ clusters and 
LS FeII hemes in the cell that are not in mitochondria.    
Human mitochondria contain ~ 90 µM of HS FeII species. Some of these species 
are undoubtedly protein-bound, while others are probably associated with the 
mitochondrial LIP. The LIP was hypothesized to be present mostly in the FeII state 151. 
Non-mitochondrial portions of the cell contain, on average, ~50 µM nonheme HS FeII; 
this is an upper limit for the cytosolic LIP. The size of the LIP has been estimated from 
the change in absorbance upon treating cell extracts with bathophenanthroline sulfonate 
106 or fluorescent iron-binding chelators 39, 151-153. Concentrations ranging from ~ 0.5 µM 
(erythroleukemic cells and lymphocytes) 154, 155  to ~ 10 µM (human and rat hepatocytes, 
liver endothelial cells)  have been reported 152, 156.  
Our results also show the presence of FeIII oxyhydroxo nanoparticles in both 
mitochondria and whole cells. Considering the total iron concentrations of whole cells 
and mitochondria as determined by ICP-MS, the concentration of these nanoparticles 
appears to be ~ 73 µM in whole cells and ~ 410 µM in isolated mitochondria. Assuming 
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that mitochondria occupy 20% of the cell’s volume, this ratio suggests that most if not 
all of the nanoparticles present in a cell are located in the mitochondria. Similar FeIII 
oxyhydroxo nanoparticles have been observed in the mitochondria and vacuoles of yeast 
cells 118-120. These particles are probably associated with phosphate (or polyphosphate) 
groups. At high fields, the Mössbauer spectra of these particles exhibit a wide 
distribution of hyperfine fields ranging from 0 - 40 T 157-159. In contrast, the magnetically 
interacting FeIII ions in the ferritin core afford a narrow range of hyperfine fields. The 
nanoparticles observed in human Jurkat cells and mitochondria exhibit a wide 
distribution of hyperfine fields, suggesting that they may have phosphate associated. 
This is the first evidence of FeIII oxyhydroxo phosphate nanoparticles in human cells.     
Our results also provide insight into the redox status of the mitochondria within 
Jurkat cells. The cells were grown in medium sparged with 20% O2, and harvested and 
packed into Mössbauer/EPR cups/tubes in air. In contrast, mitochondria were isolated in 
a glove box under strict anaerobic conditions. Interestingly, almost all heme centers (and 
the same group of Fe/S clusters) in both types of samples were reduced. The only 
exception was a small portion of heme a3 in the active site of cytochrome c oxidase, 
which was oxidized in both types of samples. This rather reduced redox state might be 
expected for mitochondria isolated anaerobically, but not for cells isolated in air. We 
conclude that the basal state of mitochondria within cells is reducing relative to most 
hemes and that this redox poise is not altered during the anaerobic isolation of the 
organelle.  
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The distribution of iron within Jurkat cells and their mitochondria are 
summarized in Figure 2-7.  A surprisingly large portion of the Fe in mitochondria (37%, 
Figure 2-7) is present as FeIII oxyhydroxo (phosphate) nanoparticles. These particles 
might be in equilibrium with the nonheme HS FeII and FeIII species (9% of 
mitochondrial Fe). Similar species are present in yeast mitochondria, where they may 
exist in redox equilibrium and function as feedstock for Fe/S cluster and heme 
biosynthesis 119, 120. Collectively, the respiratory complexes (including cytochrome c) 
account for about 17% of mitochondrial Fe. Another 14% of mitochondrial Fe is present 
as “other” [Fe4S4]2+ clusters and heme b centers. About 15% of mitochondrial Fe is 
ferritin-like; this may be a contaminant of ferritin or ferritin-like material inside the 
mitochondria (mitochondrial ferritin?).  
Approximately 20% of the volume of whole Jurkat cells is occupied by 
mitochondria, yet this fraction accounts for about 55% of the Fe in the cell. Another 40% 
of cellular Fe is stored in the cytosol as ferritin and the remaining 5% is present (outside 
of the mitochondria) as Fe/S containing proteins, nonheme HS FeII and FeIII species. 
Thus, the vast majority of Fe in human cells is either stored (as ferritin) or used (within 
mitochondria). The bulk of the latter Fe is used to synthesize Fe/S clusters and heme 
centers that are primarily installed in respiratory complexes, which are used, in turn, to 
generate cellular energy. Only  ~5% of cellular Fe is used for all other Fe-associated 
processes. This does not imply a lesser functional importance for these other processes; 
we simply lack the resolution and sensitivity required to further characterize the Fe 
species associated with these processes.  
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Figure 2-7. Ironome profile of Jurkat cells and mitochondria.  
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The iron distributions of yeast cells and mitochondria have also been studied 
using the same biophysical techniques, and it is interesting to compare the ironomes of 
yeast and human cells. The ironome of Jurkat mitochondria resides somewhere between 
those of fermenting and respiring yeast. The redox poise of the organelle and the relative    
proportion iron-containing species (including respiratory complexes) contained therein 
are very similar between yeast and humans. Clearly, yeast provides an excellent model 
of human cells for the study of Fe metabolism. Curiously even the human mitochondria 
contain nanoparticles, similar to those found in yeast. The formation of these particles is 
probably not under the genetic control of the cell. Rather, they probably result from 
chemical processes of which the cell is oblivious; thus, even human cells are unable to 
guard efficiently against iron overload. Indeed such problems are evident in human 
diseases. The significant levels of nonheme HS FeII species observed in human cells is 
also potentially significant, in that this is the type of Fe that can generate ROS through 
Fenton chemistry and thereby contribute to human disease. We plan to investigate how 
these nanoparticle and nonheme HS FeII species change under different growth and 
genetic conditions, and hopefully establish how these species can be controlled.   
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CHAPTER III 
MÖSSBAUER STUDY AND MODELING OF IRON IMPORT AND 
TRAFFICKING IN HUMAN JURKAT CELLS 
 
Introduction 
 
Iron is essential in human metabolism due to its extensive redox, substrate 
binding, and catalytic properties. This transition metal is found in various forms, 
including hemes, Fe/S clusters, and nonheme mononuclear and binuclear centers. 
Conversely, excess Fe is widely regarded to be toxic to cells because it can generate 
Reactive Oxygen Species (ROS) through the Fenton reaction 125. Hence, Fe import, 
trafficking, utilization and storage must be tightly regulated by cells.  
Mammalian cells import Fe through many pathways, the best studied of which 
involves transferrin, a blood plasma protein that coordinates two FeIII ions 24. The cell-
surface transferrin receptor TfRC1 mediates the endocytic import of transferrin-bound 
iron (TBI). This is followed by acidification of the endosome, release of FeIII from 
transferrin, reduction of FeIII to FeII and subsequent export of FeII from the endosome to 
the cytosol via the divalent metal transporter DMT1 29. The expression of TfRC1 is 
regulated post-transcriptionally by the iron regulatory proteins IRP1 and IRP2 87.  Both 
bind to and stabilize the 3’-UTR of TfRC1 mRNA under iron-deficient conditions. This 
promotes TfRC1 translation and thus Fe import via the TBI pathway 87.   
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IRP1/2 also regulate the concentration of ferritin in the cell. Ferritin is a spherical 
24- subunit protein complex used by the cell to store Fe. It has a hollow 7 nm-diameter 
core that can store up to ~ 4500 FeIII ions as an oxyhydroxide aggregate 11. When cells 
are iron deficient, IRP1/2 bind to the 5’-UTR of ferritin mRNA. This prevents mRNA 
translation, and leads to a decline of ferritin expression. When cells are Fe replete, 
IRP1/2 do not bind ferritin mRNA which increases ferritin expression, allowing storage 
of excess cellular Fe 87.  
Other Fe import pathways are less well defined, and are often referred to as a 
single pathway in which a poorly defined species called non-transferrin-bound iron 
(NTBI) is imported 160. FeIII citrate (FC) is a likely component of NTBI 127, 161. However, 
few details are known regarding the NTBI import pathway and the role of this/these Fe 
species in cellular physiology. An uncharacterized cell-surface ferrireductase has been 
implicated in the reduction of NTBI FeIII to FeII prior to uptake 128. Cell-surface metal 
transporters such as DMT1 162, the zinc transporter ZIP14 30 and L-type calcium 
channels 28 may be involved. NTBI may also be imported via bulk/adsorptive 
endocytosis 36.  
Although poorly defined, NTBI plays important roles in a number of diseases. 
NTBI is found in the blood plasma of patients with Fe-overload diseases such as β-
thalassemia 27, idiopathic hemochromatosis 163, hypotransferrinemia 164, and hereditary 
hemochromatosis 165. This typically leads to iron accumulation in the liver and/or spleen.  
NTBI has also been implicated in the pathology of Alzheimer’s disease 166. NTBI uptake 
is not as tightly controlled as that of TBI, consistent with a role for NTBI in cellular Fe 
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overload and Fe-induced toxicity 160. Hepatocytes import NTBI > 20-fold faster than 
they import TBI 167, which explains why NTBI is cleared efficiently from the blood by 
the liver 168. Growth of cells on NTBI leads to severe Fe overload and oxidative damage 
25, 169, 170.  
Few studies have probed Fe metabolism in human cells using iron-centric 
methods such as Mössbauer (MB) spectroscopy. This technique, used in conjunction 
with EPR and other biophysical methods (e.g. UV-vis and EM), can effectively evaluate 
the speciation of Fe in cells 124, 171, 172, including human Jurkat cells grown in medium 
containing 10 µM FC 124. The majority of Fe in these Fe-replete cells is bound to ferritin.  
Also evident are [Fe4S4] clusters and heme centers primarily associated with 
mitochondrial respiratory complexes, and FeIII oxyhydroxide nanoparticles that exhibit 
superparamagnetic behavior 124. In low-temperature low-field MB spectra, the 
nanoparticles exhibited a broad quadrupole doublet with δ = 0.48 mm/s, ΔEQ = 0.57 
mm/s.   
Whitnall et al. recently used MB spectroscopy to identify nonferritin 
mitochondrial Fe deposits in a mouse model of Friedreich’s ataxia 173. Friedrich’s ataxia 
is the most common autosomal recessive ataxia; it causes progressive degeneration of 
the nervous system and heart.  The deposits which they observed in heart tissue 
exhibited a broad quadrupole doublet in low-temperature low-field MB spectra. The 
parameters associated with this doublet (δ = 0.48 mm/s, ΔEQ = 0.71 mm/s) are similar to 
those observed in Jurkat cells 124. The mice had a muscle creatine kinase conditional 
knockout of frataxin, a mitochondrial matrix protein involved in Fe/S cluster 
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biosynthesis 174. Yeast lacking the frataxin homolog (Yfh1p) accumulate massive 
amounts of FeIII phosphate oxyhydroxide nanoparticles in their mitochondria, along with 
a deficiency of Fe/S clusters and heme centers 159.  
Here, we report how the cellular concentrations of such Fe-containing species in 
human Jurkat cells vary with the concentration of FC and TBI in the growth medium. 
We examine the effect of different carbon sources (glucose vs. galactose) on the Fe 
content of these cells, and the effect of altering the expression levels of the transferrin 
receptor and frataxin. A mathematical model defining the fate of Fe that enters the cell 
as TBI and FC is developed.  
 
Experimental Procedures 
 
Cell Culture 
Cells were grown in a 24 L custom-designed all-glass bioreactor 124. Cells were 
counted and viability evaluated as described 124. Glucose-free RPMI 1640 custom-
formulated powder (Gemini Bio-Products, West Sacramento, CA) was reconstituted in 
distilled deionized water as per manufacturer’s instructions, and supplemented with 
glucose or galactose (10 mM final concentration). The medium was supplemented with 
57FeIII citrate (57FC) to 3, 10, and 30 µM (final concentrations). Aqueous 57FeIII was 
obtained by dissolving 57Fe metal (Isoflex USA) in a 1:1 mixture of trace-metal-grade 
HNO3 and HCl. The solution was diluted to a concentration of 80 mM 57Fe with double-
distilled deionized (DDDI) H2O to prepare a stock solution of 57Fe. 57FC was prepared 
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by mixing the stock solution with DDDI H2O, and a 4:1 molar ratio of sodium citrate 
dihydrate: 57Fe. The pH of the solution was adjusted to 5.0, and the volume adjusted 
with DDDI H2O to obtain a final concentration of 40 mM 57FC. 57Fe2Tf (diferric 
transferrin = 57TBI) was prepared as described 175. Apo-transferrin (Lee Biosolutions, St. 
Louis, MO) was dissolved at 10 mg/mL in phosphate-buffered saline (PBS, pH 7.4) 
containing 0.01 M NaHCO3. Four molar equivalents of 57FC were added per mol Tf. 
After 4 hr at RT, the solution was centrifuged through a 20 kD MW cut-off membrane 
(Amicon Ultra 15 mL Concentrator) to remove excess unbound 57FC. The 57TBI-
containing retentate (~1 mL) was washed twice with 10 mL of PBS buffer containing 
0.01 M NaHCO3, spun through the 20 kD cut-off membrane and re-suspended in PBS 
buffer (Phosphate Buffered Saline, pH 7.4) at a concentration of 10 mg/mL. 57TBI was 
added to the cell culture medium affording 3, 10, and 30 µM final concentrations. 
Whole-cell MB and EPR samples were prepared as described 124.  
 
Total RNA Isolation and cDNA Synthesis 
 Total RNA was extracted from Jurkat cells using the hot-phenol method 172. 
Cells were grown to maximum density (~2.5 × 106 cells/mL) in 200 mL of culture 
medium and harvested by centrifugation at 700×g for 5 min. Cells were washed twice 
with PBS buffer, re-suspended in 2 mL of AE buffer (50 mM sodium acetate, pH 5.3, 10 
mM EDTA) and lysed by adding SDS (1% w/v, final concentration). An equal volume 
of AE-saturated phenol was added to the cell lysate. The mixture was incubated at 65°C 
for 10 min and vortexed every 2 min. The mixture was chilled rapidly in liquid N2 and 
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spun at 4000×g for 5 min (Beckman Coulter) to separate the phases. The aqueous phase 
was collected, mixed thoroughly with an equal volume of a 25:24:1 volume-ratio 
solution of phenol:chloroform:isoamyl alcohol, and spun at 4000×g. The aqueous phase 
was collected and mixed with 0.1 volumes of 3M sodium acetate and 2.5 volumes of 
pure ethanol. The solution was spun at 6400 rpm on a Qualitron DW-41 microcentrifuge 
for 5 min. The RNA-containing pellet was washed 3× with 80% ethanol, allowed to air-
dry for 1 hr and re-suspended in 200 µL TE buffer (10 mM Tris, pH 7.5, 1 mM EDTA). 
Contaminating DNA was removed using the DNA-Free reagent kit (Ambion) as per 
manufacturer’s instructions. cDNA was synthesized from RNA using the Super-Script 
Vilo cDNA synthesis kit (Applied Biosystems) as per manufacturer’s instructions.  
 
Transferrin Receptor-1 (TfRC1) Overexpression 
 Primers for cDNA amplification of the ORF of the TfRC1 gene were custom-
designed (Life Technologies: forward primer: 5’-
CACCATGATGGATCAAGCTAGATCAGC-3’; reverse primer: 5’-
TTAAAACTCATTGTCAATGTCCCA-3’). Underlined nucleotides were added to the 
5’ end of the forward primer to enable directional cloning into the pcDNA 3.1 vector 
(Life Technologies). The TfRC1 gene was amplified from the cDNA using Accuprime 
Supermix (Life Technologies), along with 300 nM of the forward and reverse primers, as 
per manufacturer’s instructions. PCR product size was determined by electrophoresis at 
50 V using a 0.7% agarose gel and visualized using SYBR Green Fluorescent dye. The 
PCR-product was sequenced using 3 sets of forward and reverse primers that were 
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complementary to 3 adjacent 800 bp regions of the TfRC1 cDNA ORF sequence. Each 
800 bp region was amplified via sequencing PCR, using BigDye Terminator mix (Life 
Technologies) as per manufacturer’s instructions. PCR products were sequenced and 
analyzed on an ABI PRISM 3100 Genetic Analyzer. The TfRC1 PCR product was 
directionally cloned into pcDNA 3.1 vector as per manufacturer’s instructions (Life 
Technologies). The resulting plasmid was transformed into OneShot TOP10 E.coli 
competent cells (Life Technologies), which were then plated and grown at 37°C 
overnight on LB agar plates containing 100 µg/mL of ampicillin. A colony was picked 
from the plate and grown overnight in liquid LB containing 100 µg/mL of ampicillin. 
Plasmids were purified from these E.coli cells using the PureLink Quick Plasmid 
Miniprep kit (Life Technologies) as per manufacturer’s instructions. The insertion of the 
TfRC1 gene into the plasmid was verified by performing PCR on the isolated plasmid 
using the forward and reverse primers (T7 forward and BGH reverse) provided with the 
pcDNA 3.1 Directional TOPO expression kit (Life Technologies). The sequence of the 
product cloned into the isolated plasmid was verified as described above.  
TREx Jurkat cells were transfected with the TfRC1 plasmid using Lipofectamine 
2000 (Life Technologies) as per manufacturer’s instructions. Transfected cells were 
selected by growth for 2 wks on medium containing 1000 µg/mL geneticin.  TfRC1 
overexpression was verified by Western Blot, using a rabbit anti-TfRC1 primary 
antibody (Santa Cruz Biotechnology) and an HRP-conjugated anti-rabbit secondary 
antibody (Life Technologies).  
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For the iron starvation experiment, cells were first grown in 500 mL of medium 
to a density of 2×106 cells per mL, then spun down and washed once with sterile PBS 
containing 1 mM EGTA, and then suspended in neat sterile PBS buffer. The cells were 
spun down again, and resuspended in complete unsupplemented medium containing 100 
µM desferrioxamine for 12 hr. The cells were pelleted again, washed with sterile neat 
PBS buffer, and resuspended again in 1500 mL of complete growth medium 
supplemented with 3 µM 57TBI. Cells were grown to a maximum density of 3×106 cells 
per mL, and a MB sample was prepared as described 124.  
 
Mitochondria Isolation 
 Mitochondria were isolated anaerobically from cells grown with 3 and 30 µM 
FC, as well as from cells grown with 1.5 µM diferric transferrin (i.e. 3 µM TBI) as 
described 124. Freshly harvested cells were washed twice with PBS buffer (pH 7.4), then 
re-suspended in degassed Mitochondria Isolation Buffer (MIB: 225 mM D-mannitol, 75 
mM sucrose, 5 mM HEPES, 1 mM EGTA and 1 mM PMSF, pH 7.4). The cell 
suspension was subjected to N2-cavitation at 800 psi for 15-20 min using a disruption 
vessel (model 4635, Parr instruments). The cavitation extract was centrifuged at 800×g 
for 10 min. The resulting supernatant was centrifuged at 9000×g for 30 min. The pellet 
was re-suspended in MIB buffer and the resulting solution was layered over a 
discontinuous gradient of 7.5 mL of 6% Percoll : 3 mL of 17% Histodenz : 3 mL of 35% 
Histodenz in MIB as described 137. The gradients were centrifuged at 45000×g for 1 hr. 
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Mitochondria were collected at the 17-35% interface, washed once with MIB, packed 
into Mössbauer cups or EPR tubes at 9000×g, frozen and stored in liquid N2. 
 
Quantitative Western Blots 
  Whole cell samples were packed into EPR tubes and diluted by a known 
volume of cell lysis buffer (0.1 M Tris-HCl buffer (pH 7.4) containing 1% Triton X-100 
(a non-denaturing detergent) and 1 mM PMSF). Protein concentrations were determined 
using the BCA Protein Assay kit (Thermo Scientific Pierce Protein Research Products). 
Various known amounts of human holo-ferritin (Lee Biosolutions, St. Louis, MO) were 
loaded and separated on a 7.5% polyacrylamide native gel, along with 20 µL of cell 
lysates from cells grown in glucose or galactose-containing medium supplemented with 
3 µM, 10 µM, or 30 µM of either FC or TBI. Proteins were transferred to Immun-Blot 
PVDF membranes (Bio-Rad) overnight at 40 V. Membranes were treated for 2 hr with 
Blocker casein solution (Thermo Scientific), then incubated for 1 hr with rabbit 
monoclonal primary antibody specific to mammalian ferritin (Abcam) diluted 1:1000 in 
Blocker casein solution. Membranes were then incubated with goat anti-rabbit HRP 
conjugated secondary antibody (Life Technologies) diluted 1:3000 in Blocker casein 
solution, followed by detection using the Thermo Scientific Enhanced 
Chemiluminescent Western Blotting substrate. Images were acquired using the FujiFilm 
LAS-4000 mini imager. Ferritin bands were analyzed using MultiGauge software. A 
calibration curve was generated using the intensities of the human holo-ferritin bands. 
Ferritin concentrations of various cell lysates were quantified in terms of absolute 
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cellular concentrations by accounting for the dilution factors and employing the packing 
efficiency of Jurkat cells that was determined previously 124.  
 
Biophysical Studies 
EPR spectra of whole cells and isolated mitochondria were acquired using an X-
band EMX spectrometer (Bruker Biospin Corp., Billerica, MA) equipped with an 
Oxford Instruments ER900A cryostat. Spin quantifications were performed with 
SpinCount (http://www.chem.cmu.edu/groups/hendrich/facilities/index.html), using 1.00 
mM CuSO4-EDTA as a standard. MB spectra were collected on a model MS4 WRC 
spectrometer and a model LHe6T spectrometer, capable of generating 0-6 T fields (SEE 
Co., Edina, MN).  Both instruments were calibrated using the spectrum of α-Fe foil 
collected at room temperature.  
For UV-visible spectroscopy, packed whole cell and mitochondrial samples from 
EPR tubes were diluted 2-fold with PBS buffer and MIB buffer respectively, placed in a 
custom 2 mm pathlength quartz UV-vis cuvette (Precision cells) and sealed with a 
rubber septum. Spectra were collected on a Hitachi U3310 spectrometer with a Head-on 
photomultiplier tube. Heme signals were simulated using OriginPro as described. 119 
 
Ferritin Loading with FeII Sulfate in Whole-Cell Lysates 
After collecting Mössbauer spectra of Jurkat cells grown with 30 µM 57FC, the 
sample was thawed at RT and re-suspended homogenously in an equal volume of non-
denaturing cell lysis buffer containing 1 mM of PMSF. The lysate was split into two; to 
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half was added 56FeII sulfate in aqueous solution to a final concentration of ~ 6.25 mM; 
the other half was left untreated. Both samples were exposed to air and mixed regularly 
for 2 h. Each sample was placed in a 3 mL Mössbauer cup and frozen immediately in 
liquid N2.  
 
Electron Microscopy and EDX Imaging 
 Cells were pelleted at 700×g for 10 min and washed 3 times with RPMI 1640 
medium. Cells were fixed overnight with acrolein vapor, dehydrated for 2 days with 
ethylene glycol, infiltrated and embedded in epoxy resin by polymerization at 60 °C 
overnight. Ultrathin sections were obtained using an Ultracut E microtome (Reichert-
Jung). Sections were carbon-stabilized overnight. Elemental analysis was performed on 
a TECNAI F20 Twin (scanning) transmission electron microscope ((S)TEM) fitted with 
a Schottky field emission gun, a high-angle-annular-dark-field (HAADF) detector, and 
an Oxford instruments ultrathin window energy-dispersive-X-ray spectroscopy (EDX) 
detector. EDX spectra were collected at a ~ 15o tilt angle with a stationary electron probe 
in STEM mode. The STEM was operated at a 200 kV accelerating voltage. Spectral 
images were obtained from areas of interest by the electron-microscope-spectroscopy 
system. Elemental maps were acquired after choosing proper energy windows for 
element-specific transitions along with STEM-HAADF images. 
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Extracellular Flux Measurements 
Cells were grown in RPMI 1640 medium containing 10 mM glucose or 
galactose, 5% Newborn Calf Serum (Invitrogen), 10 µM FC, 100 units/L penicillin, 100 
µg/L streptomycin, and 0.25 µg/L amphotericin B. Cells were spun at 700g for 5 min 
and the pellet was washed with PBS buffer (pH 7.4). Cells were re-suspended in 
Modified DMEM XF Assay medium (Seahorse Biosciences, Billerica, MA) 
supplemented with either 10 mM glucose or 10 mM galactose. Cell-TakTM (BD 
Biosciences), a cell and tissue adhesive, was diluted in 0.1 M sodium bicarbonate buffer 
(pH 8.0) as per manufacturer’s instructions and used to coat the wells of a 24-well plate 
(Seahorse) by adding ~4 µg of Cell-TakTM in a total volume of 50 µL per well. O2 
consumption (OCR) and extracellular acidification rates (ECAR) were measured on the 
Extracellular Flux Analyzer (XF24) (Seahorse Biosciences) as described 176 with minor 
modifications. Briefly, Jurkat cells were seeded in Cell-TakTM treated XF24-well cell 
culture microplates at 250,000 cells/well in 10 mM glucose- or 10 mM galactose–
containing XF assay media and incubated at 37°C  for ~1 hr prior to measurements. The 
baseline was measured 3 times prior to adding oligomycin (1 µM final concentration); 
the data presented here represent the third measurement. Each measurement included a 
mix (2 min), wait (3 min) and measure (2 min) cycle.  
 
Oxyblot Assays 
Whole-cell lysates were prepared in cell lysis buffer (0.1 M Tris-HCl, 1% Triton 
X-100, 1 mM PMSF). Twenty µg of cellular protein from each extract was solubilized 
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with 10% w/v SDS, derivatized with 2,4-dinitrophenylhydrazine (DNPH) and loaded 
onto a 12% SDS-PAGE gel. Oxyblot analysis was performed using the DNPH-primary 
antibody and the HRP-conjugated secondary antibody provided with the manufacturer’s 
kit (Millipore). 
  
ICP-MS 
Packed whole cells and mitochondrial samples from EPR tubes were diluted with 
a known volume of PBS buffer and MIB buffer respectively. Suspensions were digested 
overnight with concentrated trace-metal-grade nitric acid (final concentration 20-30%) in 
15 mL plastic screw-top tubes (BD Falcon). Digested samples were diluted with 4 mL of 
double-distilled and deionized water. Metal concentrations were measured in H2 and He 
collision modes using ICP-MS (Agilent Technologies model 7700x). The absolute metal 
concentrations in the samples were obtained by adjusting for dilution factors and 
packing efficiencies, and then averaging individual numbers.  
 
Frataxin Knockdown 
Frataxin protein knockdown was performed using the BLOCK-iT Inducible H1 
RNAi Entry Vector kit (Life Technologies) as per manufacturer’s instructions. Four 
DNA oligonucleotide sequences encoding shRNA sequences specific to frataxin mRNA 
were designed using Life Technologies’ BLOCK-iTTM RNAi Designer 
(rnaidesigner.invitrogen.com/rnaiexpress/) and cloned into pENTRTM/H1/TO vector 
(Life Technologies). The plasmids were separately transformed into One Shot® TOP10 
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chemically competent E. coli cells, which were plated and selected on LB agar plates 
with 50 µg/mL kanamycin. Bacterial colonies were picked and grown in liquid LB with 
50 µg/mL kanamycin. Plasmids were purified from the liquid cultures using PureLinkTM 
HQ Mini Plasmid Purification kit (Life Technologies) as per manufacturer’s instructions. 
Plasmids were transfected into Jurkat cells using XfectTM transfection reagent (Clontech) 
as per manufacturer’s instructions. Cells were grown under selection for 2-3 weeks in 
RPMI-1640 medium supplemented with tetracycline-negative fetal bovine serum (PAA 
Laboratories), 10 µg/mL blasticidin, and 50 µg/mL Zeocin. After selection, frataxin 
knockdown was induced by adding tetracycline to a final concentration of 3 µg/mL in 
the cultures. Transfected cells were allowed to grow in the presence of tetracycline for 4-
5 days before being assayed for frataxin knockdown.  
 To assay for frataxin knockdown, transfected cells (both uninduced and induced) 
were grown to a maximum density of 2×106 cells/mL. Cells were spun down, washed 
with PBS buffer, and lysed using ice-cold RIPA buffer (RadioImmunoprecipitation 
Assay Buffer: 50 mM Tris HCl, 150 mM NaCl, 1% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% SDS, pH 8.0). Protein concentrations of cell lysates were 
determined using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) as per 
manufacturer’s instructions. Forty µg of protein was boiled with denaturing Laemmli 
buffer and loaded on a 10% polyacrylamide gel. SDS-PAGE was carried out at 100 V, 
and proteins were transferred to Immunblot-PVDF membranes for 16 hr at 20 V. 
Membranes were blocked for 2 hr using Blocker Casein solution (Thermo Fisher 
Scientific). Membranes were then incubated (with shaking) in rabbit polyclonal anti-
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frataxin primary antibody (Abcam) diluted 1:500 in PBS buffer. Membranes were 
subsequently rinsed 3× with PBS buffer, and incubated with goat anti-rabbit HRP 
conjugated secondary antibody diluted 1:3000 in PBS buffer. Membranes were again 
rinsed 3× with PBS buffer, and immersed in Pierce ECL Western Blotting substrate 
(Thermo Fisher Scientific). Frataxin bands were detected using FujiFilm LAS-4000 mini 
imager. The frataxin band intensities were analyzed by densitometry using ImageJ 
software. The DNA oligonucleotide encoding the shRNA sequence 5’-
GGACTATGATGTCTCTTTGGCGAACCAAAGGAGACATCATA-3’ (loop region 
indicated in bold), which targets bases 583-603 of frataxin mRNA, resulted in 50%-70% 
knockdown of frataxin protein after 4-5 days of induction by tetracycline, as judged by 
densitometry analysis of frataxin bands. The remaining shRNA sequences tested did not 
result in measurable frataxin knockdown. Therefore, the cells expressing the shRNA 
targeted to bases 583-603 were chosen for further analysis.  
 For spectroscopic investigations, transfected cells expressing shRNA targeted to 
frataxin were grown up to 3 L in complete RPMI-1640 medium supplemented with 50 
µg/mL Zeocin, and 10 µg/mL tetracycline to ensure continuous frataxin knockdown. 
57FC was added to a final concentration of 10 µM to the cell culture. Cells were washed 
with PBS containing 1 mM EGTA, followed by PBS without EGTA, packed into MB 
cups, and flash-frozen in liquid N2. After MB analysis, cells were thawed and analyzed 
by UV-Vis spectroscopy and ICP-MS as described before. WT cells grown with 10 µM 
57FC were analyzed alongside the transfected cells for comparison. 
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Figure 3-1.  Mössbauer spectra of Jurkat cells grown in medium supplemented with 3 
µM 57FeIII citrate. A, 3 µM FC at 5K, 0.05 T; B, same as A but at 70 K. Simulations are 
as follows: CD (blue, δ = 0.46 mm/s; ΔEQ = 1.2 mm/s), ferric nanoparticles (purple, δ = 
0.48 mm/s and ΔEQ = 0.57 mm/s), ferritin (brown, δ = 0.54 mm/s; ΔEQ = 0.20 mm/s; Heff 
= 480 kG), HS FeII hemes (orange, δ = 1.00 mm/s; ΔEQ = 2.00 mm/s), and NHHS FeII 
(green, δ = 1.30 mm/s; ΔEQ = 3.00 mm/s) C, 5 K, 0.05 T MB spectrum of isolated 
mitochondria from cells grown with 3 µM FC. Total simulations for A and C are shown 
in red. 
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Results 
 
3 µM 57FC-Grown Cells 
 To evaluate the essential Fe content of human cells, we prepared cells under Fe-
limited conditions. However, the concentration of natural abundance endogenous Fe in 
the medium was substantial (~ 6 µM 124). Unlike yeast cells that can be grown in 
chemically-defined minimal synthetic medium, human cells require fetal bovine or 
newborn calf serum which contains significant amounts of Fe. Grown in such 
unsupplemented medium, Jurkat cells contained 100 ± 20 µM of Fe. These cells grew at 
about the same rate as when grown in medium supplemented with 3 – 30 µM 57FC, 
namely with a doubling time (DT) of 24 hr. This indicates that growth was not limited 
by the endogenous Fe content of the unsupplemented medium.  
We attempted to reduce the concentration of endogenous Fe by adding (in 
different batches) desferrioxamine (DFO) and bathophenanthroline sulfonate (BPS), 
well-known chelators of FeIII and FeII ions, respectively. Similar procedures have been 
used to create Fe-deficient conditions in yeast 171. However, Jurkat cells did not grow in 
the presence of 100 µM DFO or BPS, which disallowed further analysis of cells 
subjected to Fe-deficient conditions.   
For MB studies, we grew cells in medium supplemented with as little as 3 µM 
57FC (Figure 3-1). Although not strictly Fe-deficient, this Fe concentration was 
significantly lower than used in our previous investigation 124.  
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Table 3-1. Iron-related properties of Jurkat cells. Cellular states are designed by the 
nomenclature #AB where # indicates the concentration of Fe supplementing the growth 
medium, with values 0, 3, 10, 30 or 100 µM, A indicates whether the Fe was TBI (T) or 
FC (F), and B indicates whether the medium used glucose (U) or galactose (L) as the 
carbon source. WT indicates normal cells, TfRC+ indicates cells overexpressing TfRC1, 
and Frxn- indicates frataxin-deficient cells. Replicates n are given in parentheses where 
applicable. The concentration of endogenous Fe was assumed to be 4-6 µM, and was 
added to the concentration of ferric citrate. For all simulations, KIc = 9 µM; cs = 3; KIm = 
120 µM; KIf = 130 µM; kt = 0.3 hr-1 (except for 3TU “starved” cells for which kt = 3 hr-1 
and TfRC+ cells for which kt = 1.8 hr-1), km = 0.27 hr-1; kf = 0.55 hr-1; knp = 0.000045 µM-
1.9 hr-1, and p = 2.9. Values for kr are given in the table. The unusually high value of kr 
for 3TU “starved” cells suggests that the receptor for FC was also upregulated during the 
“starving” step of the experiment. α = 1/24 hr-1 for all simulations except for 10FL and 
30FL, in which case α = 1/34 hr-1, and for Frxn- cells where α = 1/30 hr-1. For 20FU 
(1:4), the sample was diluted into medium without Fe supplementation and allowed to 
grow for 2 doublings. To simulate this, the initial Fe concentrations were set to those 
obtained for 20FU before dilution, and final Fe concentration were recorded at t = 48 hr. 
Read the table as we illustrate with the row beginning with 3FU, WT and the next row 
labeled “sim”. The upper row indicates the data while the lower row indicates the 
simulation. The overall concentration of FC in the experiment includes the 3 µM 57Fe 
that was added to the medium plus 6 µM endogenous Fe. No TBI was added. The rate-
constant kr used in the simulation was 1.0 hr-1. The cellular Fe concentration was 220 ±  
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Table 3-1 (Continued) 
65 µM (average of 3 experiments) while the simulation afforded a concentration of 216 
µM. The concentration of ferritin protein in one of the samples was 0.3 µM, with an 
average loading of 380 Fe’s per ferritin.  The next 5 columns indicate the percentage of 
Fe in the sample due to particular groups of Fe centers in the sample (based on MB 
quantification) followed, after the comma, by the absolute concentration of that group of 
species (obtained by multiplying the percentage by [Fecell]/100). Simulated analogous 
values are given in the row below. Two of the groups (Fe/S clusters + LS hemes 
combined with HS FeII hemes) were collectively viewed as “mitochondrial Fem” by the 
model. Thus, to compare the data and simulations for this category, add the two 
percentages in the data row (25% + 5% = 30%) and compare it to the percentage in the 
simulation row (38%). Likewise, compare the sum of absolute concentrations (55 µM + 
11 µM = 66 µM) in the data row to 82 µM in the simulation row. In the remaining 4 
columns, the experimental and simulated percentages and absolute concentrations can be 
compared directly. For the Frxn- cells, the concentration of nanoparticles includes both 
those in the cytosol (Fen) and those in the mitochondria (Femp).   
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Table 3-1 (Continued) 
Sample [FC] (µM) 
[TBI] 
(µM) 
kr 
(hr-1) [Fecell] (n) 
[Ferritin 
Protein], 
Fe/Ferritin 
Fe/S+LS 
Hemes 
%, µM 
 
HS FeII 
hemes 
%, µM 
 
Ferritin 
[Fef] 
%, µM 
NHHS 
FeII 
[Fec] 
%, µM 
Nano-
particles 
[Fen] 
%, µM 
0U, WT 0 + 6 = 6 
0  100 ± 3 (1) ---,--- --- --- --- --- --- 
sim 4 0 0.8 105  31, 33= [Fem] 64,67 5,5 0,0 
3FU, 
WT 
3 + 6 
= 9 
0  220 ± 65 (3) 0.3, 380 25,55 5,11 52,114 13,29 5,11 
sim 9 0 1.0 216  38, 82  55,119 13,6 1,2 
10FU, 
WT 
10 + 6 
= 16 
0  400±70 (5) 0.3, 530 27,108 4,16 40,160 11,44 18,72 
sim 16 0 1.0 384  32,124 38,146 12,45 18,69 
30FU, 
WT 
30 + 6 
= 36 
0  840±276 (3) 0.4, 275 13,109 2,17 13,109 7,60 65,546 
sim 36 0 1.0 865  16,135 18,157 10,89 56,483 
100FU, 
WT 
100+6
= 
106 
0  3700±200 (2) 0.5,--- 5,185 --- --- --- 93,3440 
sim 106 0 1.3 3307  4,144 5,167 5,163 86,2833 
3TU, 
WT 
0+6=
6 
3  142±24 (3) 0.6,95 40,57 ---,--- 40,57 ---,--- ---,--- 
sim 5 3 1.1 145  32,46 63,92 5,7 0,0 
10TU, 
WT 
0+6=
6 
10  160±20 (2) 0.8,80 40,64 --- 40,64 --- --- 
sim 5 10 1.1 170  33,56 61,104 5,9 0,1 
30TU, 
WT 
0+6=
6 
30  225±25 (3) 0.4,300 30,68 2,5 54,122 8,18 6,14 
sim 5 30 1.1 209  37,78 56,117 6,12 1,2 
3FL, 
WT 
3+6=
9 
0  130±6 (2) 0.4,115 35,46 2,3 35,46 11,14 14,18 
sim 8 0 0.8 218  39,86 56,121 5,10 0,1 
10FL, 
WT 
10+6
=16 
0  580±160 (2) 0.4,290 26,151 2,12 20,116 13,75 38,220 
sim 16 0 1.1 598  23,135 26,157 10,62 41,244 
30FL, 
WT 
30+6
=36 
0  2000±300(2) 1.2,167 10,200 ---,--- 10,200 ---,--- 79,1580 
sim 36 0 1.3 1591  9,143 10,165 7,107 74,1176 
3TU,TfR
+ 
0+6=
6 
3  400±29 (2) 0.5,480 25,100 3,12 60,240 6,24 2,8 
sim 6 3 1.2 302  38,115 46,138 10,29 7,20 
10TU, 
TfR+ 
0+6=
6 
0  510±14 (2) 0.7,290 25,127 2,10 40,204 3,15 30,153 
sim 6 0 1.0 528  25,130 29,151 12,63 35,183 
20FU, 
WT 
20+6
=26 
0  675±33 (2) --- 20,135 2,14 20,135 4,27 45,304 
sim 26 0 1.1 686  19,133 22,154 11,77 47,322 
20FU 
(1:4), 
WT 
0+6=
6 
0 
 225±8 (1) --- 37,83 2,5 45,90 10,23 3,7 
sim 6 0 1.1 229  30,69 45,104 3,8 21,48 
3TU 
(starved) 
WT 
0+6=
6 
3 
 330±5 (1) --- 19,63 2,7 50,165 16,53 13,43 
sim 5 3 2.6 328  36,119 43,141 11,35 9,31 
10FU 
(Frxn-) 
10+6
=16 
0 --- 550±36 (2) --- 28,154 3,17 20,110 5,28 40,220 
sim 16 0 1.1 528  12,64 27,146 7,37 53,281 
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The 5 K 0.05 T MB spectra of such cells (Figure 3-1A) was dominated by a 
sextet which collapsed into a doublet at 70 K (Figure 3-1B). This behavior and the 
apparent hyperfine splitting of the sextet (Heff = 480 kG) and MB parameters for the 
resulting doublet (δ = 0.55 mm/s, ΔEQ = 0.25 mm/s) are typical of ferritin. We have 
assigned this feature as such (see Table 3-1 for a list of Fe-containing species found in 
these cells). Fe-bound ferritin represented about half of the Fe in the sample (52% of 220 
µM = 114 µM). Assuming that this storage form of Fe is unnecessary for cellular 
metabolism, the remaining ~ 100 µM Fe in these cells matches the concentration of Fe in 
cells grown on unsupplemented medium. We suggest that Jurkat cells require ~ 100 µM 
cellular Fe for normal growth; this is the concentration of essential Fe in these cells.  
The non-ferritin forms of Fe evident in the spectra of these cells included the 
central doublet (CD) and non-heme high-spin (NHHS) FeII doublet. The CD primarily 
includes the S = 0 [Fe4S4]2+ clusters and HS FeII hemes found in mitochondrial 
respiratory complexes. This doublet represented ~ 25% of the intensity (55 µM) of the 5 
K low-field MB spectrum of Figure 3-1A. At 70 K the ferritin sextet collapsed, revealing 
the high-energy line of a NHHS FeII doublet (simulated by the green line in Figure 3-
1B). The NHHS FeII doublet represented 13% of spectral intensity, which corresponds to 
ca. 30 µM FeII ions. The observed spectral parameters (δ = 1.30 mm/s, ΔEQ = 3.00 
mm/s) are typical of FeII ions coordinated primarily by O and N ligands. These two 
species (the CD and NHHS FeII) represent the majority of the essential Fe in Jurkat cells. 
Interestingly, Fe-deficient yeast cells which also contained only essential Fe exhibited 
significant contributions from the same two components 171. Although the function of the 
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NHHS FeII ions in yeast has not been established, most of it was not located in 
mitochondria.  
The concentration of the ferritin protein complex in 3 µM 57FC-grown cells was 
determined by quantitative Western blotting (Figure 3-2, Table 3-1) to be 0.3 µM, 
indicating an average of 400 Fe atoms per ferritin complex (114 µM Fe/0.3 µM ferritin). 
Populations of purified ferritin complexes afford binomial-like Fe-loading distributions 
177, 178, and we interpret our results similarly for in vivo ferritin populations.   
 We isolated mitochondria from 3 µM 57FC-grown cells. The Fe concentration of 
the organelle was low (280 µM) compared to mitochondria isolated from 10 µM 57FC-
grown cells 124. Also, the corresponding 5 K low-field MB spectrum (Figure 3-1C) was 
weak. Nevertheless, the CD doublet clearly dominated the spectrum, corresponding to at 
least half of the total intensity. The degree of resolution between the two legs of the CD 
indicated that the level of FeIII nanoparticles in the sample was low. HS FeII heme and 
NHHS FeII species contribute quadrupole doublets with well-defined δ and ΔEQ values. 
Such doublets at ca. 5% intensity for each can easily be fitted in the spectrum of Figure 
3-1C (this is not conclusive evidence that such material is present, given the noise). 
Isolated mitochondria did not exhibit significant levels of a ferritin-like sextet. A minor 
ferritin-like feature could be distinguished from the baseline, but whether it arose from 
mitochondrial ferritin or a contaminant of cytosolic ferritin could not be determined (we 
suspect the latter). 
 The lack of a significant NHHS FeII doublet in the spectrum of isolated 
mitochondria indicates that the bulk of the associated NHHS FeII species observed in our  
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Figure 3-2.  Quantitative Western blot of ferritin in cell lysates. The lanes given in 
parentheses were loaded with (1) 1000, (2) 500, (3) 100, (4) 50 and (5) 10 ng of holo-
ferritin. The following lanes were loaded with 10 µL of lysates: (6) 3FU, (7) 10FU, (8) 
30FU, (9) 100FU, (10) 3FL, (11) 10 FL, (12) 30FL, (13) 3TU, (14) 10TU, (15) 30TU, 
(16) 3TU TfRC+, (17) 10TU TfRC+, (18) 30TU TfRC+.   
 
 
 
 
 
 
 
 
 
 
 
 
  78 
whole cell spectrum was located in one or more non-mitochondrial regions of the cell 
(assumed for this study to be the cytosol). This is similar to the Fe content of Fe-
deficient yeast cells 171. In a previous study 124, we showed that the equation  
  
followed from the conservation of matter and that Vmito/Vcell ~ 0.2 for Jurkat cells. Along 
with the concentrations obtained in the current study for 3 µM FC-grown cells, this 
relationship and ratio suggest that ca. 50 µM of Fe in these cells (primarily the NHHS 
FeII species) is found in regions other than mitochondria (e.g. the cytosol). 
Equivalent samples of whole cells and their isolated mitochondria were 
characterized by EPR (Appendix II, Figure A5 and A6) and UV-vis (Appendix II, 
Figures A7 and A8) spectroscopies. EPR signals were weak, consistent with the low 
concentration of EPR-active Fe in these cells. Spectra included signals in the high-field 
and g = 2 regions. Observed resonances at g = 6.3 and 5.4 were assigned to the mixed-
valence state (Heme a3 FeIII CubI) of the cytochrome c oxidase active-site 124. The g = 4.3 
signal was assigned to HS FeIII species with rhombic symmetry. The g = 2 region 
included signals at g = 2.00 due to an unidentified organic radical, and at gave = 1.94 and 
1.90 (due primarily to mitochondrial respiratory complexes). The standard set of FeII 
heme UV-vis features were observed for all the whole cell and isolated mitochondria 
samples. Our analysis of these EPR and UV-Vis spectral features indicated that they 
were similar in concentration as observed in 10 µM FC-grown cells studied previously 
124.  
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30 µM 57FC-Grown Cells 
 We next analyzed cells grown in medium supplemented with 30 µM 57FC. Such 
cells contained nearly 4-times more Fe than those grown with 3 µM 57FC (Table 3-1) 
and 2-times more Fe than cells grown with 10 µM FC 124. The corresponding 5 K low-
field MB spectrum (Figure 3-3A) was dominated by a broad quadrupole doublet with 
parameters typical of FeIII oxyhydroxide nanoparticles (δ = 0.48 mm/s, ΔEQ = 0.57). 
This doublet represented 65% of the Fe in the sample and corresponded to ~ 550 µM Fe 
(65% of 840 µM total Fe). Nanoparticles were also present in cells grown on 10 µM 
57FC, but their concentration was 7-fold less.  
The MB spectrum of 30 µM 57FC cells also exhibited a ferritin-based sextet. 
Although barely distinguishable from baseline, the sextet represented ca. 13% of the Fe 
in the sample (0.13 × 840 µM = 109 µM). This concentration was almost the same as 
that of ferritin Fe in 3 µM FC-grown cells. Quantitative Western blotting (Figure 3-2) 
indicated ~ 0.4 µM ferritin protein in the sample, again suggesting partial Fe loading 
(109 µM/0.4 µM ≈ 300 Fe/ferritin). A similar analysis of 10 µM 57FC-grown cells also 
indicated partial ferritin loading (160 µM/0.3 µM ≈ 500 Fe/ferritin). The uncertainty in 
these determinations was such that loading ratios are considered to be basically invariant 
for most conditions measured, with an average of 400 ± 100 Fe/ferritin (3 and 10 µM 
TBI-grown cells have even lower loading ratios).  
The Fe associated with ferritin and nanoparticles collectively accounted for all 
but 185 µM Fe in the 30 µM 57FC-grown cells. Nanoparticles and ferritin-bound Fe  
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Figure 3-3.  Mössbauer spectra of high-Fe Jurkat cells and mitochondria. A, 30FU, 
5K, 0.05T; B, 30FU, 70K, 0.05T; C, 100FU, 5K, 0.05T; D, 100FU, 4.3K, 6T, overlaid 
with a 6T, 4.3 K spectrum (red) of yeast mitochondria isolated from Aft1-1up cells 120; E, 
5K, 0.05T spectrum of mitochondria isolated from cells grown on glucose with 30 µM 
FC. Overall simulations for A and D are shown in red.  
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probably do not contribute to cellular physiology; the majority of the remaining Fe is 
probably due to the essential Fe described above. The CD in the 5 K MB spectrum 
(Figure 3-3A) could not be cleanly resolved from the nanoparticles doublet; however, 
subtracting various percentages of a doublet fixed with CD parameters from the 
unresolved nanoparticle-dominated feature suggested that 10 - 15% of the spectral 
intensity (100 - 130 µM) was due to the CD. At 70 K, the ferritin sextet collapsed into a 
doublet revealing a NHHS FeII doublet (green line in Figure 3-3B) that corresponded to 
ca. 7% of spectral intensity (60 µM FeII). These two features, the CD and NHHS FeII, 
undoubtedly represented much of the essential Fe in the sample. Somewhat lower 
concentrations of these two species were observed in the 3 µM FC-grown sample.   
 The extent of nanoparticle formation scaled nonlinearly with the concentration of 
Fe in the medium. Cells were grown in 100 µM 57FC to maximize formation of these 
particles; such a sample was characterized by MB spectroscopy at 5 K and 0.05 T 
(Figure 3-3C). These cells accumulated 3.5 - 4 mM total Fe, > 90% of which was in the 
form of nanoparticles. The corresponding 6 T spectrum (Figure 3-3D, black hashmarks) 
was dominated by a broad magnetic feature suggesting superparamagnetic behavior. 
This spectrum was compared to that of previously-characterized FeIII oxyhydroxide 
phosphorous-associated nanoparticles from the Aft1-1up yeast strain 172 (Figure 3-3D, red 
line). Spectral features were similar but not identical, indicating a different distribution 
of hyperfine coupling constants. These magnetic differences must correspond, at some 
level, to structural differences. 
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MB spectra of mitochondria isolated from 30 µM 57FC-grown cells were also 
dominated by nanoparticles (Figure 3-3E). Approximately 690 µM Fe in these isolated 
organelles originated from nanoparticles whereas the concentration of nanoparticles in 
corresponding whole cells was ~ 550 µM. Since mitochondria occupy ~ 20% of the 
cell’s volume, we would expect that if all nanoparticles in the cell were present in these 
organelles, the concentration of nanoparticles in isolated mitochondria would be ~ 2.7 
mM Fe (5× more than observed). Furthermore, upon increasing the FC concentration 
from 10 to 30 µM in the medium, the whole-cell Fe concentration doubled, but the Fe 
concentration associated with isolated mitochondria did not change significantly. These 
considerations imply that the extra Fe in the 30 µM FC-grown cells (primarily 
nanoparticles) accumulated in one or more non-mitochondrial regions of the cell, 
possibly the cytosol.   
Although the concentration of Fe in 30 µM FC mitochondria was similar to that 
of 10 µM FC mitochondria 124, the MB distribution of that Fe was different. 
Mitochondria from the 30 µM FC-grown cells exhibited a significant decrease in 
absolute concentration of ferritin-like Fe, HS FeII hemes, and NHHS FeII, as well as a 
significant increase in nanoparticles (Table A5, Appendix I). The diminished amount of 
ferritin-like Fe may be irrelevant given that ferritin is cytosolic. The difference in 
ferritin-like material is probably the consequence of small-number-variations (we 
prepared two batches at each concentration) and less contamination in the 30 µM FC 
samples. UV-vis analysis of these samples exhibited similar levels of cytochromes    
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Figure 3-4.  EDX images of glucose-grown cells in medium containing 30 µM FC. A, 
Fe map; B, P map; C, 320K magnified image of Fe deposits. The box in C indicates the 
region in which the elemental maps were obtained.  
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(Figure A8, Appendix II). EPR spectra were also determined for cells grown on 3 and 30 
µM FC. The same group of signals, with similar intensities, was observed as for the 10 
µM FC sample 124. The spectral intensities of the CD component of MB spectra were 
similar for the samples. These characteristics, considered collectively, suggest that the 
concentrations of respiratory complexes in the mitochondria isolated from 3, 10, and 30 
µM FC-grown cells were approximately the same. The major difference was the 
presence of more nanoparticles in the 30 µM FC-grown cells.  
 We were initially concerned that the doublet attributed to nanoparticles in these 
cells actually represented ferritin loaded with small amounts of Fe (≤ 10:1 Fe:Ferritin 
ratio). At ~ 4 K, such species exhibit quadrupole doublets rather than a sextet 73. We 
reasoned that if the superparamagnetic doublet actually arose from poorly-loaded 
ferritin, adding an excess of FeII under aerobic conditions would load the ferritin, 
causing the doublet to disappear and the sextet to appear. However, the results (Figure 
A4, Appendix II) did not show such a shift, indicating that the majority of the broad 
doublet arose from nanoparticles rather than from poorly-loaded ferritin. 
 EDX EM imaging of cells grown with 30 µM FC revealed ~ 1 nm diameter 
particles in what appears to be the cytosol (Figure 3-4C). Elemental mapping revealed 
that these particles were associated with both Fe and P in approximately a 1:1 molar 
ratio (Figures 3-4 A-B and Appendix II, A3). Results for O were ambiguous due to 
strong background levels of O in the cytosol and/or in the embedding medium. Such 
nanoparticles were not detected by EDX imaging in cells grown in medium containing 3 
µM TBI or FC.  
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Figure 3-5.  Oxyblot analysis of cells grown under different conditions. Samples 
include (with lanes in parentheses) (1) 3FU; (2) 10FU; (3) 30FU; (4) 100FU; (5) 3FL; 
(6) 10FL; (7) 30FL. Percentages of intensities relative to lane 1 are designated below 
each lane.  
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Oxidative Damage in Glucose-Grown Cells 
In yeast cells, nanoparticle formation is reportedly associated with oxidative 
damage 117, 139. To investigate whether nanoparticle formation is associated with 
oxidative damage in human cells, we performed an Oxyblot analysis on Jurkat cells 
grown on 3, 10, 30 and 100 µM FC (Figure 3-5, lanes 1 - 4). In this experiment, the level 
of oxidative damage increased slightly as the FC and nanoparticle levels increased. In 
another experiment (Figure A9, Appendix II), there was no correlation between ROS 
and Fe level. We conclude that there is little, if any, effect of nanoparticle formation on 
ROS levels in glucose-grown Jurkat cells.  
 
Bioavailability of Nanoparticles 
We wondered whether cells can utilize the Fe in nanoparticles. Cells were 
overloaded with nanoparticles (by growth in 20 µM 57FC medium) and then transferred 
to unsupplemented medium. They were grown to maximum density, and a portion was 
used to prepare a MB sample. Remaining cells were washed once with PBS containing 1 
mM EGTA (to remove excess Fe), followed by another wash with PBS buffer lacking 
EGTA. The cells were diluted 4-fold in unsupplemented medium, allowed to grow to 
maximum density (two doubling times), and then harvested. The cells grown on 20 µM 
57FC accumulated significant amounts of nanoparticles (Figure 3-6A), but nanoparticles 
were absent in the cells that were subsequently grown on unsupplemented medium; only 
the CD, ferritin, NHHS FeII and HS FeII hemes were evident in the 5 K low-field MB  
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Figure 3-6.  Bioavailability of nanoparticles. A, 5K, 0.05T Mössbauer spectra of 
20FU cells (half-filled cup); B, derived from A, but after washing and further growth on 
medium unsupplemented with 57Fe (filled cup).  
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spectrum (Figure 3-6B). Metal analysis combined with MB simulations of different Fe 
species (Table 3-1) indicated that the only feature that declined considerably in 
concentration (> 40-fold decrease) upon growth of the split cells was nanoparticles. 
Other features remain roughly unchanged, with minor decreases attributed mainly to 
dilution due to growth of the cells. These results indicate that Jurkat cells can utilize 
nanoparticle Fe, converting it into mitochondrial Fe, ferritin, and presumably all other 
Fe-containing species required for cellular metabolism.  
 
Galactose-Grown Cells 
Cells were grown with 3, 10, and 30 µM 57FC in medium containing galactose 
rather than glucose as a carbon source. Cells grown on galactose and 3 µM 57FC 
accumulated ca. half as much Fe as equivalent glucose-grown cells. However, the Fe 
concentration of galactose-grown cells increased faster than did glucose-grown cells as 
the FC concentration in the growth medium was raised. The concentration of Fe in cells 
grown with galactose and 10 µM FC was ~ 50% higher than in corresponding glucose-
grown cells. Cells grown on galactose and 30 µM FC contained > twice as much Fe as 
the corresponding glucose-grown cells (Table 3-1). Galactose-grown cells had a longer 
doubling time (ca. 34 hr) which may have promoted Fe uptake.  
MB analysis revealed that cells grown on galactose and 3 µM 57FC were largely 
devoid of nanoparticles (Figure 3-7A, Table 3-1). Interestingly, the 5 K 0.05 T MB 
spectrum of cells grown on galactose and 10 µM FC exhibited a 3-fold greater 
contribution from nanoparticles and a decline of ferritin Fe relative to comparable  
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Figure 3-7. 5K, 0.05T Mössbauer spectra of galactose-grown cells. A, 3FL; B, 10FL; 
and C, 30FL. Simulations are shown in red. 
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glucose-grown cells (Figure 3-7B and Table 3-1). The nanoparticle doublet obscured the 
CD in the MB spectrum of galactose-grown cells, but simulation of the MB spectrum 
afforded an estimate of the percentage due to the CD. The low-intensity NHHS FeII 
doublet was evident, with a concentration similar to that observed for cells grown with 
glucose and 10 µM 57FC. The absolute concentrations of nanoparticles (and possibly the 
CD) were significantly larger in galactose-grown cells grown on 30 µM 57FC than in 
equivalent glucose-grown cells (Figure 3-7C, Table 3-1). Distinguishing these two 
contributions is difficult because they are not well resolved. UV-vis spectra of galactose-
grown cells do not exhibit increased concentrations of cytochromes (Appendix II, Figure 
A7) suggesting that there is no significant increase in mitochondria concentration (and 
thus no significant increase in the CD). The concentration of ferritin Fe also did not 
change considerably in galactose-grown cells upon increasing the FC concentration in 
the medium.  
The observed difference in nanoparticle level might be related to the different 
metabolic activity of galactose- vs. glucose-grown cells, and/or different growth rates. 
The oxygen consumption (OCR) rate of galactose-grown cells was 2 - 3 times greater 
than that of glucose-grown cells (Figure 3-8A). On the other hand, the normalized extra-
cellular acidification rate (ECAR) of the glucose-grown cells was 3 - 4 times greater 
than that of the galactose-grown cells. The OCR of cells grown under the two different 
carbon sources was also determined in the absence and presence of oligomycin (an 
inhibitor of F1F0 ATP synthase). The normalized OCR of glucose-grown cells decreased  
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Figure 3-8. Oxygen consumption rate (OCR) and extracellular acidification rate 
(ECAR) of glucose- and galactose-grown cells. A. Normalized ECAR vs. OCR 
measurements of cells grown in glucose or galactose. B. Normalized OCR 
measurements of cells grown in glucose or galactose in the absence (black) or presence 
(grey) of 1 µM oligomycin.  
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~60% in the presence of oligomycin, whereas that of galactose-grown cells decreased 
almost ~80% (Figure 3-8B) indicating tighter coupling of respiration and ATP synthesis 
in galactose-grown cells 176. These results confirm that our galactose-grown cells 
depended more heavily on oxidative phosphorylation (i.e. mitochondrial respiration) for 
ATP production than they did on glycolysis.   
 
Oxidative Damage in Galactose-Grown Cells 
Cells grown on galactose and FC exhibited ~ 50% higher levels of oxidative 
damage than cells grown on glucose and FC (Figure 3-5). The effect of cellular Fe 
concentration on the level of ROS damage was again minor, if any.  The increased 
damage to galactose grown cells may be caused by the greater dependency on 
mitochondrial respiration and oxidative phosphorylation for ATP production in 
galactose-grown cells 179.  
 
Increased Transferrin-Receptor Expression 
 Cells were grown on medium supplemented with 3 µM transferrin-bound 57Fe 
(57TBI). The total Fe concentration in such cells was quite low (140 µM) and the 57Fe 
enrichment was only ~ 50%. Consequently, the corresponding 5 K low-field MB 
spectrum (Figure 3-9A) had a low percent-effect and was noisy. The general pattern 
indicated less ferritin and relatively more CD, compared to the Fe content of 3 µM 57FC-
grown cells. Spectral noise precluded a more detailed analysis. MB spectra of 
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mitochondria isolated from cells grown with 3 µM TBI (Figure 3-9C) exhibited little 
evidence of a nanoparticle doublet.  
Increasing the 57TBI concentration in the medium to 30 µM yielded an 
intracellular Fe concentration of 225 µM, which resulted in a more intense and 
analyzable 5 K low-field MB spectrum (Figure 3-9B).  The spectrum was dominated by 
ferritin and CD Fe, and displayed a negligible nanoparticle doublet (Table 3-1). The 
extent of ferritin loading was ~3 times larger than in 3 µM or 10 µM (spectrum not 
shown) TBI-grown cells (Table 3-1), but was still low (~300 Fe/ferritin) relative to full 
loading.  
In an effort to increase the Fe concentration in TBI-grown cells, cells were 
genetically modified to overexpress ~3-fold more TfRC1 than normal (Figure A10, 
Appendix II). Such cells (called TfRC+) grown on 3 µM 57TBI contained 3-times as 
much total Fe as equivalently grown WT cells. Correspondingly, the MB spectrum 
exhibited by the TfRC1+ cells (Figure 3-9D) was more intense. Sixty percent of the Fe in 
the cells was ferritin-bound, which was the highest percentage of Fe found in this form 
for any cell conditions examined. The sextet contribution was simulated and removed, 
revealing CD and NHHS FeII contributions. The spectrum included little if any 
nanoparticle doublet. TfRC+ cells were also grown with 10 µM 57TBI; such cells 
accumulated ~ 25% more Fe than cells grown with 3 µM 57TBI. MB analysis of these 
cells revealed a more significant accumulation of nanoparticles (Figure 3-9E and Table 
3-1).   
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Figure 3-9. 5K, 0.05T Mössbauer spectra of Jurkat cells grown on TBI and 
mitochondria isolated therefrom. A, 3TU WT; B, 30TU WT; C, mitochondria isolated 
from cells in A; D, 3TU TfRC+; E, 10TU TfRC+; F, WT cells grown in unsupplemented 
glucose-containing medium with 100 µM DFO, and then transferred to medium 
containing 3 µM 57TBI. Red lines are overall simulations using percentages given in 
Table 3-1 and parameters given in the Figure 3-1 legend.  
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Figure 3-10. Effect of frataxin deficiency. A, 5K, 0.05T Mössbauer spectrum of WT 
10FU; B, frataxin-deficient cells grown with 10 µM FC. Total simulations are showed in 
red using percentages given in Table 3-1. 
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We also attempted to stimulate WT cells to uptake TBI by first starving them of 
Fe in the presence of DFO for 12 hours (to upregulate TfRC1 expression), and then 
adding 3 µM 57TBI to the growth culture. These cells incorporated ca. 3 times more 57Fe 
than cells grown on 3 µM 57TBI without this stimulation.  These cells accumulated Fe 
mainly in the form of ferritin and CD (Figure 3-9F, Table 3-1).  
 
Reduced Frataxin Expression 
We also examined the Fe content of Jurkat cells in which frataxin expression was 
reduced by RNAi. Western blot analysis indicated that the expression  level of frataxin 
in frataxin-deficient cells was 30-50% that of WT levels in cells grown under the same 
conditions (10 µM FC) (Figure A11, Appendix II). Frataxin-deficient cells grown with 
10 µM FC accumulated significantly more nanoparticles than normal cells grown under 
the same conditions (Figure 3-10, Table 3-1). The concentration of nanoparticles 
detected by MB spectroscopy was ca. 3× greater in frataxin-deficient cells (220 µM vs. 
72 µM in WT cells). These cells accumulated more total cellular Fe than WT cells (550 
µM vs. 400 µM) (Table 3-1), with most of the excess Fe present as nanoparticles. UV-
Vis analysis indicated a ~ 40% decline in cytochrome levels of frataxin-deficient cells 
relative to WT cells (Figure A12, Appendix II).    
    
 
 
 
  97 
Analysis 
 
We analyzed our data by developing a chemical model for the import and 
trafficking pathways in human Jurkat cells (Figure 3-11). Cellular Fe was assumed to be 
composed of 4 species, namely . Fe could enter the 
cell by either TBI or FC import pathways. Both pathways merged at Fec, an unidentified 
cytosolic Fe species presumed to correspond to the NHHS FeII spectral feature observed 
in MB spectra of Jurkat cells. According to the model, Fec can react to form Fef, Fem and 
Fen, which represent the Fe associated with ferritin, mitochondria and nanoparticles, 
respectively. Fem is the sum of cellular Fe-S clusters and hemes, which we assumed to 
be originating exclusively from mitochondria.  
The model was translated into ordinary differential equations (ODE’s) [1] – [4] 
which describe the factors that influence the changes in concentration of each cellular 
component.  
 
  
 [1] 
  
       [2] 
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Figure 3-11. Model of Fe import and intracellular trafficking in Jurkat cells. Solid 
arrows indicate reactions associated with rate-constants kt, kr, kf, km and kn. Reactions kt 
and kr represent import of TBI and FC Fe, respectively. Reactions kf and km represent 
transfer of Fec to ferritin and mitochondria, respectively. Reaction kn represents 
conversion of cytosolic Fe into nanoparticles. Dashed lines terminating at short straight 
orthogonal segments represent regulation sites. The lines emanate from the sensed form 
of Fe. The triple-headed arrow indicates higher-order dependence of Fec on that reaction.   
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       [3] 
   
       [4] 
 
The first term on the right-hand-side of equation [1] describes the rate of import 
of TBI through the TfRC1 on the plasma membrane. Regulation of this and two others 
rates in the model are described by the function  
 
in which species Fes is  sensed by the regulatory system, KIs is an apparent inhibition 
constant associated with the sensing event (also called a set-point concentration), and s is 
a sensitivity parameter. Reg- is a form of the Hill equation that we have used as a 
surrogate for poorly defined or highly complex regulatory mechanisms. Reg- could 
reflect the direct (or indirect) binding of Fes to: a) the promoter of a gene (i.e. 
transcriptional regulation); b) an mRNA strand (translational regulation); or c) an 
allosteric site of a protein (enzyme regulation). Reg- can be viewed as a valve that opens 
wide when [Fes] < KIs, shuts down when [Fes] > KIs, and is half-opened when [Fes] = KIs. 
The rate of TBI influx is regulated by Reg-, with Fec serving as Fes. In this case, Reg- is a 
surrogate for the Fe-dependent binding of IRP1/2 to the mRNA of the transferrin 
receptor mRNA.  
  100 
The second term of [1] reflects the unregulated import of FC. Our model is 
minimal in that no unnecessary terms are included. We could fit the data in Table 3-1 
acceptably well without assuming that the import of FC was regulated. The third term of 
[1] reflects the flow of Fec into mitochondria. The rate of mitochondrial Fe import via 
mitoferrin1/2 is regulated but the mechanism has not been established in non-erythroid 
cells, except for the fact that these proteins are regulated post-translationally 42, 43. The 
sensed molecule in this process was assumed to be the concentration of mitochondrial 
Fem.  
The fourth term of [1] reflects the loading of Fe into ferritin. IRP1/2 also regulate 
ferritin synthesis in an Fe-dependent manner, stimulating production of ferritin under 
high-Fe conditions 87. We initially tried to regulate the system in this manner (by 
multiplying the rate of Fe loading into ferritin (kf) by the function Reg+ = 1 – Reg-, using 
Fec as the sensed molecule) but the resulting behavior was not satisfactory, as the 
observed ferritin concentrations changed significantly less than the simulated 
concentrations. This suggested that the regulation of ferritin loading was more like the 
regulation of mitochondrial Fe import. Thus, we employed the Reg- function in the 
manner used to regulate mitochondrial Fe import, namely by assuming that the sensed 
Fes was ferritin Fef.  
The fifth term of [1] refers to the rate of nanoparticle formation. We initially 
assumed a first-order dependence of [Fec] in this process, but our simulations could not 
reproduce the disproportionate increase in nanoparticles (Fen) that occurred when the FC 
concentration in the growth medium increased (e.g. from 3 → 30 or →100 µM). 
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Mimicking this behavior required that we assumed a higher-order dependence on [Fec]  
(Table 3-1). This order-dependence is consistent with a mechanism in which multiple (~ 
3) Fe ions react at or before the rate-determining step in the formation of nanoparticles.  
The last term of [1] reflects dilution due to cell growth. In our model, the cell is 
growing as Fe is imported, such that a steady-state Fecell concentration is eventually 
achieved (The Fe concentration data of Table 3-1 was interpreted as representing steady-
state values). Each component of a growing cell requires a dilution term in its ODE 180. 
The growth rate α was assumed to be the inverse of the doubling time.  
The sum of ODEs [1] – [4]  
 
defines how the overall Fe concentration of the cell changes in time. In the absence of 
TBI and under Fe-limiting steady-state growth conditions, . [FC] in 
this equation includes not only the concentration of ferric citrate in the medium, but the 
endogenous Fe (6 µM). In the absence of FC, [Fecell] ≈ 100 µM and [FC] = 6 µM such 
that a DT of 24 hr implies that kr ≈ 0.7 hr-1.  When grown on 100 µM FC, [Fecell] = 3500 
µM, [FC] = 106 µM, and thus kr ≈ 1.3 hr-1. We view this range for kr (1.0 ± 0.3) as 
acceptable, given the simplicity of the model.  
Sensitivity factors ms and fs were set semi-arbitrarily to 10 to provide extremely 
tight regulation. The other parameters of the system (cs, KIc, KIm, KIf, kt, km, kf, kn and p) 
were estimated by attempting to simulate the entire dataset of Table 3-1. The ODEs were 
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numerically integrated using Maple software (http://www.maplesoft.com/). Growth 
conditions of the simulation model cell were varied to mimic the conditions listed in 
Table 3-1. For TfRC+ cells, the constitutive overexpression of TfRC was mimicked by 
assuming a 6-fold faster import rate constant kt AND by removing the Reg- term. Cells 
grew slower on galactose than on glucose (DT = 34 hr rather than 24 hr) so α was 
adjusted accordingly for those simulations. Each simulation was allowed to continue for 
1000 hr (where time refers to that indicated in the ODEs) to assure that steady-state 
conditions had been achieved. Resulting simulated concentrations are given in Table 3-1. 
The uncertainties associated with the data were estimated to be ± 20% so that minor 
discrepancies between simulations and data are considered irrelevant. The model is 
simple, semi-quantitative, and foundational. It captures the essential features of Fe 
import and trafficking in Jurkat cells, but lacks many details associated with these 
processes. 
 One advantage of ODE models is that they have predictive power. Thus, our 
model can predict the distribution of these 4 forms of Fe in Jurkat cells grown with any 
concentration of TBI or FC. It can also be modified so as to explore genetic changes in 
the cell - such as the consequences of reducing the expression level of frataxin. Previous 
studies in yeast and mice have shown that a frataxin deficiency causes the accumulation 
of nanoparticles in mitochondria. This leads to an Fe-deficiency condition in the cytosol 
130, 174, 181. To examine how our model would respond to this phenotype, we allowed for    
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Figure 3-12. Simulation of the changes in cellular iron distribution following frataxin 
depletion. The simulation at t < 0 is of WT glucose-grown cells in 10 µM FC, with DT = 
24 hr and kmp = 0. At t = 0, kmp was set to 0.000045 hr-1 and DT to 30 hr.  
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the possible formation of nanoparticles in the mitochondria (by adding the term 
( ) to the ODE of equation [3] and by adding ODE [5] 
    [5] 
to the set of ODEs [1] – [4]. For simplicity, we assumed that the kinetics of nanoparticle 
formation in the mitochondria were the same as for nanoparticle formation in the 
original model (presumably in the cytosol). As such, we assigned kmp and mp to the same 
values assigned to knp and p, respectively. 
 As a control, we solved the new system assuming kmp = 0 and α = 1/24 hr so as to 
mimic WT expression levels of frataxin and the growth rate of WT cells. Resulting 
steady-state simulated concentrations are shown in the early region of the plot of Figure 
3-12. We then set kmp = 0.00045 hr-1 and α to 1/30 hr-1 to stimulate mitochondrial 
nanoparticle formation and mimic the slower-growing frataxin-deficient cells. The 
overall Fe concentration increased in our simulations from 461 to 528 µM, similar to the 
change observed experimentally. The simulation included an increase in mitochondrial 
nanoparticles as well as a decline of non-nanoparticle forms of mitochondrial Fe 
(interpreted as Fe/S clusters, hemes and the pool of NHHS FeII). These latter changes are 
consistent with the deficiencies of Fe/S clusters and hemes that are associated (along 
with the dominance of nanoparticles) with the frataxin phenotype 182. The simulated 
response to frataxin deficiency also included a decline of cytosolic and ferritin Fe, 
consistent with the cytosolic Fe-deficiency phenotype that has been reported 130. We 
repeated the simulation at 3 µM FC concentration, but no phenotype was evident.      
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Discussion 
 
Using MB spectroscopy and other biophysical methods, we have investigated the 
Fe import pathways and downstream trafficking of two forms of Fe in human Jurkat 
cells, namely transferrin-bound iron (TBI) and ferric citrate (FC). We did this by 
characterizing the Fe content of such cells grown in media containing different 
concentrations of TBI and/or FC and different carbon sources (glucose vs. galactose). 
We also investigated cells in which the expression levels of the transferrin-receptor and 
frataxin were altered. We developed a mathematical model of Fe import and trafficking 
in these cells, and fitted simulations obtained therefrom to our data. 
 
TBI and FC Import Pathways 
Our data and simulations indicate that the import of TBI iron is highly regulated. 
Our model suggests that cytosolic Fe regulates TBI import in accordance with a set-point 
concentration of 9 µM. In contrast, the import of FC does not appear to be regulated, or 
at least our model did not require that assumption. Whether the same holds true of other 
forms of NTBI remains to be determined, but we regard this as a viable possibility. 
 The fate of TBI (after DMT1-promoted export from endosomes into the cytosol) 
and the fate of FC within the cell are largely unknown. An earlier version of the model 
assumed two forms of cytosolic Fe, one derived from TBI and the other from FC. 
However, this assumption did not improve the fits and so we merged the two import 
pathways immediately once Fe entered the cytosol. In real cells, the pathways may not 
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merge immediately. However, they must eventually merge. Fe from either source 
eventually traffics into mitochondria (via the IM transporters mitoferrin1/2 41), loads into 
ferritin (via PCBP1/2 chaperones 75, 183), and forms nanoparticles. There is probably no 
dedicated protein chaperones that traffics Fe into nanoparticles. Rather, these particles 
appear to form spontaneously via chemistry of which the cell is unaware.  
The distribution of Fe in TBI-grown cells differs relative to that in cells grown on 
the same concentration of FC, primarily because less Fe overall is imported into TBI-
grown cells. This is due, in turn, to the tighter regulation of TBI import. The higher 
concentration of cytosolic Fe in FC-grown cells increases the rate of nanoparticles 
formation disproportionately, such that it dominates the Fe content of FC-grown cells 
but not TBI-grown cells. Consistent with this, TBI-grown cells in which the transferrin-
receptor was constitutively overexpressed contained higher concentrations of Fe, relative 
to WT cells grown on TBI. The distribution of Fe in these cells was similar but not 
identical to that observed in FC-grown cells.  
Another likely reason for the different Fe distributions is that the TBI pathway 
may somehow favor storing Fe as ferritin relative to the FC pathway which tends to 
funnel more Fe into nanoparticles. Our current model does not include such distinctions, 
but the possibility of distinct intracellular pathways should be considered when 
developing more advanced models.  Supporting such a distinction at the protein 
expression level, our data show a more sensitive upregulation of ferritin protein in TBI-
grown cells relative to in FC-grown cells. For example, cells grown with 3 µM TBI had 
twice the concentration of ferritin compared to cells grown with 3 µM FC.  This suggests 
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that the IRP1/2 system of regulation responds more sensitively to Fec derived from TBI. 
Furthermore, TfRC+ cells grown on 3 µM TBI accumulated the same cellular Fe 
concentration as WT cells grown with 10 µM FC, but that Fe included significantly 
fewer nanoparticles and more ferritin Fe. Our simple model cannot account for such 
differences.  
 
Mitochondria 
The concentrations of mitochondrial Fe centers, including Fe-S clusters, hemes 
and HS FeIII ions, do not change drastically upon increasing the medium Fe 
concentration. This indicates the ability of mitochondria to regulate their own Fe import. 
The expression of the only known Fe transporters in the mitochondrial membrane, 
mitoferrin 1 and mitoferrin 2 (Mfrn1 and Mfrn2) is tightly regulated to prevent excessive 
mitochondrial Fe accumulation 42. To mimic this invariance, our model tightly regulated 
mitochondrial Fe import using mitochondrial Fe itself as the sensed species. Clearly, not 
all mitochondrial Fe is sensed. Nevertheless, this regulatory assumption would remain 
viable as long as the concentration of the sensed molecule was proportional to the 
overall mitochondrial Fe concentration. The concentration of nanoparticles in 
mitochondria does seem to increase with the concentration of Fe in the medium. Again, 
this form of Fe may not be regulated by the cell; indeed the cell may be unaware of its 
existence.  
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Ferritin 
The extent of Fe loading into ferritin was an order-of-magnitude less than the 
often-quoted value of 4500 Fe per core. Moreover, the extent of loading did not increase 
with increasing Fe concentration in the growth medium (which we presume is 
proportional to the cytosolic Fe concentration). Both results were surprising.  
The low average extent of loading is undoubtedly due to a distribution of loading 
levels in a population of ferritin molecules. Ferritin-loading distributions have been 
previously described for ferritin purified from various organs, using ultracentrifugation 
184 or MB spectroscopy coupled with electron microscopy 177, 185. Bovell et al. obtained 
similar results by performing in situ electron microscopy coupled with ASAX analysis 
on rat liver sections 178. We suggest a binomial distribution of Fe loadings in ferritin 
populations of Jurkat cells, with the maximum approaching 4500 Fe per ferritin and the 
mean near 400 Fe/ferritin. Our studies also suggest that the average ferritin-load remains 
about the same regardless of the overall Fe concentration in the cell (though perhaps 
lower load in 3 and 10 µM TBI-grown cells). Our results are consistent with an EM 
study showing a distribution of ferritin loading in iron-overloaded rat livers 178. 
The popular explanation of IRP1/2 regulation of ferritin is that the unbinding of 
these proteins to the ferritin message under high cytosolic Fe concentrations promotes 
ferritin synthesis so that excess cytosolic Fe can be removed from the cytosol and stored 
in ferritin 87. The implication is that without this promotion, there would be no way for 
excess cytosolic Fe to be removed - because the existing ferritin was already fully 
loaded.  The regulation of ferritin and the extent of loading do not appear to be so 
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simple, at least in Jurkat cells. Cells containing partially loaded ferritin responded to 
increasing (cytosolic/medium) Fe concentrations by synthesizing more ferritin proteins, 
not by loading pre-existing ferritin to the fullest possible extent. Another spurious initial 
notion of ours was that nanoparticles would form only once the cell exhausted its 
ferritin-binding capacity. In contrast, we found that the ferritin was partially loaded in 
FC-grown cells that also contained substantial quantities of nanoparticles.  
One explanation of this partial-loading behavior is that the set-point 
concentrations for ferritin synthesis and Fe-loading of ferritin differ. The set-point 
concentration of the Fe species that regulates the synthesis of new ferritin protein (via 
the IRP1/2 system) might be lower than the concentration of Fe required to fully load 
ferritin. In this way, as cytosolic Fe levels increase, they trigger further ferritin protein 
synthesis such that existing ferritin never becomes fully loaded.  
Another shift in our thinking arose from our attempt to model the concentration 
of ferritin Fe in cells grown under different conditions. The concentration of ferritin Fe 
was roughly invariant among all of the conditions tested and examined by MB 
spectroscopy (Fe-limited cells and Fe-overloaded cells could not be investigated by 
MB). We initially attempted to model this using the well-known IRP1/2 mechanism. 
This required a Reg+ function in which Fec was sensed. However, this resulted in greater 
variation in Fe ferritin levels than was evident in the data.  Thus, we abandoned that 
form of regulation and employed a Reg- function in which ferritin Fef was sensed (we 
did this after noting how well mitochondrial Fe could be regulated by assuming the Reg- 
function with Fem as the sensed molecule). This arrangement adequately reproduced 
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ferritin Fe levels under the various circumstances examined. However, the molecular-
level mechanism responsible for this form of regulation is not understood; it seems 
unlikely that ferritin Fe could directly be sensed since it is an aggregated form. The rate 
of Fe import into ferritin might be inhibited as the degree of ferritin loading reaches 
some critical threshold, as has been suggested based on the rates of ferritin loading in 
vitro 186, 187.  
 
Nanoparticles 
The nanoparticles that accumulate in Jurkat cells are similar in chemical 
composition to those found in strains of yeast that have mutations in Fe/S cluster 
metabolism proteins 117, 139. The modest differences in high-field MB spectra, relative to 
yeast nanoparticles, suggest modest structural differences. Previous MB studies of the 
spleens of β-thalassemia patients 188 indicate accumulation of a species with MB 
parameters similar to the nanoparticle doublet observed here. Ferric phosphate 
nanoparticles accumulate in the hearts of mice displaying symptoms of Friedreich’s 
ataxia 173.  The size of the particles observed in our cells are substantially smaller than 
ferritin particles (~ 1 nm vs. 2.8 – 8 nm) 177, 189 and they contain more phosphorus than 
ferritins 190. Our results suggest that the majority of nanoparticles formed in these cells 
are non-mitochondrial. Our EM results suggest that nanoparticles form in the cytosol, 
and this was assumed by our model.  
 Our model suggests that the rate of nanoparticles formation is not regulated. This 
is consistent with the idea that the cell is unaware that nanoparticles are forming, 
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suggesting that this is a purely chemical phenomenon. Although nanoparticles cannot be 
sensed by the cell, they may nevertheless play a role in cellular metabolism. We found 
that nanoparticles formation is reversible and that nanoparticle Fe can be recycled by the 
cell.  
Our model required that the rate of nanoparticle formation depend on the 
cytosolic Fe concentration to higher than first order. This high-order rate dependence 
leads to the observed “burst” phenomenon in which there is a disproportionate increase 
in nanoparticles as the Fec concentration increases. It implies that more than one FeIII 
ions (nominally 3 such ions, according to our simulations) come together to form 
nanoparticles at or before the rate-determining step in the process.  
 
Oxidative Damage 
The lack of correlation between the extent of nanoparticle formation and 
oxidative damage in FC-grown cells grown on glucose is consistent with the results of 
Hartwig et al. who found that oxidative damage to DNA and lipid peroxidation in 
glucose-grown mammalian cells is not induced by growth on up to 2 mM FC 191, 192. FeIII 
nanoparticles form from the oxidation of FeII ions, but whether this generates ROS (or is 
promoted by ROS) is uncertain. Our results indicate that the overall level of cellular 
ROS damage does NOT correlate significantly with cellular Fe or nanoparticle level. 
Nanoparticle formation may generate (or be generated by) small amounts of ROS, but 
this doesn’t impact cellular ROS levels significantly. ROS can be scavenged by 
catalases, peroxidases and antioxidants 3, 193. Perhaps the observed extent of oxidative 
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damage is inversely related to the rate of these repairs. Also, metabolic mode and growth 
rate may be factors in the level of cellular ROS damage.  These considerations are 
supported by our finding that galactose-grown cells (which are more active in terms of 
respiration and also grow more slowly) are associated with greater ROS damage.  
Our results and conclusions regarding the insignificance of nanoparticle 
formation on overall cellular oxidative damage are literally opposite of that proposed by 
Whitnall et al. 173 who identified nanoparticles in the hearts of frataxin-deficient mice. 
They proposed that nanoparticles may be an “explosive” (their emphasis) source of ROS 
in such diseased heart tissue. Our data suggest that nanoparticle formation has little 
impact on cellular ROS levels.  
 
Frataxin 
Although simple, our model reproduces the major effects of depleting cells of 
frataxin. Besides accumulating nanoparticles in the mitochondria (which was designed 
into the model), other cellular Fe species in the model responded in ways that are also 
observed experimentally. Frataxin-deficient cells “feel” Fe-deficient in the cytosol, due 
to the increased rate of Fe import into mitochondria. This effect was recreated in our 
simulations. Importantly, there was no alteration of the regulation of the entire system – 
including the regulation of Fe import into the mitochondria themselves. The increase in 
total mitochondrial Fe (including [Fem] + [Femp]) was associated with the decline in 
[Fem] as this form of Fe was used to make mitochondrial nanoparticles. This decline 
stimulated further Fe import into the organelle, which created a deficiency of Fe in the 
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cytosol. Importantly, this imbalance of Fe in the cell was due to nanoparticle formation 
in the mitochondria, not to malfunctioning regulatory systems. Our study and model 
suggest that there is nothing “wrong” with Fe regulation in cells that are deficient in 
frataxin (or by extension, in patients with Friedrich’s ataxia). The problem is that a 
deficiency of frataxin somehow alters the mitochondrial matrix so as to favor 
nanoparticle formation. This might involve changes in pH, redox state, or chemical 
composition. Understanding the mechanistic basis of these alterations will be critical in 
understanding and treating the disease.   
 
Mathematical Modeling 
Interpreting changes in cellular Fe metabolism (or any other complex cellular 
metabolic subsystem) on the molecular/mechanistic level is difficult, as the complexity 
of these systems is enormous. As more molecular-level interactions are discovered and 
characterized, it becomes increasingly difficult (and will eventually become impossible) 
to draw mechanistic inferences based merely on mentally contemplating such 
interactions. Gaining mechanistic insights will increasingly require the aid of 
mathematical models that can include an unlimited number of relationships explicitly 
and can integrate their collective effects.  
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CHAPTER IV 
 
IRON CONTENT OF SACCHAROMYCES CEREVISIAE CELLS GROWN 
UNDER IRON-DEFICIENT AND IRON-OVERLOAD CONDITIONS* 
 
 
Introduction 
 
Iron plays critical roles in cells, including as redox agents within mitochondrial 
respiratory complexes and as active-site metals in numerous metalloenzymes 194-196. Iron 
can also be deleterious, in that certain types of Fe centers, e.g. labile mononuclear 
nonheme FeII complexes, engage in Fenton chemistry to generate reactive oxygen 
species (ROS). Thus, Fe trafficking in cells must be highly regulated to allow Fe to be 
used in cellular functions while also minimizing deleterious side-processes. 
Understanding the molecular-level details of how cells do this is a current challenge in 
the field.  
 
*This chapter is reproduced with permission from: “Iron Content of Saccharomyces 
cerevisiae Cells Grown under Iron-Deficient and Iron-Overload Conditions” by 
Gregory P. Holmes –Hampton, Nema D. Jhurry, Sean P. McCormick, and Paul A. 
Lindahl, 2013, Biochemistry, 52, 105-114, Copyright 2013 American Chemical Society. 
My contributions to these studies were to isolate mitochondria from cells grown under 
fermenting conditions and varying iron concentrations, and prepare samples for 
analysis by Mössbauer, EPR, and UV-Vis spectroscopies, as well as perform Oxyblot 
analysis on isolated mitochondria. Copyright 2013 American Chemical Society. 
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Cellular Fe trafficking involves numerous components interacting as a system. 
Membrane-bound proteins transport Fe across cellular and organellar membranes, while 
Fe-binding proteins and perhaps low-molecular-mass Fe complexes traffic Fe within 
aqueous regions of the cell 197. Iron-sensing proteins and DNA-binding transcription 
factors control gene expression levels of Fe-associated species 198, 199, while various 
chaperone proteins install Fe ions into myriad target/recipient apo-proteins.  
The details of Fe trafficking are best understood in the budding yeast 
Saccharomyces cerevisiae 200. These cells import Fe through several pathways. A high-
affinity pathway imports Fe through the Fet3p/Ftr1p complex on the plasma membrane. 
This pathway allows WT cells to grow under Fe-deficient conditions 201 in which the 
growth medium is pretreated with bathophenanthroline sulfonate (BPS), a strong 
chelator of FeII ions. The resulting [FeII(BPS)3]4- complex, generated using endogenous 
Fe in the growth medium, is inaccessible to cells for growth 202. WT cells growing in Fe-
deficient medium express the iron regulon, a group of ca. 20 genes, including FET3 and 
FTR1 203. Gene expression is controlled by the transcription factor Aft1p 198, 199, 204. 
Under Fe-deficient conditions, Aft1p moves from the cytosol to the nucleus where it 
increases expression of iron regulon genes. Under Fe-sufficient and Fe-overload 
conditions, Aft1p moves to the cytosol, decreasing expression of these genes. The rate of 
Fe import into the cell by the high-affinity system is saturable, such that plots of rates 
vs. the concentration of Fe in the medium ([Femed]) can be fitted to a Michaelis-Menten-
type expression with apparent Km ~ 0.2 µM 205-208.  
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Iron metabolism in cells grown under Fe-deficient conditions is also regulated 
post-transcriptionally. Cth1p and Cth2p bind to mRNA strands transcribed from various 
Fe-associated genes 209. This destabilizes those transcripts and curtails protein synthesis. 
Cth2p binds and destabilizes the mRNA of Ccc1p, the only known Fe importer on the 
vacuolar membrane. Vacuoles store and detoxify Fe. These transcription factors also 
destabilize the mRNA of genes involved in Fe/S cluster and heme biosynthesis and 
respiration. Under Fe-deficient conditions, this regulatory mechanism minimizes the use 
of Fe by preventing vacuoles from depleting the cytosol of Fe and by curtailing synthesis 
of Fe-containing proteins.  
Fe-sufficient growth conditions are defined here as having 5 – 40 µM Fe in the 
medium ([Femed]). Cells lacking the high-affinity Fe import pathway can grow under 
such conditions 202, 207 due to low-affinity pathways. FeII ions can be imported through 
Smf1p and Fet4p on the plasma membrane, with apparent Km values of 2.2 and 33-41 
µM, respectively 206, 210-212. Once imported, Fe is trafficked to vacuoles, mitochondria, 
and other organelles. CCC1 gene expression is controlled by transcription factor Yap5 
which activates CCC1 under intermediate and high cytosolic Fe ([Fecyt]) 213. Once 
installed in the vacuolar membrane, the newly synthesized Ccc1p imports Fe into the 
vacuole 139, 196, 214. Isolated vacuoles from fermenting cells grown in medium with 
[Femed] = 40 µM contain a magnetically-isolated mononuclear HS FeIII species 120. In 
fermenting Fe-sufficient yeast cells, this species represents ~75% of total cellular Fe 118. 
Fe in vacuoles can also be found as FeIII nanoparticles 120, 215. These organelles export Fe 
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through Fet5p and Fth1p, homologs of the Fet3p and Ftr1p 216, and through Smf3p, a 
homolog of Smf1p 217.  
The same cytosolic Fe species that is imported into vacuoles 218 is presumed to 
be imported into mitochondria primarily through high-affinity transporters Mrs3/4p 219, 
220. High-affinity in this case means that ΔMrs3/4 cells cannot grow on Fe-deficient 
medium 219, 221, apparently because [Fecyt] in such cells is insufficient to be imported 
rapidly into mitochondria. Since mitochondria are the sole site of heme biosynthesis in 
the cell and the major site of Fe/S cluster biosynthesis, Fe-deficient ΔMrs3/4 cells 
probably cannot generate sufficient quantities of these prosthetic groups. These and 
other results imply that [Fecyt] is proportional to [Femed], at least under low-Fe 
conditions. These same strains can grow normally under Fe-sufficient conditions 219, 
implying that other low-affinity mitochondrial import pathways can operate when [Fecyt] 
is higher than it is under Fe-deficient conditions.  
Little is known about the Fe content and distribution in cells grown under Fe-
overload growth conditions, defined here as being > 40 µM. Only at extremely high 
concentrations is toxicity observed. WT cells grow reasonably well in medium 
containing as high as 5 mM – 10 mM FeII 222-226 and 20 mM FeIII 215.  
We use an integrated biophysical approach centered on Mössbauer spectroscopy 
to evaluate the Fe content of organelles, cells, and tissues from a systems-level 
perspective 120, 124, 227. In this paper, we analyze WT yeast cells grown on Fe-deficient 
and Fe-overloaded growth medium, as well as mitochondria isolated there-from. Under 
Fe-deficient condition, cells prioritize their use of Fe, using it for essential functions that 
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involve Fe/S cluster and heme centers, and minimizing nanoparticles and vacuolar Fe. 
Cells grown on Fe concentrations ranging from 40 – 10,000 µM [Femed] maintained 
nearly the same Fe concentration and speciation despite a 250-fold increase in 
environmental Fe, indicating an amazing ability to regulate Fe import. A model that 
rationalizes these results is presented.  
 
Experimental Procedures 
 
Cell Growth and Preparation of Samples 
 WT strain W303-1B and strain DY150, FET3-GFP::KanMX 228 were used. 
DY150 is isogenic to W303 229, and it was used for studies involving Fet3-GFP. Cells 
were grown on minimal medium without added Fe 117-119, called Fe-unsupplemented. 
The medium contained (2% w/v) glucose or galactose to establish fermenting or 
respirofermenting growth modes, respectively. Iron-deficient medium was prepared by 
adding 21 µM BPS (Sigma-Aldrich) to Fe-unsupplemented minimal medium, followed 
by supplementing with 1 µM 57Fe(citrate). This corresponded to a molar excess of BPS 
(the endogenous Fe concentration in minimal medium was ~ 100 nM). 57Fe citrate was 
prepared by dissolving 57Fe metal powder (IsoFlex USA) in a 1:1 mixture of 
concentrated trace-metal grade (TMG) HNO3 and HCl (Fisher Scientific) and diluting 
with double-distilled water. The resulting 80 mM Fe stock contained ~ 0.2% (v/v) acid. 
The solution was diluted further with distilled water and treated with a 3-fold molar 
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excess of sodium citrate (Fisher Scientific). The solution was adjusted to pH ~ 5 with 1 
M NaOH (EMD chemicals) resulting in a final concentration of 40 mM 57Fe citrate.  
Fifty mL of Fe-unsupplemented minimal medium was inoculated with a single 
colony from a YPAD (1% yeast extract, 2% peptone 40 mg/L adenine sulfate, and 2% 
dextrose) plate. Cells were allowed to grow to an OD600 of 1.0 - 1.4 in a 30 °C rotary 
incubator at 150 rpm. The culture was used to inoculate fermenting minimal media 
supplemented with different concentrations of 57Fe citrate. Once the OD600 reached 1.0 
- 1.4, cells were collected by centrifugation at 4000×g and rinsed 3× with 100 µM 
unbuffered EDTA.  Subsequently cells were rinsed 3× with water and packed into EPR 
or Mössbauer cuvettes for analysis.   
For cells from which mitochondria were isolated, 50 mL cultures were used to 
inoculate 1 L of growth medium. Once grown, these cultures were used to inoculate 24 L 
of medium in a custom glass bioreactor (ChemGlass) maintained at 30 °C.  O2 (99.99%) 
was bubbled through the bioreactor at 2 SCFM with a propeller rotation of 150 rpm. 
Cells were harvested at an OD600 of 1.0 – 1.4. Mitochondria were isolated as described 
118 with EGTA (1 mM final concentration) present in all buffers. Samples were packed 
into EPR or Mössbauer cuvettes as described 230 and stored in LN2 for subsequent 
analysis.  
 
Spectroscopic Analysis 
 Mössbauer spectra were collected using a model MS4 WRC spectrometer (SEE 
Co, Edina MN) as described 117. Parameters in the text are reported relative to α-Fe foil 
  120 
at room temperature (RT). Applied magnetic fields were parallel to the gamma radiation. 
Spectra were simulated using WMOSS software.  EPR spectra were collected on an X-
band spectrometer (EMX, Bruker Biospin Corp., Billerica MA) with an Oxford 
Instruments ER910 cryostat. Spin quantifications used a 1.00 mM CuEDTA spin 
standard and SpinCount software (http://www.chem.cmu.edu/groups/hendrich). UV-vis 
spectra were collected at RT on a Hitachi 4400U spectrophotometer with a head-on 
photomultiplier tube. Spectra were analyzed as described for reduced heme a, b, and c 
content 119. 
 
ICP-MS Analysis 
 Metal concentrations were determined by ICP-MS (Agilent model 7700x). 
Samples were packed into EPR cuvettes to determine the volume of the cell pellet 
(typically 200 - 300 µL). Following analysis by EPR, samples were diluted by a known 
factor while being transferred to a 15 mL screw-top tube containing 100 µL of 
concentrated trace metal grade HNO3 (Fisher). Tubes were sealed with electrical tape to 
prevent evaporation, and then incubated overnight at 90° C. Digested samples were 
diluted with 7.8 mL double-distilled H2O, and then analyzed by ICP-MS. Double-
distilled means that the H2O was house–distilled, deionized using exchange columns 
(Thermo Scientific 09-034-3), and distilled again using a sub-boiling still (Savillex DST-
1000).  
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Fet3-GFP Expression Western Blot 
 Cells were grown to an OD(600) of 1.0 - 1.2 on minimal medium supplemented 
with 21 µM BPS and various concentrations of Fe under both fermenting and 
respirofermenting conditions. Cells were harvested by centrifugation at 4000×g, rinsed 
3× with unbuffered EDTA (100 µM), then 3× with water. A portion of the resulting 
material was saved for Western blot analysis; the remainder was packed into EPR or 
Mössbauer cuvettes. Protein concentrations were measured and 60 µg protein of each 
sample were added per lane of the SDS-PAGE gel. Proteins were separated and 
transferred to a PVDF membrane as described 118. The membrane was then incubated 
with antibodies against GFP and actin (Thermo Scientific) with the actin serving as a 
loading control. OxyBlot assays were performed as suggested by the manufacturer 
(Millipore). 
 
Results 
 
Iron-Deficient Cells 
 For this study, iron-deficient means that BPS was added to the growth medium 
to chelate endogenous unenriched Fe and that 1 µM 57FeIII citrate was subsequently 
added to enhance Mössbauer spectral intensity. Fe-deficient cells were grown with either 
glucose or galactose as the carbon source. Yeast cells exclusively ferment when grown 
on glucose whereas they both respire and ferment (called respirofermenting) when 
grown on galactose. In a previous study, we grew cells under respirofermenting 
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Table 4-1. Characteristics of isolated mitochondria and whole cells. Metal numbers, 
percentages used for Mössbauer spectral simulation, spin intensities of EPR signals, and 
concentrations of heme centers from UV-vis spectra. Percentages are based on corrected 
Mössbauer spectra where applicable. For fermenting mitochondria obtained from cells 
grown with 100 µM Fe in the medium, the two numbers listed for percentage refer to 
each of the two batches examined. EPR and ICP-MS data have been corrected for 
packing efficiency. Numbers in parenthesis represent number of trials (n) if different 
from 1. Estimated uncertainties in Mössbauer percentages are ± 4%, except for the 
sample obtained under Fe-deficient conditions in which the uncertainty is ± 7%.  
Uncertainties for EPR spin quantifications are ± 25%. Metal concentrations in cells have 
not been corrected for adventitious [Fe2+(BPS)3]4- bound on the cell’s exterior.   
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Table 4-1 (Continued) 
Whole Cells Respiroferm. Ferm. Ferm. Ferm. Ferm. Ferm. Ferm. 
[Fe]medium (µM) BPS + 1 BPS + 1 1 10 100 1,000 10,000 
[Fe]cell (µM) 
170 ± 50 
(3) 
240 ± 80 
(3) 250 (1) 
395 ± 40 
(3) 
470 ± 100 
(3) 440  80 (3) 450 (1) 
[Cu]cell µM) 
62 ± 25 
(3) 
280 ± 20 
(3) --- 26 ± 6 (3) 20 ± 6 (3) 35 ± 8 (3) 90 (1) 
[Mn]cell (µM) 
16 ± 7 
(3) 17 ± 4 (3) --- 14 ± 4 (3) 17 ± 3 (3) 39 ± 10 (3) 30 (1) 
[Zn]cell (µM) 
160 ± 40 
(3) 
560 ± 70 
(3) --- 
600 ± 100 
(3) 
570 ± 70 
(3) 
1300 ± 130 
(3) 300 (1) 
NHHS Fe3+ (%) ~ 0 ~ 0 40 76 80 75 84 
CD (%) 43 36 22 18 10 5 3 
NHHS Fe2+ (%) 39 (66 µM) 
26 
(62 µM) 
26 
(65µM) 
7 
(26 µM) 
5 
(23 µM) 
6 
(26 µM) 5 (22 µM) 
Nanoparticles (%) 18 ~ 0 12 ~ 0 4 18 10 
[Fe2+(BPS)3]4- (%) 12 35 N/A N/A N/A N/A N/A 
g = 4.3 (µM) ~ 0 14 --- 130 360 320 290 
g = 2.0 region 
(µM) 26 14 --- 16 15 28 27 
        
Mitochondria Respiroferm. Ferm. Ferm. Ferm. Ferm. Ferm. Ferm. 
[Fe] (µM) 300 480 ± 160 (2) --- 
544 ± 70 
(2) 
710 
(1) 
840 ± 200 
(3) 500 
[Cu] (µM) 270 80 --- 48 ± 13 (2) 52 (1) 60 ± 20 (3) 65 
[Mn] (µM) 12 13 --- 12 ± 3 (2) 11 (1) 10 ± 2 (3) 22 
[Zn] (µM) 250 570 --- 236 ± 100 (2) 350 (1) 
450 ± 200 
(3) 150 
NHHS Fe3+ (%) ND < 15% --- < 15% 51,0 --- --- 
CD (%) 63 59 --- 11 12, 34 --- --- 
NHHS Fe2+ (%) 14 7 --- 28 18, 36 --- --- 
HS Fe2+ Heme 
(%) 7 9 --- ~ 0 ~ 0 --- --- 
nanoparticles (%) ND < 10% --- 57 27 --- --- 
S = 0 [Fe2S2]2+ 
(%) ND 12 --- ND ND --- --- 
S = ½ [Fe2S2]1+ 
(%) ND 12 --- ND ND --- --- 
[g = 4.3] (µM) ND ND --- 20 20 28 --- 
[Heme a] (µM) 30 30 --- 24, 43 27 13 23 
[Heme b] (µM) 70 72 --- 64, 58 78 21 40 
[Heme c] (µM) 120 120 --- 110, 129 130 40 97 
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 conditions using minimal medium supplemented with 40 µM 57Fe 119. The Fe content 
(i.e. the types of Fe centers and percentages of each type) of those cells was essentially 
indistinguishable from that of cells grown on glycerol, a respiration-only carbon source. 
Thus, at the resolution of our experiments, respirofermentation essentially mirrors 
respiration. Growing cells on galactose is more convenient than growing them on 
glycerol, and so galactose-grown cells were used here. We will refer to BPS-treated 
fermenting and respirofermenting cells as BPS-F and BPS-RF cells, respectively.  
Harvested BPS-F cells were rinsed with distilled and deionized water to remove 
[FeII(BPS)3]4-, and then packed into Mössbauer cups. The low-temperature, (6 ± 1 K) 
low-field (0.05 T) Mössbauer spectrum of these pinkish cells (see Appendix II, Figure 
A13, A) exhibited poor S/N due to the low concentration of 57Fe. An unresolved 
resonance in the center of the spectrum dominated. Authentic [FeII(BPS)3]4- exhibited a 
similar feature (Figure A13, B), suggesting that the BPS-F sample contained 
[FeII(BPS)3]4- despite having been rinsed extensively. We subtracted the [FeII(BPS)3]4- 
spectrum from that of the BPS-F cells, at 35% intensity, resulting in the spectrum of 
Figure 4-1B. Thus, only ca. 65% of the total Fe in the packed sample (Table 4-1; 240 
µM × 0.65 = 156 µM) was due to Fe contained in the BPS-F cells. Parenthetically, the 
concentration of [FeII(BPS]3]4- in the packed sample was substantially higher than the 
maximum possible concentration of [FeII(BPS]3]4-  in the medium (i.e. ~ 0.1 µM),   
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Figure 4-1.  Mössbauer spectra (5 – 7 K, 0.05 T parallel field) of 57Fe-enriched yeast 
cells at various [Fe]med. A, BPS-RF; B, BPS-F; C, 1-F; D, 10-F; E, 100-F; F, 1000-F; and 
G, 10,000-F. Red lines are simulations assuming percentages given in Table 4-1. 
Spectrum B was obtained by subtracting a contribution of the [FeII(BPS)3]4- spectrum 
from the raw spectrum (shown in Figure A13 A). Spectrum C has been published 172. 
Red lines in B – F are four-term simulations assuming the CD (δ= 0.45 mm/sec, ΔEq = 
1.15 mm/sec) and NHHS FeII doublets (δ= 1.3 mm/sec, ΔEq = 3.1 mm/sec), a 
mononuclear HS FeIII sextet, and a nanoparticle doublet (δ= 0.5 mm/sec, ΔEq = 0.6 
mm/sec). The HS FeIII sextet was simulated using D = 0.5 cm-1, E/D = 0.33, ΔEQ = 0.10 
- 0.14 mm/s, η =2.8, A0/gN⋅βN = -238 kG, δ = 0.54 mm/s, Γ = 0.9 mm/s. Assumed 
temperature in C – G was 5, 6, 5, 7, and 6 K, respectively.  
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Figure 4-1 (Continued) 
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suggesting that [FeII(BPS)3]4- collected on the cell’s exterior. In principle, BPS could 
have penetrated the cell, but the charge on the complex probably discouraged this. Our 
packed pellets contain 70% cells and 30% buffer 172. The concentrations in Table 4-1 
have been corrected for this 0.7 packing efficiency.  
The corrected BPS-F whole-cell Mössbauer spectrum was dominated by a 
quadruple doublet (δ = 0.45 mm/s, ΔEQ = 1.15 mm/s) indistinguishable from the Central 
Doublet (CD) identified previously 116.  This doublet arises from S = 0 [Fe4S4]2+ clusters 
and LS FeII heme centers 116. A second prominent feature was a quadrupole doublet with 
parameters typical of nonheme high-spin (NHHS) FeII (δ = 1.2 mm/s and ΔEQ = 3.1 
mm/s). Percentages of these and all other spectral components are given in Table 4-1. 
We estimate that the CD- and NHHS FeII –associated species in BPS-F cells are present 
at ca. 90 and 60 µM Fe, respectively. No other features, including those from FeIII 
oxyhydroxide (phosphate) nanoparticles or mononuclear HS FeIII species, were evident, 
though minor contributions could have escaped detection due to the poor S/N ratio.  
The corresponding Mössbauer spectrum of BPS-RF cells also exhibited poor 
S/N. In this case a 12% contribution of the [FeII(BPS)3]4- spectrum was subtracted, 
affording the corrected spectrum shown in Figure 4-1A. The spectrum was similar to 
that of BPS-F cells, including major contributions from CD and NHHS FeII features. The 
absolute concentrations of these features were also similar (73 and 66 µM, respectively). 
A minor feature arising from HS FeII hemes may be evident in the BPS-RF spectrum, but 
the low S/N makes this assignment uncertain.  In any event, the Mössbauer spectra of the 
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two BPS-treated samples were very similar despite the fact that cells were grown in 
different metabolic modes.  
EPR spectra of BPS-F and BPS-RF cells were also similar. Both exhibited low-
intensity signals in the g = 2 region from MnII ions, as evidenced by the hyperfine 
splitting arising from the I = 5/2 Mn nucleus (Figure 4-2, A and B). Such signals were 
observed in all whole-cell spectra (Figure 4-2, A - F) with similar intensities regardless 
of [Femed]. Also evident in the EPR spectra of BPS-F and BPS-RF cells were features at 
g ≈ 2.01, g ≈ 4.3, and minor features in the g = 6 region. The g = 4.3 signal is due to 
mononuclear HS FeIII ions with E/D ~ 1/3. The features at g = 6.4, 6.0 and 5.4 originate 
from a partially-oxidized state of cytochrome c oxidase 116, 119, 231. No signals from Cu 
ions were observed, despite the relatively high concentration of Cu in all 3 BPS-F 
samples examined. Most Cu ions in these cells are probably in the diamagnetic CuI state, 
though there may be other reasons for the EPR silence.    
 
Mitochondria from Fe-Deficient Cells 
 The pinkish color of the BPS-treated cells was absent in the corresponding 
isolated mitochondria, indicating that the BPS-Fe complex that adhered to the cell 
exterior was removed during this process. The 6 K, 0.05 T Mössbauer spectrum of 
mitochondria isolated from BPS-F cells – called “BPS-F mitochondria” (Figure 4-3B) – 
was dominated by the CD. Also present was a feature exhibiting magnetic hyperfine 
interactions that probably arose from S = ½ [Fe2S2]1+ clusters, e.g. the cluster in the 
Rieske protein associated with cytochrome bc1 232. HS heme and nonheme FeII species  
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Figure 4-2.  10 K X-band EPR spectra of unenriched fermenting whole cells. A, BPS-
RF; B, BPS-F; C, 10-F; D, 100-F; E, 1000-F; and F, 10,000-F.  Other EPR conditions 
were: microwave frequency, 9.46 GHz; microwave power, 0.2 mW; modulation 
amplitude, 10 G; modulation frequency, 100 kHz; time constant, 335 sec; sweep time, 
165 sec. The dashed line indicates g = 4.3. 
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Figure 4-3. 6 K, 0.05 T Mössbauer spectra of isolated mitochondria. A, from BPS-RF 
cells; B, BPS-F cells; C, 10-F cells; D, 100-F cells; E, 100-F cells with 1 mM dithionite 
added in 0.6 M sorbitol and 0.1M Tris, pH 8.5. Red lines are simulations using 
percentages listed in Table 4-1. The blue line is a quadrupole doublet (δ = 0.3 mm/s; 
ΔEQ = 0.6mm/s) typical of S = 0 [Fe2S2]2+ clusters.    
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were also present, as evidenced by the high-energy lines of the associated quadrupole 
doublets in the spectra.  
BPS-F mitochondria were largely devoid of FeIII oxyhydroxide nanoparticles, as 
the doublet due to this species falls between the well-resolved lines of the CD. Indeed, 
the resolution between the CD lines was sufficient to discern a resonance near ~ 0.6 
mm/s that was assigned to the high-energy line of a quadrupole doublet arising from S = 
0 [Fe2S2]2+ clusters. The blue line in Figure 4-3B is a simulation of that doublet. Such 
clusters in the oxidized diamagnetic 2+ state have not been observed previously in any 
Mössbauer spectra of mitochondria, perhaps because previous spectra inevitably 
included contributions from nanoparticles 118, 119 which absorb in the same region. The 
absence of intense NHHS FeII and nanoparticle doublets rendered the BPS-F spectrum 
more reminiscent of that obtained from 40-RF mitochondria 119, which also lacked these 
doublets, than from the spectrum of 40-F mitochondria which included them. However, 
even in 40-RF mitochondria, no feature arising from S = 0 [Fe2S2]2+ clusters was 
discerned.  Percentages used to fit the Figure 4-3B spectrum are given in Table 4-1.  
The UV-vis spectrum of BPS-RF and BPS-F mitochondria (Figure 4-4, A and B) 
exhibited features due to FeII heme centers. The concentrations of reduced hemes a, b, c 
(Table 4-1) were similar to those reported for 40-R mitochondria 119. The 10 K X-band 
EPR spectrum of BPS-RF and BPS-F mitochondria (Figure 4-5, A and B) exhibited low-
intensity signals at g = 6.5, 5.4, and 4.3. The first two signals probably arose from the 
a3:Cub site of cytochrome c oxidase 231, while the g = 4.3 signal arose from a rhombic 
HS FeIII species in BPS-F mitochondria. The g = 2 region lacked the MnII signal that was  
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Figure 4-4. UV-vis spectra of isolated mitochondria. A, BPS-RF; B, BPS-F; C, 10-F; D, 
100-F; E, 1000-F; F, 10-F from a second batch; G, 10000-F from the second batch.  
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Figure 4-5.  EPR of isolated mitochondria. A, BPS-RF; B, BPS-F cells; C, 10-F cells; 
D, 100-F cells; and E, 1000-F cells. Spectrum A is matched to Figure 4-3A; spectrum B 
is matched to spectrum 3B. EPR conditions were as in Figure 4-2. The dashed line 
indicated g = 1.94. 
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evident in whole-cell spectra, indicating that the ions affording that signal are not located 
in mitochondria.  
 
Fe-Sufficient Cells and Mitochondria 
 For comparison, we examined fermenting cells grown on medium supplemented 
with 1 µM (with no BPS) and 10 µM 57Fe. Mössbauer spectra of 1-F and 10-F cells 
(Figure 4-1, C and D) exhibited features due to mononuclear HS FeIII, the CD, NHHS 
FeII, and FeIII oxyhydroxide nanoparticles (percentages given in Table 4-1). The main 
difference in these spectra was in the percentage of the HS FeIII sextet. For 10-F cells, 
this percentage was more than double that in the 1-F spectrum. This feature undoubtedly 
arose from Fe within isolated vacuoles 120, indicating that vacuolar Fe is essentially 
absent in BPS-F and BPS-RF cells and that it starts to accumulates as cells grow in 
medium containing 1 - 10 µM Fe. ICP-MS analysis indicated that ~100 µM of the Fe in 
1-F cells and ~300 µM Fe in 10-F cells were associated with vacuoles. This 
corresponded to 40% and 76% of cellular Fe, respectively.  
EPR spectra of 10-F cells (Figure 4-2C) were generally similar to those of BPS-
RF and BPS-F cells (Figure 4-2, A and B), except for a more pronounced g ≈ 4.3 signal. 
This is consistent with an increased concentration of the vacuolar mononuclear HS FeIII 
species in the 10-F cells.  
Interestingly, the absolute concentration of NHHS FeII ions in the cells (obtained 
by multiplying the cellular Fe concentration by the fractional Mössbauer intensity) 
declined significantly (3-fold) as [Femed] increased from 1  10 µM. The average 
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NHHS FeII concentration was 64 ± 2 µM in the BPS-F, BPS-RF and 1-F samples, and 24 
± 2 µM in the 10-F, 100-F, 1000-F and 10,000-F cells (Table 4-1).  
 The low-temperature, low-field Mössbauer spectrum of 10-F mitochondria 
(Figure 4-3C) was nearly indistinguishable from that of 40-F mitochondria 118. Relative 
to BPS-RF and BPS-F mitochondria, 10-F mitochondria exhibited considerably more 
FeIII oxyhydroxide nanoparticles (Table 4-1). UV-Vis (Figure 4-4C) and EPR (Figure 4-
5C) spectra of 10-F mitochondria were also similar to those of 40-F mitochondria 119. 
The UV-Vis spectrum exhibited FeII heme concentrations similar to those seen in the 
BPS-F sample (Table 4-1). The concentration of Fe in the 10-F sample was reduced 
relative to in the 40-F sample. 
 
Fe-Overload Conditions 
 The Fe concentrations in 100-F, 1000-F and 10,000-F cells were similar to each 
other and to that of cells grown on 10 µM Fe (Table 4-1), despite the 1000-fold range of 
[Femed]. The Mössbauer spectra of these cells (Figure 4-1, E - G) were also remarkably 
similar to each other and to spectra of 40-F cells; they exhibited similar contributions of 
the CD, the NHHS FeII doublet and FeIII nanoparticles. 100-F cells contained a slightly 
lower concentration of FeIII nanoparticles relative to the other two samples. However, no 
general trend was apparent, in that the 1000-F sample exhibited a higher concentration 
of FeIII nanoparticles than did 10,000-F cells. The main point is that a 250-fold change in 
[Femed] (from 40  10,000 µM) had little effect on the concentration or distribution of 
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Fe within fermenting cells. The only noticeable exception was a gradual but significant 
decline of the CD intensity as [Femed] increased (Table 4-1).  
100-F, 1000-F and 10,000-F cells exhibited EPR spectra (Figure 4-2, C - E) 
similar to those of 10-F cells, except for more intense g ≈ 4.3 signals. Spin 
concentrations of the g = 4.3 signal (Table 4-1) represented ~70% of the Fe 
concentration associated with the HS FeIII sextet in the corresponding Mössbauer 
spectra. Although not a perfect match, this percentage indicates an acceptable 
congruence between the two types of measurements.  
The 5K, low-field Mössbauer spectra of isolated 10-F (Figure 4-3C), 40-F 118, 
and 100-F mitochondria (Figure 4-3D) all included the CD, a HS FeII doublet, and a 
doublet due to FeIII nanoparticles in approximately the same relative amounts. The 100-F 
sample also exhibited a sextet due to mononuclear HS FeIII species representing ca. 40% 
of the spectral intensity. 40-F mitochondria exhibited a similar feature but representing 
just 15% of spectral intensity 118.  
The greater intensity of the sextet in the 100-F mitochondria spectrum prompted 
us to consider whether the additional HS FeIII ions were located in the mitochondria or 
whether they were an artifact of purification and bound on the exterior of the organelle. 
To address this, we isolated a second batch of 100-F mitochondria including the 
reductant dithionite in the buffer. Dithionite does not appear to penetrate mitochondrial 
membranes 118. The resulting spectrum (Figure 4-3E) showed no evidence of the sextet, 
suggesting that most or all of the Fe associated with this feature in first sample was 
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artifactual. The expense associated with preparing 57Fe-enriched 100-F mitochondria 
from 24 L of cells prohibited us from exploring this issue further.  
 100-F and (unenriched) 1000-F mitochondria exhibited the same EPR signals 
with about the same relative intensities (Figure 4-5, D and E). 10-F (Figure 4-5C) and 
40-F 119 mitochondria exhibited very similar spectra. Importantly, the intensities of the g 
= 4.3 signal in the 100-F and 1000-F spectra were not higher than those in the 10-F or 
40-F spectra. This is further evidence that the more intense HS FeIII sextet observed in 
Mössbauer spectra of one batch of 100-F mitochondria was an artifact of that particular 
preparation. We conclude that the Fe content of 10-F, 40-F and 100-F mitochondria is 
approximately the same. 
A 100-F mitochondria sample exhibited a UV-Vis spectrum (Figure 4-4D) 
similar to that of 10-F mitochondria (Figure 4-4C) while a 1000-F sample (Figure 4-4E) 
showed diminished intensities (heme concentrations are given in Table 4-1). To address 
whether this decline reflected a cellular response to toxic levels of Fe in the growth 
medium, we isolated two batches of mitochondria, from cells grown with 10 (control) 
and 10,000 µM [Femed] in the growth medium. Both batches of cells grew at nearly the 
same rate; i.e. the 10,000 µM sample showed essentially no sign of toxicity. Oxyblot 
analysis of extracts of the two organelles (Appendix II, Figure A14) indicated just 10% 
more ROS damage in the 10,000-F sample relative to the 10-F sample. ICP-MS analysis 
indicated insignificant differences in the concentration of Fe in the organelles (Table 4-
1). However, corresponding UV-vis spectra indicated a decline in reduced heme 
intensities (Figure 4-4, F and G, and Table 4-1). The decline of heme intensity in Figure 
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4-4 E and G appears to be real. We conclude that Fe concentrations in the growth 
medium as high as 10,000 µM FeIII citrate have insignificant effects on the growth rate 
of the cell, the level of ROS damage, and the Fe concentration of cells and their 
mitochondria and vacuoles. However, there does appear to be a decline in the level of 
[Fe4S4]2+ clusters FeII hemes at very high [Femed].   
 
Fet3-GFP Expression Levels in Fermenting and Respirofermenting Cells 
The DY150, FET3-GFP::KanMX strain biosynthesizes the green fluorescent 
protein (GFP) fused to Fet3p 228. We used this strain to perform a Western blot using an 
antibody against GFP as a reporter for Fet3p expression. The analysis was performed on 
cells grown under fermenting (and BPS-RF) conditions and supplemented with various 
concentrations of Fe in the growth medium. Fet3p was detected only in the BPS-F 
sample (Figure 4-6, right-most lane). Three bands were observed, with the middle band 
displaying the highest density and the upper band ~ 7-times less intense but visible 
nevertheless. Since bands were not visible in any other lane, the concentration of Fet3-
GFP in the BPS-F sample appears to have been at least 10-times greater than in the other 
samples, assuming no threshold effects. This suggests that the Aft1-controlled Fe 
regulon was effectively shut down when cells were grown in medium containing > ca. 1 
µM of Fe. Fe-deficient respirofermenting cells do not appear to utilize the Fe regulon, as 
no Fet3p expression was observed.  
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Figure 4-6. Western blot of Fet3-GFP cells grown at various conditions. Actin was 
added as a loading control.  BPS was added to all samples.  
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Discussion 
 
The Fe-Deficient State 
Fermenting WT yeast cells grown under Fe-deficient conditions prioritize their 
use of Fe for essential functions. Such cells were devoid of vacuolar HS FeIII, a storage 
form of Fe that is not essential, and were largely devoid of FeIII oxyhydroxide 
(phosphate) nanoparticles, which do not seem to function in cellular Fe metabolism. Fe-
deficient cells had a total Fe concentration of ca. 150 µM, distributed into two major 
groups. About 80 µM was present as S = 0 [Fe4S4]2+ clusters and LS FeII hemes (the two 
types of Fe cannot be distinguished by Mössbauer), most of which are undoubtedly 
associated with mitochondria and respiration. About 60 µM cellular Fe corresponded to 
NHHS FeII species. About the same distribution of Fe was observed in both fermenting 
and respirofermenting Fe-deficient cells.  
Mitochondria from Fe-deficient fermenting and respirofermenting cells also 
prioritize their use of Fe; they contained similar levels of respiratory complexes relative 
to Fe-sufficient mitochondria, but lower concentrations of nanoparticles and NHHS 
FeII/FeIII species. This distribution was more typical of Fe-sufficient mitochondria from 
respiring cells 119. We previously proposed that the NHHS FeII and FeIII species in 
mitochondria are in equilibrium with each other and with the nanoparticles contained 
therein, and that the NHHS FeII species constitutes a pool of Fe used for heme and Fe/S 
cluster biosynthesis 118. This size of this pool declines in respiring mitochondria, which 
is consistent with the higher rates of Fe/S cluster and heme biosynthesis. The lower 
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concentrations of this pool observed in Fe-deficient mitochondria might arise instead 
from a diminished rate of Fe import from the cytosol into mitochondria due to Fe-
deficient conditions. 
 
A Non-Mitochondrial NHHS FeII Pool 
 The concentration of NHHS FeII in isolated Fe-deficient mitochondria was ~ 40 
µM. What proportion of the NHHS FeII pool observed in whole cells is due to the NHHS 
FeII species in mitochondria? Mitochondria in fermenting cells occupy between 3% and 
10% of cell volume 233. This means that the concentration of mitochondrially-associated 
NHHS FeII species in Fe-deficient cells is 1.2 - 4 µM (i.e. 40 µM × (0.03 to 0.1)). Since 
the observed concentration of NHHS FeII in Fe-deficient whole cells was ~ 60 µM, we 
conclude that > 90% of the NHHS FeII in whole cells is not located in mitochondria. Nor 
does this non-mitochondrial pool appear to be located in vacuoles 120. As a working 
hypothesis, we propose that the pool of NHHS FeII in Fe-deficient cells is located in the 
cytosol.  
 
Decrease in Non-Mitochondrial NHHS FeII as [Femed] Increases 
Under Fe-sufficient and Fe-overload conditions, mitochondria contained ~ 150 
µM NHHS FeII – a 3-fold increase relative to under Fe-deficient conditions. Under these 
high-Fe conditions, our calculations suggest that as much as 60% of the NHHS FeII 
species present in whole cells is now located in mitochondria. Thus, the decline of non-
mitochondrial NHHS FeII as cells transition from being Fe-deficient to Fe-sufficient (60 
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 25 µM) is more dramatic than implied by the ratio 60:25. These results suggest that 
during the transition from 1  10 µM [Femed], most of the non-mitochondrial (probably 
cytosolic) NHHS FeII species of whole Fe-deficient cells moves into the mitochondria 
where they contribute to the NHHS FeII pool (and ultimately nanoparticles) in this 
organelle.  
Occurring in approximately the same transition period was a decline in the 
expression of the Fe regulon as reported by Fet3p, confirming previous studies that Aft1-
dependent expression of the Fe regulon is effectively abolished at > 1 µM [Femed] 203, 234. 
The low-affinity pathways play the major role in regulating cellular Fe beyond this 
transition. The transition of non-mitochondrial NHHS FeII into the mitochondria (or 
vacuoles) might be related to the switch from high- to low-affinity Fe regulatory 
mechanisms or to the activation of CCC1.  
 
Accumulation of Vacuolar Fe 
The lack of vacuolar Fe in Fe-deficient cells is probably due to the lack of Ccc1p 
on the vacuole membrane caused by destabilization of CCC1 mRNA by Cth1p/2p under 
Fe-deficient conditions (the process also requires Aft1p/2p) 235. Cth1p/2p also destabilize 
the mRNA of genes involved in Fe/S cluster and heme biosynthesis and the mRNA of 
numerous Fe/S-containing and heme-containing proteins. Our results support previous 
studies regarding the effects of Cth1p/2p on CCC1p, but do not indicate lower 
concentrations of Fe/S cluster or heme centers in Fe-deficient cells or mitochondria. This 
is probably because we supplemented the BPS-treated medium with 1 µM 57Fe (to allow 
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Mössbauer analysis), which rendered our cells less rigorously Fe-deficient than the BPS-
treated cells of Thiele and coworkers 213. We suspect that their Fe-starved cells shut 
down Fe/S cluster and heme assembly in a final attempt to survive.  
CCC1 gene expression increases dramatically between [Femed] = 5 - 50 µM 213, 
consistent with the increased level of vacuole Fe that we observed as [Femed] increased. 
In this case, the increased CCC1 expression level is probably due to Yap5p, an Fe-
inducible transcription factor. As the concentration of Ccc1p on the vacuolar membrane 
increases, vacuoles import Fe such that the vacuoles in cells grown on 1, 10 and 40 µM 
Fe are ca. 0, 40%, and 100% filled.  
The concentration of Fe that can be associated with vacuoles maximizes between 
300 - 350 µM. We have previously estimated that the Fe concentration in vacuoles in 
cells grown on 40 µM Fe is ~ 1.2 mM, based on the assumption that these organelles 
occupy ca. 25% of cell volume 118, 172. Our results indicate that cells limit the storage of 
HS FeIII in vacuoles to this cellular Fe concentration, regardless of the concentration of 
Fe in the growth medium. Whether they do this by limiting the percentage volume of 
vacuoles in the cell and/or the concentration of mononuclear HS FeIII contained therein 
is uncertain.  
The total Fe concentration in fermenting cells is also limited, with a minimum of 
ca. 160 µM in Fe-deficient cells. This concentration gradually increasing as vacuoles fill 
and other changes occur, maximizing at ca. 450 µM in cells grown in Fe-overloaded 
medium. The increase in cellular Fe concentration is largely (but not entirely) due to the 
vacuoles filling with Fe, suggesting that the [Fe] of all non-vacuolar Fe components of 
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the cell are roughly invariant (at ~ 160 µM) during this process. The majority of this 
invariant portion of cellular Fe is mitochondrial.  
 
Modest Changes in the Fe Distribution in the Cells  
Grown on Fe-Overloaded Medium 
The concentration of Fe in cells and the distribution of that Fe into different 
groups is roughly invariant over a 250-fold range of [Femed] (40  10,000 µM). In this 
region, Fe is being imported via low-affinity pathways. The invariant Fe concentration 
suggests that the low-affinity pathway must be saturated throughout this 250-fold 
interval. The Fe import velocity might be saturable, in which case a Michaelis-Menten-
like expression with Km-app ~ 15 µM Fe could simulate this effect. This is within a factor 
of 2 of previous estimates of the apparent Km for the low-affinity transporter 206, 211, 212.  
Our results also reveal why WT yeast cells grow well under high-Fe (5 – 10 mM) 
conditions – namely because they prevent excess environmental Fe from being imported 
(rather than, for example, having special mechanisms to detoxify excess imported Fe).  
Two modest but noticeable changes in the Fe distribution of such cells were a 
decline in the concentration of Fe associated with the Mössbauer central doublet and 
heme centers as [Femed] increased. Under Fe-deficient conditions, the cellular CD 
concentration was ca. 80 µM whereas with [Femed] = 1, 10, 100, 1000 and 10,000 µM, it 
was 55, 71, 47, 22 and 14 µM, respectively. UV-Vis spectra also showed some decline 
in heme features at high medium Fe concentration. These declines might reflect a 
decline in the fractional cellular volume occupied by mitochondria or a decline in the 
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concentration of Fe-rich respiratory complexes. More extreme declines of these centers 
under even higher medium Fe concentrations might be responsible for the Fe-associated 
toxicity that is eventually observed.   
 
Cellular Manganese 
Comparing the ICP-MS-detected Mn concentrations to the spin concentrations of 
the Mn-associated EPR signal (Table 4-1, “g = 2.0 region”) indicates that the majority of 
Mn ions in the cells are mononuclear MnII species that exhibit(s) the EPR signal. This 
differs from the study of Chang and Kosman 236 who reported that the majority of 
cellular Mn is EPR-silent. McNaughton et al. used ENDOR spectroscopy to investigate 
the species affording this signal 237 and determined that > 70% of the contributing 
species are MnII ions coordinated with phosphate and/or polyphosphate anions. The 
absence of these signals in isolated mitochondria and vacuoles 120 suggests that these 
MnII(phosphate/polyphosphate) species are not located in either of these organelles. The 
concentration of MnII(phosphate/polyphosphate) species in our fermenting yeast cells 
appears to be 10 – 30 µM, regardless of [Femed]. 
 
Summary Model 
The major results of this study can be summarized by the model of Figure 4-7. 
The high-affinity Fe import pathway operates when [Femed] < ca. 1 µM (BPS-treated 
plus 1 µM 57Fe). Under these conditions, the cell is Fe-deficient and must prioritize its 
use of Fe. Most of this precious commodity goes to the mitochondria where it is 
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assembled into Fe/S clusters and heme centers, prosthetic groups that are critical for 
cellular metabolism. Little Fe is stored in vacuoles and little is present as FeIII 
nanoparticles. A significant portion of cellular Fe in Fe-deficient cells is in the form of 
NHHS FeII and is probably located in the cytosol. At [Femed] ~ 10 µM, the high-affinity 
pathway is shut-down and Fe is regulated by low-affinity pathways. The mitochondria 
remain the site where much imported Fe is sent for Fe/S cluster and heme synthesis. 
Additional Fe is imported (perhaps from the cytosolic pool of NHHS FeII), increasing 
the pool of mitochondrial NHHS FeII and FeIII oxyhydroxide nanoparticles. Cytosolic 
NHHS FeII species declines as some becomes stored in vacuoles as nonheme HS FeIII 
species. When [Femed] = 40 – 10,000 µM, the vacuoles are filled with Fe, and little else 
changes in terms of Fe content and distribution. The low-affinity import pathways are 
saturated in accordance with apparent Km 15 - 30 µM, limiting Fe import at this [Femed] 
concentration and higher. This prevents high concentrations of environmental Fe from 
entering the cell and causing toxicity. These regulatory properties allow fermenting yeast 
cells to grow on medium with Fe concentrations that vary over 4 orders of magnitude, an 
impressive feat by any standard!  
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Figure 4-7. Model of Fe distribution and regulation in fermenting yeast cells. Top, Fe-
deficient; middle, Fe-sufficient; bottom, Fe-loaded. The concentration of FeIII citrate in 
the growth medium (in µM) is indicated by the brown squares. Two import pathways are 
shown, including the high-affinity pathway (Aft1 regulating the iron regulon including 
Fet3p) and the low-affinity pathway (Fet4p-based). Also shown are mitochondria (blue 
rectangular shape) and vacuoles (red sphere). Under Fe-deficient conditions, Fe is 
imported via the high-affinity pathway; a portion is imported into mitochondria where 
Fe/S clusters (brown cube) and heme centers (disks) are predominantly made. Most of 
the rest of the imported Fe is present as a non-mitochondrial NHHS FeII pool (shown 
here in the cytosol, but this is not known). Aft1p is sensing a small portion of this pool. 
The vacuoles are empty because Cth2 working with Aft1p is activated by the absence of 
cytosolic Fe to degrade CCC1 mRNA. Under Fe-sufficient conditions, the high-affinity 
pathway is shut-down and the majority of Fe is imported via the low-affinity pathway. 
The concentration of nonmitochondrial NHHS FeII is reduced 3-fold, perhaps because a 
portion is imported into mitochondria and converted to nanoparticles (clumps of brown 
circles) and NHHS FeII and FeIII. The vacuoles are partially filled with mononuclear HS 
FeIII species, due to the absence of the Cth2 effect and the presence of Yap5p-dependent 
expression of CCC1. Under Fe-overload conditions, the Fe content is similar to that 
under Fe-sufficient conditions except that the vacuoles are filled completely. The low-
affinity import pathway is saturable such that a 250-fold change in the Fe concentration 
of the medium does not significantly impact the cellular Fe content.     
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Figure 4-7 (Continued) 
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CHAPTER V 
 SUMMARY AND FUTURE STUDIES 
 
Summary 
 
The major objective of this dissertation has been to study iron trafficking, 
distribution, and speciation in Jurkat cells and Saccharomyces cerevisiae. An integrative 
biophysical and bioanalytical approach, centered on Mössbauer spectroscopy has been 
successfully adopted, for the first time, in the detailed study of iron in Jurkat whole cells 
and isolated mitochondria. The first objective of this dissertation, described in Chapter 
II, was to characterize the iron distribution and speciation in wild-type Jurkat cells and 
isolated mitochondria grown in glucose-containing medium, supplemented with 10 µM 
ferric citrate. Procedures were established and optimized for the large-scale (up to 24 
liters) growth of Jurkat cells in a bioreactor, and the anaerobic isolation of ‘pure’ and 
intact mitochondria from Jurkat cells. Isolated mitochondria were analyzed by 
transmission electron microscopy and Western blot analysis for intactness and purity. 
The packing efficiencies (defined as the percentage of a packed sample due to the 
sample only, excluding interstitial buffer) of whole cells and isolated mitochondria were 
also determined by use of a fluorescent dye. Packing efficiencies allowed us to calculate 
the absolute concentration of Fe in samples in µM, rather than having to rely on ratios of 
[Fe]: [protein] for quantification of cellular iron.  
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Mössbauer spectroscopy revealed that, in whole intact cells, the majority of Fe 
was associated with ferritin or the Central Doublet (CD), which consists of [Fe4S4]2+ 
clusters and low-spin hemes.  A significant amount of ferric nanoparticles was also 
found to accumulate in Jurkat cells under the growth conditions studied, and the large 
majority of the nanoparticles appeared to accumulate in the mitochondria. The presence 
of these ferric nanoparticles was confirmed using EPR and high-field Mössbauer 
spectroscopies, and was indicative of iron overload. The Mössbauer spectra of isolated 
mitochondria were dominated by the CD and the ferric nanoparticles, and were largely 
devoid of ferritin-bound Fe. A significant level of NHHS FeII (~5-10 fold greater than 
previously reported) was also detected in whole Jurkat cells and isolated mitochondria. 
UV-Vis spectroscopy revealed significant levels of reduced hemes a, b, and c in intact 
Jurkat cells and in anaerobically isolated mitochondria. EPR spectroscopy of isolated 
mitochondria allowed us to quantify the amount of Fe present in various respiratory 
complexes, such as succinate dehydrogenase, cytochrome bc1, and cytochrome c 
oxidase, whereas ICP-MS provided absolute concentrations of Fe and other metals, such 
as Mn, Cu, and Zn. By integrating all the information provided by our biophysical and 
bioanalytical methods, a ‘snapshot’ of the iron distribution and speciation in Jurkat cells 
was obtained (Figure 2-7), whereby the iron-containing species associated with the 
mitochondria were distinguished from those found in cellular compartments outside the 
mitochondria.  
We were intrigued by the presence of ferric nanoparticles in our samples, since 
such a form of iron was never before found to accumulate in mammalian cells. Our next 
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objective, described in Chapter III, was to study, in more detail, the conditions of growth 
that affected the formation of ferric nanoparticles. We again relied heavily on Mössbauer 
spectroscopy to study the formation of these ferric nanoparticles. We observed that cells 
grown on increasing concentrations of ferric citrate (FC) accumulated significant 
amounts of iron, mainly in the form of ferric nanoparticles. Mitochondria isolated from 
these cells did not accumulate more than ~1000 µM Fe, and the additional ferric 
nanoparticles, which were found to be ferric phosphate, accumulated mostly in the 
cytoplasm, as suggested by EDX EM images. The concentrations of other iron-
containing species, such as ferritin, Fe/S clusters, and hemes did not vary significantly 
with increase in FC in the growth medium. Furthermore, ferritin in cells accumulating 
ferric phosphate nanoparticles was only partially loaded with Fe. We grew cells with 
galactose instead of glucose to study the effect of switching to a carbon source that 
favors mitochondrial respiration. Galactose-grown cells were found to suffer more ROS 
damage, and also accumulate more ferric phosphate nanoparticles than glucose-grown 
cells. However, the level of ROS damage, under either carbon source, did not increase 
with increased nanoparticle formation, suggesting that there was no correlation between 
nanoparticle formation and ROS damage. The increased nanoparticle formation in 
galactose vs. glucose grown cells could be a result of metabolic differences, and possibly 
differences in growth rate. 
Cells grown on increasing concentrations of transferrin-bound iron (TBI) 
accumulated significantly less iron than cells grown with FC. The large majority of the 
iron was either associated with ferritin, or with the Central Doublet of the Mössbauer 
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spectra, even when we overexpressed the transferrin receptor (TfRC1) in Jurkat cells. 
This is because TBI uptake is a lot more tightly regulated than FC uptake. TfRC1-
overexpressing cells only started accumulating significant levels of ferric nanoparticles 
when grown on higher concentration of TBI. Cytosolic labile Fe is presumably sensed 
by the IRP1/2 system (for ferritin regulation), and also by PCBP1/2 (for Fe loading into 
ferritin). Fe uptake via the TBI pathway appeared to favor excess Fe storage in ferritin 
whereas FC uptake tended to lead to more ferric nanoparticle formation. However, even 
in TBI grown cells, ferritin was still only partially loaded. Furthermore, ferritin protein 
upregulation, in response to increased intracellular Fe, appeared to be more sensitive to 
iron originating from TBI uptake than from FC uptake. These results suggest that the 
cytosolic labile form of Fe that accumulates in Jurkat cells through TBI pathway may 
differ chemically (in terms of ligands bound) from the labile form of Fe that accumulates 
through the FC pathway. We also knocked-down frataxin protein in Jurkat cells, and 
observed an increase in ferric nanoparticle formation in frataxin-deficient cells. We 
developed a mathematical model centered on parameters and processes depicted in 
Figure 3-11, to simulate the accumulation of various Fe-containing species in Jurkat 
cells grown under the various conditions studied. Using the model, we were able to 
predict the time-dependence of Fe accumulation in frataxin-deficient cells (Figure 3-12). 
Iron content of fermenting Saccharomyces cerevisiae cells under iron-deficient 
and iron-overload conditions was also studied as described in Chapter IV. The high-
affinity Fe import pathway was active only in Fe-deficient cells, indicating that Aft1-
dependent expression of the Fe regulon was essentially non-existent at > 1 µM Fe in the 
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medium. At higher [Fe] in the medium, low-affinity iron transporters are presumed to 
play a greater role in iron import than the high-affinity Fe import pathway. Fe-deficient 
cells contained primarily nonheme high-spin (NHHS) FeII species (most of which was 
not located in the mitochondria) and mitochondrial Fe. Mitochondria isolated from Fe-
deficient cells contained [Fe4S4]2+ clusters, low- and high-spin hemes, S=½ [Fe2S2]1+ 
clusters, NHHS FeII species, and [Fe2S2]2+ clusters. The presence of [Fe2S2]1+ clusters 
was not observed in previous Saccharomyces cerevisiae samples 117-119, 139, 172  since the 
Mössbauer spectra were obscured by the presence of FeIII nanoparticles. The absence of 
nanoparticles allowed such clusters to be observed in Fe-deficient cells.  
Fe-deficient cells were found to prioritize their use of Fe to essential forms, and 
were devoid of nanoparticles and vacuolar Fe.  As iron concentration was increased in 
the growth medium 250-fold, fermenting cells accumulated no more than 400 – 450 µM 
Fe. However, the concentration of non-mitochondrial NHHS FeII declined, whereas the 
concentration of vacuolar NHHS FeIII increased to a limiting cellular concentration of ~ 
300 µM. On the other hand, isolated mitochondria from cells grown in Fe-sufficient 
conditions contained more NHHS FeII ions and significant amounts of FeIII 
nanoparticles. The lower NHHS FeII pool in Fe-deficient mitochondria was attributed to 
a decreased rate of import of Fe from the cytosol into the mitochondria due to Fe 
deficiency.  The transition of non-mitochondrial NHHS FeII into the mitochondria (or 
vacuoles) upon Fe increase in the medium might be a result of the switch from high- to 
low-affinity Fe regulatory mechanisms or the upregulation of CCC1 (a vacuolar Fe 
import protein).  
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Future Studies 
 
A topic that has remained of central interest to the field of iron metabolism for 
more than three decades is elucidation of the nature of the labile iron pool (LIP) present 
in cells and organelles. The LIP is hypothesized to be low-molecular-weight (LMW), 
‘loosely’ coordinated by various organic ligands 197, and believed to play a role in Fe 
sensing and trafficking by the cells. Over the past five years, our lab has developed the 
capability to separate low-molecular-weight metal complexes found in cells 238. This is 
achieved by exploiting anaerobic liquid chromatography, interfaced with an on-line ICP-
MS. The system has been successfully tested on mouse brain homogenates.  We may 
now use this set-up to characterize, and potentially identify, the ligands associated with 
the LMW Fe-containing species (which may form part of the LIP) present in Jurkat cells 
and isolated mitochondria. This can potentially provide great insight in understanding 
how these LMW species are sensed and trafficked within the cell.  
Disruptions in iron homeostasis are linked to a variety of human diseases, most 
of which are a result of mutations and deficiencies in proteins involved in iron 
metabolism and trafficking.  For example, depletion of the frataxin protein leads to 
Friedreich’s ataxia, and depletion of ABCB7 leads to X-linked Sideroblastic anemia, 
both leading to mitochondrial iron overload, and mitochondrial dysfunction. Frataxin is 
involved in mitochondrial Fe/S biogenesis, and one of its hypothesized functions is that 
of an iron chaperone that delivers Fe into the Fe/S biogenesis machinery. ABCB7 is a 
mitochondrial membrane transporter that is hypothesized to export an unidentified 
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species, X, from the mitochondria into the cytosol, where X may be sensed by cytosolic 
proteins that are involved in cellular iron homeostasis. It would be of great interest to 
examine the LMW Fe profiles of cells depleted of frataxin or ABCB7, using our LC-
ICP-MS set-up, and compare them to the profiles of normal Jurkat cells. Differences in 
the LMW Fe profiles upon depletion of these proteins of interest may point to the Fe-
species that are involved in the processes controlling iron homeostasis inside the cell. 
These studies may, for example, provide insight into the nature of the species ‘X’, which 
is presumably exported by ABCB7.  
One major challenge of studying the effects of disrupting iron homeostasis is 
teasing apart primary effects from secondary effects of depleting any protein involved in 
iron homeostasis, thus making it difficult to elucidate protein function.  This is because 
disruption of iron metabolism most often results in similar ultimate phenotypes, namely, 
ferric nanoparticle accumulation, increase in oxidative stress, damage to Fe/S clusters 
and hemes, and mitochondrial dysfunction. Our ability to perform tetracycline-inducible 
knockdown of proteins in Jurkat cells implies that we can knock down proteins to 
various extents by varying the concentration of tetracycline added to the medium.  The 
effect of ‘dialing’ down the levels of proteins such as frataxin and ABCB7 on the iron 
distribution of cells and isolated mitochondria can be studied using our biophysical and 
bioanalytical methods, as well as our LC-ICP-MS separation set-up. The primary effects 
of protein depletion may be potentially distinguished from secondary effects by the 
chronology of how oxidative stress, Fe distribution and Fe concentration of cells are 
affected.  
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Another avenue that may be worthwhile pursuing is the study of other organelles 
that are crucial for iron metabolism. After the mitochondrion, which is considered the 
‘hub’ of iron metabolism, the organelle that comes to mind is the lysosome. The iron 
distribution of the vacuole, which is the yeast equivalent of the lysosome, has been 
studied in detail by our lab 120. Vacuoles and lysosomes are similar in that they are both 
involved in degradation and recycling of macromolecules. However, vacuoles also have 
the added function of storing excess cellular iron in yeast, whereas that function is 
performed by ferritin (a 24-mer protein) in mammalian cells. On the other hand, 
autophagic events, namely the degradation of ferritin and mitochondria, may lead to an 
iron-rich environment in lysosomes, which increases their sensitivity to oxidative stress 
239, leads to lysosomal instability, and impairs further autophagy. During the past decade, 
iron was found to be the major cause of lysosomal instability in the presence of 
hydrogen peroxide, leading to lysosomal rupture and apoptosis/necrosis, while hydrogen 
peroxide alone was harmless. Lipofuscin (the poorly characterized ‘ageing pigment’) 
and hemosiderin (the presumed breakdown product of ferritin) are two iron-rich, non-
degradable materials most commonly found to accumulate in lysosomes. These 
lysosomal Fe-rich species are correlated with increased sensitivity of lysosomes to 
oxidative stress, and postmitotic ageing of cells 38, 239. It would be of interest to examine 
and compare the iron content and speciation of lysosomes in ‘young’ vs. ‘old’ cells to 
elucidate the type of iron that might have a role in cellular ageing processes. It may also 
be of interest to see how the addition of an anti-oxidant (preferably one that does not 
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participate in redox chemistry with Fe) might affect the iron speciation of lysosomes and 
their sensitivity to oxidative stress. 
Jurkat cells are easily scaled up in bioreactors by virtue of being a suspension 
cell line. However, other cell types that are more directly involved in systemic iron 
homeostasis, such as liver cells, macrophages, and enterocytes. These cell lines, 
although ordinarily grown as adherent cultures, may be adapted to grow in suspension, 
scaled up, and studied by our Mössbauer-centered biophysical techniques. Iron may be 
metabolized differently by these cells, and hence lead to varied iron distribution and 
speciation in these cells. Diseased states may also be studied by genetically modifying 
these cells. For example, hereditary hemochromatosis is one of the most common iron 
overload diseases, and involves a mutation in the HFE gene, which is expressed 
primarily in liver cells. The HFE gene product is believed to modulate (decrease) the 
affinity of the transferrin receptor for Fe in liver cells, and a dysfunctional HFE protein 
potentially leads to increased Fe binding to the transferrin receptor and increased Fe 
uptake, resulting in severe liver iron overload 240. It would be of interest to study the 
effect of HFE depletion on the iron distribution of liver cells (whether we would observe 
more ferritin-bound Fe or more ferric nanoparticles).  
The field of iron metabolism has witnessed tremendous breakthroughs in the past 
decade. However, numerous challenges remain in identifying the basic species involved 
in iron trafficking and sensing in the cell, and our understanding of the iron speciation 
and distribution in mammalian cells is still quite preliminary. Our biophysical methods, 
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teamed with our LC-ICP-MS separation methods, promise to be quite powerful in 
probing some of those challenges.  
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APPENDIX I 
 
Table A1. Batches of cells analyzed. 
Batch Packing Expt. 
Mössbauer 
Spectroscopy 
EPR 
Spectroscopy 
UV-Vis 
Spectroscopy ICP-MS 
C01-
C05 
Whole cells in from C01-C05 were used solely for mitochondria isolation and Western Blot 
analysis for purity 
C06 Yes Weak Table 2-1 - Table A4 
C07 - Figure 2-3A,  2-3B, and 2-3C Table 2-1 - Table A4 
C08 Yes - - - Table A4 
C09 - - - Table 2-1 - 
C10 - - - Figure 2-5C and 2-5D - 
C11 - - Figure 2-4A and 2-4B - Table A4 
C12 - - - Table 2-1 - 
C13 - Figure A1A and A1B Table 2-1 Table 2-1 - 
C14 Table A3 - - - Table A4 
 
Table A2. Batches of mitochondria analyzed  
Batch 
Cell 
batch 
used 
Wester
n Blot EM 
Packing 
Expt. 
Mössbauer 
Spectroscopy EPR UV-Vis ICP-MS 
M01 C01 Yes - - - Table  2-1 Table 2-1 - 
M02 C02 Yes Yes - - - - Table A4 
M03 C06 Figure  2-1 Yes - Figure A1D - Table 2-1 - 
M04 C08 - - - Figure 2-2A, 2-2B, 2-2C - - - 
M05 C09 - - Yes - Figure 4C Table 2-1 Table A4 
M06 C10 - Figure 2-1 Yes Table 2-1 
Figure 
4A and 
4B 
Figure  
2-5A and 
2-5B 
Table A4 
M07 C11 - - Yes - Table  2-1 Table 2-1 Table A4 
M08 C13 - - - Figure A1C Table  2-1 - - 
M09 C14 - - Table A3 - - - Table A4 
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Table A3. Volumes of pellets of whole cells and isolated mitochondria determined from 
packing experiments and calculated packing efficiencies.   
Sample (Run) Csup1,2 (µM) 
Vsup1,2 
(µL) 
Vint1,2 
(µL) 
Vpellet 1,2 
(µL) 
Packing 
efficiency (%) 
Whole cells      
C14.1 (1) 82 200 43 250 83 
C14.1 (2) 18 200 57 250 77 
C14.2 (1) 91 200 18 250 93 
C14.2 (2) 20 210 59 225 74 
C14.3 (1) 84 200 38 250 85 
C14.3 (2) 19 210 61 250 76 
C14.4 (1) 77 200 59 300 80 
C14.4 (2) 15 200 48 275 83 
Mean packing efficiency of whole cells 81±6 
Mitochondria      
M09.1 (1) 65 151 80 175 55 
M09.1 (2) 10 143 26 100 74 
M09.2 (1) 67 151 73 150 51 
M09.2 (2) 12 140 31 100 69 
M09.3 (1) 76 149 48 150 68 
M09.3 (2) 13 150 31 100 69 
M09.4 (1) 64 149 85 175 51 
M09.4 (2) 10 140 26 100 74 
M09.5 (1) 64 200 112 225 50 
M09.5 (2) 12 195 45 175 74 
M09.6 (1) 82 195 45 200 77 
M09.6 (2) 14 210 43 150 72 
Mean packing efficiency of mitochondria 65±10 
 
Vbuffer1,2 for whole cell samples W, X, Y, and Z = 200 µL  
Vbuffer1,2 for mitochondria samples A, B, C and D = 150 µL 
Vbuffer1,2 for mitochondria samples E and F = 200 µL 
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Table A4. Metal concentrations from each batch 
 [Fe] (µM) [Cu] (µM) [Mn] (µM) [Zn] (µM) 
Whole cell batch     
C06 336 22 6.7 323 
C06 346 25 7.0 353 
C07 341 25 7.4 385 
C07 385 29 7.4 384 
C08 469 30 7.4 574 
C08 509 36 6.8 617 
C11 447 33 7.4 665 
C11 468 29 6.7 555 
C14 325 27 8.6 630 
Average ± SD 402 ±70 28±4 7.2±0.6 498±135 
     
Mitochondria 
batch     
M02 1140 112 17 72 
M05 1160 115 17 57 
M06 1210 129 11 245 
M07 1130 112 11 232 
M09 960 108 16 227 
Average ± SD 1120±95 115±8 14±3 167±94 
 
 
Table A5.  Analytical properties of isolated mitochondria from Jurkat cells. Replicates n 
are given in parentheses. Mössbauer percentages are denoted followed by absolute 
concentrations in µM.  
Name Total Fe [Fecell] (n) 
NHHS 
FeII 
(%,µM) 
Fe/S+LS 
Hemes 
(%,µM) 
Ferritin-
like 
(%,µM) 
HS FeII 
hemes 
(%,µM) 
Nano-
particles 
(%,µM) 
3FU, WT 282 ± 20 (2) 10,28 70,198 20,56 10,28 10,28 
30FU, 
WT 
1060±37 
(2) 2,21 27,286 4,42 2,21 65,689 
3TU, WT 296±50 (1) ---,--- 70,207 20,60 ---,--- 10,30 
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Table A6. Concentrations of reduced hemes a, b, and c in Jurkat cells grown under 
various conditions and isolated mitochondria. Nomenclature is the same as described in 
the Table 3-1 legend. Concentrations are given in µM. 
Growth conditions [heme a] [heme b] [heme c] 
 WHOLE CELLS 
3 FU, WT 8±1 5±2 12±2 
30 FU, WT 7±1 5±2 14±2 
100 FU, WT 4±1 4±1 10±2 
3 FL, WT 5±1 5±1 13±2 
10 FL, WT 8±2 5±2 10±2 
30 FL, WT 4±1 4±1 10±2 
3 TU, WT 5±1 6±2 12±2 
3 TU, TfRC+  6±1 6±2 12±2 
    
 MITOCHONDRIA 
3 FU, WT 32±6 14±4 40±10 
30 FU, WT 34±8 19±5 44±11 
3 TU, WT 27±7 14±4 40±10 
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APPENDIX II 
 
Figure A1. Low field (0.05 T) Mössbauer spectra of other batches. A, 5 K spectrum of 
whole cells, batch C13 (Table S1), with simulation in red (11% NHHS FeII, 28% CD, 
3% HS FeII Hemes, 18% FeIII oxyhydroxide nanoparticles, 40% ferritin).  B, 70 K 
spectrum of the same batch of cells. C, 5 K spectrum of isolated mitochondria, batch 
M08 (Table S2), with simulation in red (7% NHHS FeII, 27% CD, 5% HS FeII Hemes, 
40% FeIII oxyhydroxide nanoparticles, 19% ferritin-like). D, 5 K spectrum of isolated 
mitochondria, batch M03 (Table S2), with simulation in red (9% NHHS FeII, 29% CD, 
5% HS FeII Hemes, 37% FeIII oxyhydroxide nanoparticles, 18% ferritin-like). For all 
spectra, the field was applied parallel to the radiation. 
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        Figure A2. Additional electron micrographs of isolated mitochondria (X 40 000) 
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Figure A3. TEM image of Jurkat cell grown with 30 µM FC?Horizontal lines denote 
ferric nanoparticles.   
 
2 µm 
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Figure A4. Test to distinguish low-loaded ferritin from nanoparticles. Mössbauer 
spectra of cells grown under 30 µM Ferric citrate. A. 5K, 0.05T spectrum. B. 5K, 0.05T 
spectrum of cell lysate after incubation with 6.25 mM 56Ferrous sulfate in air. C. 5K, 
0.05T of control cell lysate incubated in air without addition of ferrous sulfate.   
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Figure A5. X-band EPR spectra of Jurkat cells. A, 3FU; B, 30FU; C, 3TU; D, 3TU 
TfRC+ cells; E. 10FL.  Spectra A-C and E were collected at frequency of 9.473 GHz. 
Spectrum D was collected at frequency of 9.642 GHz and normalized to 9.473 GHz. 
Temperature = 4 K, power = 0.2012 mW, modulation amplitude = 10 G, modulation 
frequency = 100 kHz, conversion time = 164 ms, and sweep time = 336 s. 
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Figure A6. EPR spectra of isolated mitochondria from Jurkat cells. A, 3TU; B, 3FU; C, 
10FU; and D, 30FU. Spectrum A was collected at frequency of 9.642 GHz and 
normalized to 9.473 GHz. Spectra B-D were collected at frequency of 9.473 GHz. 
Temperature = 4 K, power = 0.2012 mW, modulation amplitude = 10 G, modulation 
frequency=100 kHz, conversion time= 164 ms, and sweep time= 336 s. 
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Figure A7. UV-Visible spectra of whole Jurkat cells. A, 3TU; B, 3TU TfRC+ cells; C, 
3FU; D, 10FU; E, 30FU; F, 100FU; G, 3FL; H, 10FL; I, 30FL.  
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Figure A8. UV-Visible spectra of mitochondria isolated from Jurkat cells. A, 3TU; B, 
3FU; C, 10FU; D, 30FU. Mitochondrial samples for UV-Vis were prepared 
anaerobically.  
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Figure A9. Oxyblot analysis of cells grown under different conditions. Samples include 
(with lanes in parentheses) (1) 3TU; (2) 10TU; (3) 30 TU; (4) 3TU TfRC+’; (5) 10TU 
TfRC+; (6) 30TU TfRC+; (7) 3FU; (8) 10FU; (9) 30FU; and (10) 100FU. Percentages of 
band intensities relative to the standard (Lane 1) are designated below each lane.  
Twenty µg of protein was loaded per lane on a 12% polyacrylamide gel, and SDS-PAGE 
was carried out at 100 V. 
 
 
 
 
 
 
 
 
 
  207 
 
 
        1                    2 
Figure A10. Western blot indicating overexpression of TfRC in genetically modified 
Jurkat cells. Lanes: 1. Normal cells, 2. TfRC+ cells. Amount of protein loaded per lane = 
60 µg.  
 
  
 
1      2 
 
Figure A11. Western blot indicating partial knockdown of frataxin protein in genetically 
modified Jurkat cells. Lanes: 1. Normal cells, 2. Frataxin-deficient cells. Amount of 
protein loaded per lane = 50 µg. 
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Figure A12. UV-Vis spectra of A. normal cells, and B. frataxin-deficient cells grown 
with 10 µM FC.  
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Figure A13. Mössbauer spectra (5K, 0.05T) showing the contribution of BPS in Fe-
deficient fermenting cells. A, BPS-F cells; B, [Fe2+(BPS)3]4-; C, overlay of A and B at 
35% intensity. 
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Figure A14. Oxyblot analysis of mitochondria isolated from WT fermenting yeast 
grown with 10 µM and 10,000 µM of Fe in the medium. Each lane contains 20 µg of 
protein.  
 
 
 
 
 
 
  211 
APPENDIX III 
 
NOMENCLATURE
 
 
BPS  Bathophenanthroline Sulfonate 
CD  Central Quadrupole Doublet 
DFO  Desferrioxamine  
DDDI  Double-Distilled and Deionized 
DMT1  Divalent Metal Transporter 1 
δ  Isomer Shift 
ΔEQ  Quadruple Splitting 
DT  Doubling Time  
ECAR  Extracellular Acidification Rate 
EDTA   Ethylenediaminetetraacetic Acid  
EDX  Energy Dispersive X-ray  
EM   Electron Microscopy  
EPR   Electron Paramagnetic Resonance  
FC   Ferric Citrate  
Fecell   Overall Cellular Fe  
Fec   Cytosolic Fe 
Fef   Ferritin-bound Fe 
Fem   Mitochondrial Fe, except for Fe found as nanoparticles  
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Femp   Nanoparticles found in mitochondria 
Fen   Cytosolic Nanoparticles Fe 
Fes   Sensed Fe 
HAADF High-Angle-Annular-Dark-Field  
HS  High Spin  
ICP-MS Inductively Coupled Plasma Mass Spectrometry 
IRP1, IRP2  Iron Responsive Element binding proteins 1 and 2  
LIP  Labile Iron Pool 
LS  Low-Spin  
MB   Mössbauer  
NHHS  Non-Heme High Spin  
NTBI   Non-Transferrin-Bound Iron  
OCR  Oxygen Consumption Rate  
ODE  Ordinary Differential Equation  
PBS  Phosphate-Buffered Saline 
RCI-RCIV Mitochondrial Respiratory Complexes I-IV 
Reg-  Surrogate for regulation in which increasing Fes inhibits  
Reg+   Surrogate for regulation in which decreasing Fes stimulates 
ROS   Reactive Oxygen Species  
STEM  Scanning Tunneling Electron Microscopy 
TBI  Transferrin-Bound Iron  
TfRC1  Transferrin Receptor 1 
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TfRC+  Cells genetically modified to overexpress TfRC1 
TMG  Trace Metal Grade 
UTR   Untranslated Region  
UV-vis  Electronic Absorption Spectroscopy 
 
